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1) ABSTRACT 
During my thesis work, I have been interested in extending our understanding of the 
pathogenicity of the notorious human pathogen Streptococcus pyogenes, also called 
group A streptococcus (GAS). This thesis manuscript is divided into four parts: 1) role of 
superantigen-encoding lysogenic bacteriophages in the acquisition and spread of 
virulence genes among streptococci, 2) the identification of small RNAs with potential 
regulatory functions in GAS, 3) the role of the interspecies communication system 
luxS/AI-2 in GAS metabolism and survival under stress conditions and 4) the role of 
streptolysins in the innate immune responses of macrophages upon GAS infection.  
 
1) Since the late 1980s, there has been a significant reemergence of severe forms of 
human diseases caused by GAS. One hypothesis to explain this phenomenon has focused 
on an enhanced virulence of the pathogen itself. In GAS, prophages encode one or more 
putative or established virulence factors including superantigens. The first part of my 
thesis describes the identification of an inducible prophage Φ149 encoding superantigen 
SSA in an M12 GAS clinical isolate. By lysogenic conversion the phage was transferable 
ex-vivo among GAS clinical isolates of various M serotypes (M1, M3, M5, M12, M19, 
M28 and M94) as well as of Group C Streptococcus equisimilis (GCSE). Our data 
indicate that horizontal transfer of lysogenic phage among GAS can occur across the M-
type barrier and provide further support for the concept of interspecies lysogenic toxin-
conversion. Therefore, lysogenic conversion would allow GAS to more efficiently adapt 
to the changing host conditions, thus potentially leading to fitter and more virulent 
clones. 
 
2) Recent studies show that in bacteria small RNAs (sRNAs) play a significant role in the 
regulation of gene expression. However, information regarding sRNAs in S. pyogenes is 
rather limited. Thus, in the second part of my thesis, our aim was to identify novel 
sRNAs in S. pyogenes. For this purpose, we used an in silico approach focusing on the 
intergenic regions of the GAS M1 serotype genome. From 178 identified putative loci, 90 
were further selected for analysis and 29 (32%) of these sRNAs showed expression under 
normal growth conditions. Expression of the candidates was verified in M1, M3, M5 and 
M49 serotypes, their 5’ and 3’ ends were mapped, their stability was determined and their 
in silico secondary structures were predicted. We found 5 riboswitches, 6 leader 
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elements, 4 functional RNAs, 8 T-boxes and 5 novel sRNAs. Two of the sRNA 
candidates residing in the 5’ UTR of the riboflavin and tryptophan transporter genes 
seemed to control the transporter genes via transcriptional or translational attenuation 
mechanisms. This shows the importance of sRNAs in the control of the uptake of 
essential metabolites by regulating gene expression in bacteria. In addition, one sRNA 
SpyRNA049 identified in the intergenic region, was further analyzed for its potential role 
in GAS pathogenicity.  
 
3) Previous studies showed that the interspecies luxS/AI-2 cell-cell communication 
system plays a role in metabolism and pathogenicity. In the third part of my thesis we 
aimed at understanding the role of the luxS/AI-2 system in S. pyogenes serotypes M1 and 
M19. Our results indicated a limited role of luxS/AI-2 in the activated methyl cycle 
metabolism. Survival assays with luxS mutants as well as luxS expression and AI-2 like 
activity assays under low acidic conditions demonstrated the involvement of luxS/AI-2 
system in the adaptation of GAS to stress. Interaction analysis with host cells showed that 
the luxS mutants survived in epithelial cells and macrophages to a higher degree 
compared to the wild-type. Overall, our data show that the luxS/AI-2 system is not only 
involved in the regulation of virulence factor expression but also provides bacteria an 
advantage to survive in challenging host environments.  
 
4) Bacteria are generally recognized by host immune cells by the pattern recognition 
receptors like toll-like receptors (TLRs). However, little is known about the recognition 
of GAS by macrophages.  Data described in the fourth part of my thesis suggest that S. 
pyogenes is recognized by macrophages independently of the most commonly TLRs used 
to recognize gram-positive pathogens, TLR2, TLR4 and TLR9 and their combination. 
However, the signaling events observed in macrophages upon GAS infection were still 
dependent on the TLR-adaptor MyD88. Surprisingly, IFN production was independent of 
the GAS cytolysins, SLS and SLO, often required in other gram-positive bacteria. 
Overall our data indicate that GAS is recognized by a MyD88-dependent receptor other 
than those commonly used to detect bacteria and reveal a new type of bacterial 
recognition for the production of type I IFN.  
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1b) ZUSAMMENFASSUNG 
Während meiner Dissertation lag mein Interesse in der Erweiterung des Verständnisses 
der Pathogenität des bekannten humanen Pathogens Streptococcus pyogenes, auch 
bekannt als Gruppe A Streptococcus (GAS). Dieses Manuskript ist in vier Teile 
unterteilt: 1) die Rolle von Superantigen-codierenden lysogenen Bakteriophagen in 
Erwerb und Verbreitung von Virulenzgenen in Streptococci, 2) der Identifikation von 
small RNAs mit potentiellen regulatorischen Funktionen in GAS, 3) der Rolle des 
interspezifischen Kommunikationssystems luxS/AI-2 in GAS Metabolismus und 
Überleben unter Stresskonditionen und 4) der Rolle von Streptolysinen in der 
angeborenen Immunantwort von Makrophagen auf GAS Infektion. 
 
1) Seit den späten 1980er Jahren, war ein signifikanter Anstieg von schweren Formen 
durch GAS verursachter Krankheiten im Menschen zu beobachten. Eine Hypothese um 
dieses Phänomen zu erklären, beruht auf einer gesteigerten Virulenz des Pathogens 
selbst. In GAS codieren Prophagen für einen oder mehr putative oder bekannte 
Virulenzfaktoren, einschließlich Superantigenen. Im ersten Teil meiner Dissertation wird 
die Identifikation des induzierbaren Prophagen Φ149, welcher für das Superantigen SSA 
in einem klinischen Isolat von GAS des Serotyps M12 codiert, beschrieben. Durch 
lysogene Konversion war der Phage zwischen klinischen Isolaten von verschiedenen 
GAS M-Serotypen (M1, M3, M5, M12, M19, M28 und M94), als auch in Gruppe C 
Streptococcus equisimilis (GCSE), ex-vivo transferierbar. Unsere Ergebnisse zeigen, dass 
horizontaler Transfer von lysogenen Phagen zwischen GAS durch die M-Typ-Barriere 
möglich ist und unterstützen das Konzept der interspezifischen lysogenen Toxin-
Konversion. Somit würde lysogene Konversion es GAS ermöglichen, sich effizienter an 
die wechselnden Bedingungen im Wirt anzupassen, was wiederum zu potentiell 
konkurrenzfähigeren, virulenteren Klonen führen würde. 
 
2) Kürzlich erschienene Studien zeigen, dass small RNAs (sRNAs) in Bakterien eine 
signifikante Rolle in der Regulation der Genexpression spielen. Jedoch sind 
Informationen über die Rolle von sRNAs in S. pyogenes relativ begrenzt. Aus diesem 
Grund war unser Ziel im zweiten Abschnitt meiner Arbeit die Identifikation neuer sRNAs 
in S. pyogenes. Zu diesem Zweck wurde ein in silico Verfahren angewandt, fokussierend 
auf die intergenen Regionen des Genoms von M1-Serotyp GAS. Von 178 identifizierten 
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putativen Loci wurden 90 zur weiteren Analyse ausgewählt, wobei 29 (32%) dieser 
sRNAs unter normalen Wachstumsbedingungen exprimiert werden. Die Expression der 
Kandidaten wurde verifiziert in den Serotypen M1, M3, M5 und M49, ihre 5’ und 3’ 
Enden wurden determiniert, ihre Stabilität bestimmt und ihre in silico Sekundärstruktur 
wurde vorhergesagt. Gefunden wurden 5 Riboswitches, 6 leader elements, 4 funktionelle 
RNAs, 8 T-Boxen und 5 neue sRNAs. Zwei dieser sRNA Kandidaten befinden sich in 
der 5’ UTR von Riboflavin- und Tryptophan- Transportergenen und scheinen diese Gene 
durch trankriptionelle oder translationelle Attenuierungsmechansimen zu kontrollieren. 
Das zeigt die Wichtigkeit von sRNAs in der Kontrolle der Aufnahme essentieller 
Metaboliten in Bakterien durch regulatorische Genexpression. Zusätzlich wurde eine in 
der intergenen Region identifizierte sRNA SpyRNA049 auf ihre potentielle Rolle in 
GAS-Pathogenität weiter analysiert. 
 
3) Frühere Studien zeigten, dass das interspezifische Zell-Zell-Kommunikationssystem 
luxS/AI-2 eine Rolle in Metabolismus und Pathogenität spielt. Im dritten Abschnitt 
meiner Dissertation war das Ziel, die Rolle des luxS/AI-2 Systems in den S. pyogenes 
Serotypen M1 und M19 zu verstehen. Unsere Ergebnisse lassen auf eine limitierte Rolle 
von luxS/AI-2 im S-Adenosylmethioninzyklus schließen. Überlebensassays mit luxS-
Mutanten sowie luxS-Expression und AI-2-ähnliche Aktivitätsassays im leicht sauren 
Milieu demonstrierten die Beteiligung des luxS/AI-2 Systems in der Stressadaptation von 
GAS. Interaktionsanalyse mit Wirtszellen zeigte, dass die luxS-Mutanten im Vergleich 
zum Wildtyp in höherem Ausmaß in Epithelzellen und Makrophagen überlebten. Alles in 
allem zeigen unsere Daten, dass das luxS/AI-2 System nicht nur in die Regulation der 
Virulenzfaktorexpression involviert ist, sondern auch für Bakterien einen Vorteil 
darstellt, in herausfordernden Wirtsumgebungen zu überleben. 
 
4) Im Allgemeinen werden Bakterien von den Immunzellen des Wirts durch pattern 
recognition receptors, wie Toll-like receptors (TLRs), erkannt. Über die Erkennung von 
GAS durch Makrophagen ist jedoch wenig bekannt. Die Ergebnisse, die im vierten Teil 
meiner Dissertation beschrieben werden, lassen darauf schließen, dass  Makrophagen S. 
pyogenes unabhängig von den TLRs die typisch für gram-positive Pathogene sind (TLR2, 
TLR4 und TLR9 sowie ihre Kombinationen), erkennen. Jedoch waren die in 
Makrophagen beobachteten Signalereignisse auf GAS-Infektion immer noch abhängig 
vom TLR-Adaptor MyD88. Überraschenderweise war die IFN-Produktion unabhängig 
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von den GAS-Cytolysinen SLS und SLO, die oft von anderen gram-positiven Bakterien 
benötigt werden. Alles in allem lassen unsere Ergebnisse darauf schließen, dass GAS 
durch einen MyD88-abhängigen Rezeptor, anders als die üblicherweise verwendeten, 
erkannt wird und lassen einen neuen Typ der bakteriellen Erkennung für die Produktion 
von TypI IFN erkennen.  
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2) INTRODUCTION 
 
2.1 Streptococcus pyogenes (Group A Streptococcus) 
 
Group A streptococcus (GAS) or Streptococcus pyogenes is a fermentative, facultative 
anaerobe, nonmotile, nonspore-forming gram-positive coccus, which occurs in chains or 
pairs, having a diameter of 0.5-1.0 μm. GAS are beta haemolytic streptococci. They 
require an enriched medium containing blood to grow. They belong to the lactic acid 
branch of species with low G+C content (Canchaya et al., 2003). The complete genome 
sequence of 12 GAS clinical isolates have been sequenced so far and the GAS genome 
size is ~1.8 to 1.9 Mb (Musser & DeLeo, 2005). 
 
2.2 Classification of Streptococci 
 
Streptococci are classified on the basis of their cell wall polysaccharides into different 
groups: groups A, B, C, G and F when they have N-acetylglucosamine linked to 
rhamnose polymer backbone and group D on lipoteichoic acids (LTA) presence (Fig 1 A, 
B). S. equi (subspecies equi and zooepidemicus), S. dysgalactiae (subspecies dysgalactiae 
and equisimilis), S. anginosus and S. constellatus belong to beta-hemolytic GCS, while S. 
dysgalactiae, S. canis, S. uberis, S. intestinalis, and S. anginosus belong to beta-hemolytic 
GGS. Some of these bacteria cause various infections mostly in domestic animals and 
sometimes in humans. Group C and G have been considered as non pathogenic flora of 
throat, gut and vagina for a long time. Recently, some studies reported cases of 
streptococcal toxic shock syndrome (STSS) associated with GCS and GGS (Hashikawa 
et al., 2004). 
GAS is further subdivided into different serotypes based on highly variable N terminal 
sequences of the cell surface M protein as described by Dr. Rebecca Lancefield. 
Currently, there are over 190 types of M-protein genes (emm) identified in GAS 
(Maripuu et al., 2008). 
. 
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Figure 1 A. Classification of eucaryota, archaea and bacteria 
(http://www.newjerseymoldinspection.com/images/PhylogeneticTree.jpg) 
 
Figure 1 B. Phylogenetic tree of 49 species in the firmicutes (Kochiwa et al., 2007) 
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2.3 Pathogenesis of S. pyogenes 
 
S. pyogenes is an obligate human pathogen. It is a cause of major human morbidity and 
mortality worldwide. Streptococcal infections have been documented in all races, sexes 
and age groups. GAS causes 18 million cases of severe diseases resulting in 517,000 
deaths each year (Cho & Caparon, 2008). GAS is responsible for a number of diseases 
ranging from common clinical illnesses such as pharyngitis, impetigo (Figure 2a), 
cellulitis (Figure 2b) and scarlet fever to severe invasive infections such as puerperal 
sepsis, myositis, necrotizing fasciitis (NF) (Figure 2c) and streptococcal toxic shock 
syndrome (STSS) and post infectious sequelae such as rheumatic fever and acute 
glomerulonephritis (Table 1). NF and STSS are rare but potentially fatal human diseases. 
NF also called as flesh eating disease is a disease of deeper skin layers and tissues and 
STSS is caused by bacterial toxin which is responsible for pyrogenicity, hypotension, 
shock, multi-organ failure and ultimately death.  
 
 
Figure 2. GAS diseases: (a) Impetigo (b) Cellulitis (c) Necrotizing fasciitis. 
(a:http://pathmicro.med.sc.edu/fox/staph-impetigo.jpg, b:http://www.latrobe.edu.au/podiatry/vascular/vascp 
ics/footcellulitisbig.jpg,  c: http://www.bestsyndication.net/images_com/ 2008/02_ february/22/20080222_ 
hospital_diseases.jpg) 
 
 
 
 
 
Impetigo Necrotizing fascilitisCellulitis
a b c
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Table 1. Diseases caused by GAS (adapted from Maria Siller thesis) 
GAS diseases 
Superficial skin and soft- tissue infections 
Cellulitis 
Tonsillitis 
Pharyngitis 
Erysipelas 
Impetigo 
Scarlet fever 
Invasive Group A streptococcal diseases 
Streptococcal toxic shock syndrome (STSS) 
Necrotizing fasciitis (NF) 
Bacteremia 
Osteomyelitis 
Septic arthritis 
Pneumonia 
Complications of GAS illness - nonsuppurative 
Acute Rheumatic fever 
Poststreptococcal glomerulonephritis 
Complications of GAS illness - suppurative 
Cervical lymphadenitis 
Endocarditis 
Fasciitis/myositis syndrome 
Mastoiditis 
Meningitis 
Otitis media 
 
 
Since the late 1980s, there has been a significant reemergence of severe forms of diseases 
(particularly necrotizing fasciitis and STSS) caused by GAS worldwide (Banks et al., 
2002; Cunningham, 2000). These outbreaks were associated with new serotypes, 
especially M1, M3 and M18 (Cleary et al., 1992; Howe et al., 1996; Stevens et al., 1989; 
Stevens, 1992; Stevens, 2000). One hypothesis to explain this phenomenon has focused 
on host responses to GAS infections (Howe et al., 1996; Kotb et al., 2002); while others 
focused on changes in the virulence of the pathogen by acquisition of new virulence 
factors especially superantigens (Aziz et al., 2004; Aziz et al., 2005; Howe et al., 1996). 
S. pyogenes was considered as an extra-cellular organism, but studies have shown 
bacterial recovery from inside host cells (Medina et al., 2003), indicating that S. pyogenes 
can survive intra-cellularly (Medina et al., 2003). In general, host defense system to 
bacterial infection involves many mechanisms allowing destroying the incoming 
pathogen like neutrophil recruitment, opsonization, bacterial entrapment and uptake, 
intracellular effectors mediated bacterial killing but bacteria use their virulence factors to 
interfere and impair each of these mechanisms. In the case of GAS, factors which avoid 
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entrapment by phagocytes include peptidase ScpA, serine protease ScpC, DNAses. 
Capsule, M and M-like proteins and Sfb1, SIC (Streptococcal inhibitor of complement), 
SpeB (cysteine protease) inhibit complement and antibody functions. GAS also impairs 
phagocytic mechanisms with the help of the factors EndoS, Mac (1 and 2) and protein 
SIC. Cytolysins which promote phagocytic lysis and apoptosis are also used by GAS. 
Finally, GAS resist effectors of phagocytic killing by D-alanylation of LTA, SpeB, SIC, 
M protein and GpoA (glutathione peroxidase) (Figure 3) (Kwinn & Nizet, 2007). 
 
Figure 3. GAS interference with host phagocytic defenses. A (Kwinn & Nizet, 2007), B 
(http://www.biken.osaka-u.ac.jp/act/act_yoshimori_e.php) 
 
2.4 Virulence factors produced by S. pyogenes 
 
GAS survival and pathogenesis is mediated by several virulence factors involved in 
adhesion, colonization, evasion, persistence and spread in the host (Table 2). GAS 
virulence factors can be divided into two groups. 
 
 
 
 
 
 
 
A B
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Table 2. Virulence factors in S. pyogenes (adapted from (Bisno et al., 2003; Commons et al., 2008) 
GAS virulence factors 
Antiphagocytic 
Streptococcal inhibitor of complement (Sic) 
Cysteine proteinase (SpeB) 
Immunoglobulin G degrading enzyme (IdeS) 
Immunogenic secreted protein (Isp) 
M protein 
M-like protein (Mrp, Enn and others) 
Hyaluronic acid capsule 
C5a peptidase (ScpA) 
Adherence to epithelial cells 
Lipoteichoic acid (LTA) 
Fibronectin binding proteins 
M protein 
Hyaluronic acid capsule 
Lamin-binding protein (Lmb) 
Streptococcal collagen-like surface protein A (SclA) 
Streptococcal collagen-like surface protein B (SclB) 
Internalisation 
M protein 
Protein F1 
Inavsion 
Hyaluronic acid capsule 
M protein 
Spread through tissues 
Hyaluronidase 
Streptokinase 
SpeB (cysteine protease) 
DNAses A-D 
Systemic toxicity 
Streptolysin O 
Streptolysin S 
Superantigenic exotoxins 
Superantigens 
SpeA 
SpeC 
SpeG 
SpeH 
SpeI 
SpeJ 
SpeK 
SpeL 
SpeM 
SSA 
SmeZ 
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2.4.1 Somatic virulence factors 
 
Somatic or surface-exposed virulence factors include M protein, capsule and adhesions. 
 
M protein 
The M-protein consists of two polypeptides arranged in a coiled-coil structure that is held 
in the cell membrane (Figure 4). The C-terminal domain is highly conserved, anchored in 
the cell membrane via the LPSTGE motif, while the surface-exposed N-terminal portion 
is highly variable and is responsible for serotype specificity. M protein is a major surface 
antigen and virulence factor, which is encoded by the emm gene. M proteins are involved 
in various stages of GAS pathogenesis including adhesion, internalization, immune 
evasion and tissue invasion. It confers resistance to phagocytosis and killing by 
polymorphonuclear leukocytes by binding to complement control factors and other host 
proteins to prevent activation of the alternate complement pathway (Bisno et al., 2003).  
 
Figure 4. Structure of M protein (Efstratiou, 2000) 
 
Capsule 
Capsule is made up of hyaluronic acid (Figure 5) and encoded by an operon composed of 
hasA, hasB and hasC genes.  The capsule has a role in colonization, phagocytic killing 
and infection, thus encapsulated strains are more pathogenic (Mitchell, 2003; Wessels & 
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Bronze, 1994). Degree of encapsulation varies among GAS strains. By means of the 
capsule, bacteria attach to the receptors of host cells. Such binding induces cytoskeleton 
changes, which help in cellular invasion. 
 
 
Figure 5. Cell wall structure of S. pyogenes  (http://gsbs.utmb.edu/microbook/ch013.htm) 
 
Adhesins 
Apart from the M protein and capsule, streptococci have at least 17 other adhesion 
candidates that promote adhesion to host cells. LTA is anchored to the proteins on the 
bacterial surface. S. pyogenes encodes several fibronectin binding proteins (FBPs), which 
are important for the adhesion to different cell types. Protein F, the fibronectin-binding 
protein, also mediates streptococcal adherence to the amino terminus of fibronectin on 
mucosal surfaces. FBPs can help GAS in the internalization of human respiratory 
epithelial cells. This event may protect streptococci from the host immune responses and 
antibiotics (Bisno et al., 2003; Cue et al., 1998; LaPenta et al., 1994; Molinari et al., 
1997; Osterlund & Engstrand, 1997). The host receptors, which are involved in the 
adhesion of GAS include fibronectin, vitronectin, fibrinogen, laminin, CD44, CD46 and 
galactose and fructose containing glycoproteins (Musser & DeLeo, 2005). 
. 
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2.4.2 Extracellular virulence factors 
 
Extracellular virulence factors include Streptococcal hemolysins (SLO, SLS) and 
Streptococcal pyrogenic exotoxins (Spes). GAS secretes two main types of hemolysins: 
Streptolysin S (SLS) and Streptolysin O (SLO).  
 
Streptolysin S 
SLS is a non-immunogenic, oligopeptide, oxygen-stable, thermolabile cytolysin, 
responsible for the β-hemolysis on blood agar medium. It is produced when cells are in 
stationary phase of growth (Sierig et al., 2003). SLS is one of the most potent cytotoxins 
known. It has a broad spectrum cytolytic activity on the membranes of erythrocytes, 
leukocytes, platelets and sub-cellular organelles such as lysosomes and mitochondria 
(Bisno et al., 2003; Nizet, 2002). The genetic locus identified for production of SLS is 
the sag operon, which includes nine genes sagA-sagI. SLS is effective in forming 
transmembrane pores and causing lysis when GAS is in contact with target cells. SLS 
also promotes resistance to phagocytic killing by exerting cytocidal activity on 
neutrophils (Kwinn & Nizet, 2007).  
 
Streptolysin O 
SLO is an immunogenic, oxygen-labile, 540 amino acid secreted cytolysin that binds to 
cholesterol in eukaryotic cell membranes, where it oligomerizes to produce large 
transmembrane pores leading to cell lysis. When grown in culture it is produced during 
exponential to early stationary phase growth (Sierig et al., 2003). SLO can lyse a number 
of eukaryotic cell types including erythrocytes, leukocytes, PMNs, macrophages, 
platelets and various cell culture lines (Palmer et al., 1998). Thus SLO can impair host 
phagocytic capacity. In an epithelial cell model SLO allows bacteria to avoid lysosomal 
localization (Kwinn & Nizet, 2007). SLO also translocates NAD-glycohydrolase (SPN) 
into the cytoplasm of host leading to increase in cytotoxicity in a process called 
cytolysin-mediated translocation (CMT) (Meehl & Caparon, 2004) and depletes the host 
cell energy stores.  
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Streptococcus pyrogenic exotoxins/Superantigens 
 
GAS strains express 11 distinct but structurally related streptococcal pyrogenic exotoxins 
(SPEs) including 8, which are encoded on prophages: SpeA1-4, SpeC, SpeH, SpeI, SpeK, 
SpeL, SpeM, streptococcal superantigen SSA and 3, which are encoded on the 
chromosome: SpeG, SpeJ and the streptococcal mitogenic exoprotein smeZ (Banks et al., 
2003; Beres et al., 2002; Commons et al., 2008; Ekelund et al., 2005; Petersson et al., 
2004; Sriskandan et al., 2000; Sriskandan et al., 2007). 
 These SPEs also known as superantigens (SAgs), are roughly 25 kDa secreted proteins 
that are thought to contribute to the pathogenesis of some GAS diseases, including scarlet 
fever, streptococcal toxic shock syndrome (STSS) and rheumatic fever. SAgs have the 
unique ability to cross-link class II major histocompatibility complexes (MHC) on 
antigen-presenting cells (APCs) to specific variable β-chains of T-cell receptors 
(TCRVβ) resulting in activation of up to 20% of T cells (Figure 6). Normally peptide 
antigen activates 0.001% of all T cells. This unspecific massive T-cell proliferation 
causes release of large amounts of the cytokines, such as interleukin-2 (IL-2), tumour 
necrosis factor-α (TNF-α) and interferon-γ from the T cells and IL-1 and TNF-α from the 
APCs. SAgs cause induction of T-cell proliferation in femtomolar concentrations, hence 
are the most powerful T cell mitogens known. In addition to cytokine production and T-
cell proliferation, SAgs are capable of inducing cytotoxicity towards target cells. These 
exotoxins also induce pyrogenicity, cause capillary leakage, activation of complement, 
coagulation and fibrinolytic cascades, leading to hypotension through cytokine release 
and this leading to shock, multi-organ failure and death. Apart from SAgs, proven and 
potential virulence factors such as hyaluronidase (hyl), mitogenic factor (mf) and 
phospholipase A2 (sla) are encoded on prophages.   
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Figure 6. Cross-linkage of superantigens with APC and T cells (Sriskandan et al., 2007)  
 
SSA 
The streptococcal superantigen SSA is widely distributed among S. pyogenes, found in 
12.5% of 80 distinct clonal lineages (Igwe et al., 2003). It is a 260 amino-acid protein 
that can play a role in symptoms similar to STSS. The amino terminus of SSA displays 
striking homology to the staphylococcal enterotoxins B, C1, and C3 (SEB, SEC1 and 
SEC3) rather than to the characterized streptococcal SAgs. In addition to confirmation of 
SSA mediated activation of T cells, T cell proliferation studies could confirm differences 
in the stimulation pattern between native and recombinant SSA or even between SSA 
alleles. 
Three ssa alleles were found in natural population of S. pyogenes. ssa-1 differs from ssa-
3 by a single synonymous substitution in codon 94. ssa-2 was present in a single lineage. 
It is identical to ssa-3 at codon 94 but has a non synonymous substitution at codon 28 
(Reda et al., 1996). Studies of allelic variations at the ssa locus, revealed sequence 
variations upstream of ssa in different clonal lineages. All six isolates had a 34 bp insert 
located at 103 bp 5' end of the ssa start codon. This element IS1239, had 30% sequence 
similarity to insertion sequences and transposases from several other bacterial species. 
The presence of one copy immediately upstream of ssa suggests that the ssa gene may be 
horizontally transferred by a composite transposon in normal bacterial populations 
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(Kapur et al., 1994). This hypothesis is further supported by the identification of ssa-3 
allele from group C and G streptococci, isolated from patients with invasive streptococcal 
infections.  
 
2.4.3 Regulation of virulence factor expression in S. pyogenes 
 
To establish a successful infection, bacterial pathogens must precisely control the 
expression of their virulence genes in response to host signals. These signals inform the 
bacterium that it has reached the proper niche to begin its virulence program. Virulence 
gene expression in pathogenic bacteria is controlled mainly at the transcriptional level by 
activation or repression by proteins. Bacteria can also regulate their gene expression via 
regulatory RNA molecules and in response to their cell density. As in other bacteria, 
virulence factor expression in GAS is coordinately regulated. Regulation occurs via 
“stand-alone” response regulators (RRs) and two-component signal transduction systems 
(TCSs) (Figure 7). The complete genome sequences of 12 GAS strains corresponding to 
nine serotypes contain 13 TCS and about 30 stand alone transcriptional regulators (Table 
3) (Kreikemeyer et al., 2007). 
 
Figure 7. Regulation of virulence factor expression in GAS 
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Table 3. Regulators in GAS (adapted from Maria Siller thesis) 
Stand-alone regulators 
Regulator Targets References 
CodY UR: pel/sagA, nga-slo, mga, grab, scl, prtS, scpA, speH, ideS, hasA  
DR: covRS, ropB, opp, ska, sda 
Malke et al., 2006; Malke and 
Feretti, 2007 
LacD.1 UR: manL, slo, sagH, ntpK 
DR: speB, salA, scrA 
Loughman and Caparon, 2006 
MalR 
 
DR: transcripts of polysaccharide utilization proteins. 
MalR contributes to the persistence of GAS in the oropharynx. 
Shelburne et al., 2007 
 
Mga UR: arp, emm, enn, scpA, fcrA, nra, mga, ska, speB, scnA/salA, opp, fbA, 
sic, lbp, scl1/scl-A, sof, mrp 
DR: genes for sugar utilization 
Deutscher et al., 2005; Hondrop 
and McIver, 2007; McIver et al., 
1999; Kreikemeyer et al., 2003  
MsmR UR: prtF2, cpa, nra, spy0128, nga, spy0166, slo, spy0170, spy2006, sof,  
sfbx, hasA 
Nakata et al., 2005 
MtsR UR: htsA 
DR: sia operon, mtsA 
The mtsR mutant is hypersensitive to streptonigrin and hydrogen peroxide. 
Bates et al., 2005; Hanks et al., 
2006 
RALP3 
 
DR: hasA, spn, sdal, lsap, speB, mga, slo, covR, sic, sagA, grab, emm, eno 
(at logarithmic growth phase), ska, scpC 
UR: scpA, cpa, eno (at stationary growth phase), sic 
RALP3 contributes to epithelial cell inavasion and bloodstream survival. 
Counteracts Nra and MsmR regulation. 
Kreikemeyer et al., 2007 
 
RALP4 
(RivR) 
 
UR: mga, emm, scpA, fba, sic, scl, grm (Mga regulated genes), speB, 
spy1508/NT01sp1245, M5005_spy0190/NT01sp0244 and NT01sp1815 
(hypot. proteins); required for virulence in covR deleted mutant. 
Roberts and Scott, 2007 
 
Nra 
 
DR: cpa, mga, nra, prtF2, operon orf5-nifR3L-kinL, operon cpa-lepAL-
egfflSL-orf2, sof/sfbII, sagA, speA, speB, ralp3 
Kreikemeyer et al., 2003; 
Kreikemeyer et al., 2007; Molinari 
et al., 2001; Podbielski et al., 1999 
RofA 
 
UR: prtF, rofA, rpsL, hasB, emm2 
DR: emm6, mga, sagA, speA, speB, ska 
 
Beckert et al., 2001; Fogg and 
Caparon, 1997; Kreikemeyer et al., 
2003 
Rgg/RopB 
 
UR: speB, autolysin, clpB, lysozyme, covR, covS, fasBCA, isp1, isp2, ihk, irr 
DR: mf, DNA entry nuclease (orf226), orf953, emm, grab, hasAB, orfX, 
sagA, scl1, scpA, ska, slo, speH, mac, mga, cpsX, yufM, lytR, spy0875, 
ClpE, ClpL 
Chaussee et al., 2002; Chaussee 
et al., 2004; Neely et al., 2003  
PerR 
 
UR: csp, sod, czcD 
DR: mtsA, mrgA, pmtA, phtY, phtD, lsp, lrpsN2 
Brenot et al., 2005; Brenot et al., 
2007 
P-Ser-HPr UR: mga Deutscher et al., 2005 
Srv 
 
UR: sir, spy0044 (zinc containing dehydrogenase), spy0285 (ATP binding 
protein), spy0714 (zinc binding protein), spy2007, sic, speB 
Reid et al., 2004; Reid et al., 2006 
Two-component systems 
Regulator Targets References 
CovRS 
 
UR: spy0138, spy1062, spy1680, spy1755, spy533 
DR: covR, grab, has-operon, dppA, ideS, ihk/irr, isp2, lmb, mac, mspA, 
ralp3, ralp4, sagA, sda, ska, speB, speF, speMF 
 
Federle et al., 1999; Gao et al., 
2005; Gusa and Scott, 2005; Heath 
et al., 1999; Levin and Wessels, 
1998; Roberts et al., 2007 
fasBCAX 
 
UR: ska, SLS activity 
DR: fbp45, mrp, sagA 
Kreikemeyer et al., 2001 
 
Ihk/Irr 
 
UR: cytokine genes, fbp, gidB, mf/mf3, mryY, sagA, spy0510, spy1035, 
spy1093, spy1205, spy1311 
Voyich et al., 2003; Voyich et al., 
2004 
SilA/B 
 
UR: silE/D/CR, spyM3-1016 (transposase), bacteriocin like peptide (blp) 
DR: silC 
Eran et al., 2007; Hildalgo-Grass et 
al., 2002 
SptRS 
 
UR: carbyhydrate metabolism enzymes, emm, hasA, perR, rofA, sagA, sic, 
spd,  
speB, spy0470 
Shelburne et al., 2005 
 
VicRK 
 
UR: putative cell wall hydrolase gene pcsB, putative phosphotransferase 
system enzyme II for carbohydrate transport. 
DR: spy0183, spy0184 (osmoprotectant transporter OpuA) VicRK regulates 
processes involved in cell wall metabolism, nutrient uptake 
and osmotic protection. 
Liu et al., 2006 
 
TrxSR UR: emm1, sic, fba, scpA, sclA, grm  (Mga regulated genes), mga 
DR: rbfA, nusA, aroB, secA, dnaJ, miaA, nagB, rplT, polA, lacE, flaR, aroD, 
phnA, clpL, opuAA, opuABc 
 
 
 
Leday et al., 2008 
 24
Regulatory RNAs 
Regulator Targets References 
fasX 
 
UR: ska, SLS activity 
DR: fbp45, mrp, sagA 
Kreikemeyer et al., 2001 
 
pel UR: emm, nga, sic, SpeB activity Mangold et al., 2004 
RivX 
 
UR: mga, emm, scpA, fba, sic, scl, grm (Mga regulated genes), speB, 
spy1508/NT01sp1245, M5005_spy0190/NT01sp0244 and NT01sp1815 
(hypot. proteins); required for virulence in covR deleted mutant. 
Roberts and Scott, 2007 
 
UR: up-regulation 
DR: down-regulation 
 
2.4.3.1 Two component systems and response regulators 
 
TCSs consist of a sensor histidine kinase, a transmembrane protein, which senses an 
external signal with its extra cellular domain, and a response regulator located in the 
cytoplasm, which after activation acts as a transcription factor, to control target gene 
expression. GAS has 13 common TCSs, however only some of them have been well 
studied, like CsrRS/ CovRS, FasBCAX, Ihk/ Irr, SilA/B, VicRK and SptRS. 
 
CsrRS/ CovRS 
CsrRS/ CovRS is the best described TCS in GAS. CovR controls the expression of ~15% 
of GAS genome transcripts (Graham et al., 2002). Cov stands for control of virulence and 
Csr for capsule synthesis regulator. It encodes two proteins similar to response regulator 
and sensor components. These proteins repress the expression of the has operon 
(capsule). Apart from this CsrR repress transcription of the genes encoding streptokinase 
(ska), streptolysin S (sagA), mitogenic factor (speMF), streptodornase (Sda), cysteine 
protease (SpeB) and CsrR itself (Figure 8) (Darmstadt et al., 2000; Federle et al., 1999; 
Heath et al., 1999). The system is triggered by Mg2+, which is low in extra-cellular body 
fluids but high inside host cells or outside the human body. The CovRS system 
inactivates many invasion related GAS virulence genes outside the human body (and 
inside a host cell), but activates virulence factors at Mg2+ concentrations encountered in 
human mucosal secretion and extra-cellular fluids. If CovS is mutated, completely 
abolishing any activity of this system, GAS becomes significantly more invasive (Bernish 
& van de Rijn, 1999; Darmstadt et al., 2000; Graham et al., 2002; Gryllos et al., 2003; 
Levin & Wessels, 1998; Sumby et al., 2006; Wessels, 1999). A phenotypic switch from 
mucosal to invasive forms of GAS infection was correlated with mutations in the covR/S 
locus (Sumby et al., 2006). 
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Figure 8. CovRS regulation (Roberts & Scott, 2007) 
 
FasBCAX 
FasBCAX is the fibronectin/ fibrogen binding haemolytic activity/ streptokinase 
regulator. It encodes two sensor histidine kinases (FasBC) and one response regulator 
(FasA), integrating different signals into one adaptive response. The main effector of the 
Fas system is the putative untranslated 200 nt regulatory RNA encoded by fasX 
(Kreikemeyer et al., 2001). The Fas operon upregulates the expression of sagA and ska, 
and downregulates the expression of adhesin genes (fbp54 and mrp). FasBCAX shows 
homology to quorum-sensing TCSs in S. aureus and S. pneumoniae and assist in tissue 
invasion and destruction (Klenk et al., 2005). Expression of fasBCA genes changes in 
response to temperature change from 29ºC to 37ºC (Sitkiewicz & Musser, 2006).  
 
Ihk/ Irr 
The Ihk/ Irr (isp-adjacent histidine kinase/response regulator) TCS has an important role 
in immune evasion as it controls the expression of genes that facilitate protection from 
PMN leukocytes mediated killing and assist in GAS survival and pathogenesis response 
(Federle et al., 1999; Voyich et al., 2003; Voyich et al., 2004). It down regulates genes 
involved in cell wall metabolism, transcription, oxidative stress and virulence. The Ihk/ 
Irr mutant was found more susceptible to killing by H2O2 and neutrophil primary 
granules (Musser & DeLeo, 2005). 
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Sil operon 
The Sil locus stands for streptococcus invasive locus and is present in about 18% of 
clinically relevant GAS isolates. The Sil system consists of the TCS SilA/B, two putative 
ABC-transporters SilD and SilE and SilCR, which seems to be a quorum sensing effector 
molecule. Sil upregulates the transcription of its own signalling molecule and the two 
ABC transporters. The bacteriocin like peptide (blp) operon and the spyM3_1016 
transposase have already been identified as targets (Eran et al., 2007; Hidalgo-Grass et 
al., 2002).  
 
VicRK 
VicR inactivation down-regulates the transcription of 13 genes including the putative cell 
wall hydrolase gene pcsB and a putative phosphotransferase system enzyme II for 
carbohydrate transport, and up-regulates the expression of five genes, including an 
osmoprotectant transporter OpuA. vicR inactivation induced osmotic stress and increased 
susceptibility to osmotic pressure. VicRK regulates processes involved in cell wall 
metabolism, nutrient uptake, and osmotic protection (Liu et al., 2006). 
 
SptRS 
SptR and SptS encode two component gene regulatory systems, involved in the 
persistence of GAS in saliva, as the mutant of sptR was less able to survive in saliva. 
Microarray analysis of GAS grown in saliva showed that the expression of several 
virulence factors in sptR mutant was significantly decreased (Shelburne et al., 2005). 
 
TrxSR 
The recently described TrxSR (two-component regulatory system X) displays 
homologies to a virulence related TCS in S. pneumoniae. A Trx response regulator 
mutant is defective in Mga expression and is attenuated in virulence in a murine model of 
GAS soft tissue infection. TrxR is the first TCS that regulates Mga expression in 
response to a yet unidentified signal. trxSR is a part of CovR-repressed virulence operon, 
which performs a range of different functions in translation, transcription, replication, 
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transport and stress. As CovR can influence Mga expression, this shows that important 
global regulatory networks can influence each other to affect pathogenesis in GAS 
(Leday et al., 2008). 
 
Response regulators 
Apart from TCS, GAS also relies on about 30 stand-alone response regulators, for which 
sensory elements have not been described. These response regulators control the 
expression of virulence factors in response to environmental signals. 
 
Mga 
Mga stands for multiple gene activator. It is a ubiquitous stand-alone virulence response 
regulator. It is necessary for adherence, internalization and host immune evasion. Mga 
activates the expression of virulence genes by directly binding to their promoters. 10% of 
the three GAS genome transcriptome was affected when mga was deleted (Ribardo & 
McIver, 2006). Mga activates transcription of a number of virulence genes in GAS 
including its own gene. The Mga regulon is expressed maximally during exponential 
phase and activates factors involved in early stages of GAS infection. Repression of mga 
transcription is mediated by Rgg/RopB and Nra (RALP), while it is activated in response 
to CO2 levels and inhibited by high salt and iron limitation conditions (Caparon et al., 
1992; McIver et al., 1995; McIver & Scott, 1997). Mga regulates the expression of M 
protein (emm and arp), M-like proteins (mrp), C5a peptidase (scpA), SIC, SpeB and 
extracellular matrix binding proteins (sclA and fba, Figure 9) (Frick et al., 2003; 
Kreikemeyer et al., 2003; Rasmussen et al., 2000; Roberts & Scott, 2007).  
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Figure 9. Mga regulon in GAS (Hondorp & McIver, 2007) 
 
RALP (RofA like proteins) 
The RALP regulator family of GAS comprises four homologous members: RofA, Nra, 
RALP-3 and RALP-4 (Granok et al., 2000; Kreikemeyer et al., 2003). These are involved 
in the control of GAS-host cell interactions, avoidance of host-cell damage and balanced 
virulence factor expression during stationary phase. Maximal expression of RALP occurs 
at stationary growth phase. RALP-regulated genes are fibronectin-binding proteins F 
(sfbI) and F2 as well as collagen-binding protein (cpa), hemolysins (sagA), proteases 
(speB); superantigens (speA) and other virulence regulators (mga) (Kreikemeyer et al., 
2003). 
A second well known RALP protein is Nra. It acts as a negative regulator of expression 
of cpa, prtF, speA, sagA, mga and nra itself conditions (Jaffe et al., 1996; Podbielski et 
al., 1999). Strain-specific differences are observed with Nra transcriptional circuit as Nra 
is a negative regulator of pilus gene transcription in M49 serotype but a positive regulator 
of pilus gene transcription in M53 serotype (Luo et al., 2008). In contrast to RofA, Nra 
expression is maximal at early stationary phase and its expression is not affected due to 
environmental conditions (Jaffe et al., 1996; Podbielski et al., 1999). 
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Rgg/RopB 
Rgg also known as RopB, stands for regulation of proteinase. It plays a role in host cell 
apoptosis, necrosis and dissemination. Rgg controls gene expression during late 
stationary growth phase. It is a positive regulator of the cysteine protease SpeB. It has a 
negative influence on the transcription of regulatory factors such as mga and pel/sagA 
and a positive influence on transcription of covRS and fasBCA (Chaussee et al., 2004; 
Neely et al., 2003). 
 
Srv regulon 
Srv stands for streptococcal regulator of virulence. The putative regulator protein Srv is 
homologous to the transcriptional regulator PrfA of Listeria monocytogenes. It belongs to 
the first GAS member of the Crp/Fnr family of transcriptional regulators. The mortality 
of mice injected with the srv mutant was significantly less as compared to the wild-type 
(Reid et al., 2004). Another study showed that Sic levels were decreased while SpeB 
levels were increased in a srv mutant (Reid et al., 2006). 
 
CodY 
CodY is a nutritional regulator mainly involved in amino-acid metabolism. This protein is 
highly conserved in low G+C gram positive organisms. It has been identified as a 
pleiotropic transcriptional regulator, activated by branched chain amino-acids. CodY 
controls many genes, which are operative in low nutrition conditions. To some extent 
CodY also regulates a RelA-independent response to amino acid (Steiner & Malke, 
2001). CodY induces the expression of pel/sagA and mga, so this suggests a link between 
nutritional regulation and virulence (Malke et al., 2006). 
 
2.4.3.2 RNA regulators 
 
Virulence gene regulation, as gene regulation in general, was up to recently believed to 
be exerted mainly by repressor or activator proteins. However, it has become increasingly 
evident that RNA can control gene expression more commonly than previously 
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anticipated (Johansson & Cossart, 2003; Shimizu et al., 2002). The RNAs that are 
involved in gene regulation are discussed in details in section 2.6. 
 
2.4.3.3 Cell density-dependent regulation 
 
Bacteria communicate with each other using small chemical signal molecules called 
autoinducers. This process involves the production, release, detection and responding to 
signal molecules by bacteria. These autoinducers are detected when a certain threshold 
level of these molecules accumulate in the surroundings. Thus this process is called 
quorum sensing, as it senses a certain number (quorum) of autoinducer molecules. 
Quorum sensing allows bacteria to modulate gene expression according to the number of 
bacteria in a community and according to different environmental conditions. 
 
Quorum sensing in gram-negative bacteria 
Quorum sensing was first discovered in Vibrio fischeri, where it colonizes the light organ 
of Hawaiian squid Euprymna scolopes.  Bacteria grow to high density to induce the 
expression of genes for bioluminescence. Two proteins LuxI and LuxR are responsible 
for the control of luciferase operon (luxICDABE), which is required for the light 
production. Here, LuxI is the autoinducer synthase, which produces acyl-homoserine 
lactone (AHL), while LuxR is the cytoplasmic DNA binding transcriptional activator. At 
first, LuxI is produced and it can freely diffuse out of cell. Once it reaches a certain 
threshold concentration it can bind to LuxR and then this complex can bind to promoter 
region of a target operon (luxICDABE) and activates its transcription (Figure 10). 
Activation of this operon also activates luxI expression as it is also encoded in this 
operon, thus leading to a positive feedback loop (Waters & Bassler, 2005a). Hence the 
whole population acts like a synchronous behavior. In quorum sensing there is extreme 
specificity between autoinducer molecule and autoinducer receptor, so even in mixed 
population each species can respond only to its own signal. 
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Figure 10. Quorum sensing in gram-negative bacteria (Waters & Bassler, 2005b) 
 
Quorum sensing in gram-positive bacteria 
In gram-positive bacteria quorum sensing involves modified oligopeptides as signal 
molecules instead of AHL. The peptides that are produced are first binding to membrane 
bound sensor histidine kinases as receptors. Simultaneously they are modified, processed 
and transported by dedicated oligopeptide transporters. These molecules can not diffuse 
freely in and out of the cell as AHLs do. 
A well known example of quorum sensing system in gram-positive bacteria is the 
Staphylococcus aureus Agr quorum sensing system. At low density bacteria express 
protein factors that promote colonization and attachment, while at high density bacteria 
repress these factors and express toxins and proteases required for dissemination (Lyon & 
Novick, 2004). In S. aureus, the autoinducing peptide (AIP) is encoded by agrD and 
signals through the sensor kinase AgrC and response regulator AgrA. The role of AgrB is 
to modify and transport AIP out of the cell (Saenz et al., 2000). Thereafter, AIP binds to 
AgrC and phosphorylates AgrA, which induces expression of RNAIII. This regulatory 
RNA represses the expression of cell adhesion factors and induces expression of secreted 
factors (Waters & Bassler, 2005a). AgrA also induces the expression of agrBDCA thus 
leading to a positive feedback loop (Figure 11). In S. pyogenes, two putative quorum 
sensing systems have been described: silABCD and fasBCA (chapter 2.4.3.1). No 
signaling peptide has been discovered from the fasBCA locus, however the putative 
 32
pheromone peptide SilCR from the sil operon regulates DNA uptake and the ability to cause 
invasive infection (Eran et al., 2007). 
 
Figure 11. The agr system and RNAIII in S. aureus 
(http://www3.imperial.ac.uk/cmmi/research/sivarameshwigneshweraraj) 
 
Interspecies communication 
Yet another autoinducing system has been discovered, which detects a furanone-like 
signaling molecule termed “autoinducer 2” (AI-2). AI-2 regulates bioluminescence in 
Vibrio harveyi (Figure 12) (Bassler et al., 1997; Surette et al., 1999). It is synthesized by 
the luxS gene, which is found in over 55 gram-negative and gram-positive bacterial 
species. AI-2 is proposed to have a role in interspecies communication. Many studies in 
gram-positive bacteria have shown the role of luxS in pathogenesis. LuxS and AI-2 have 
potential role in metabolism and quorum sensing. In many oral pathogens, the luxS 
mutant leads to a modified biofilm architecture (Table 4). In some oral bacteria, the 
luxS/AI-2 signaling pathway has been also associated with acid and oxidative stress 
tolerance, bacteriocin synthesis, competence and antibiotic susceptibility. In Clostridium 
perfringens, transcription of three toxins encoding genes was reduced in a luxS mutant 
strain. However in S. aureus, a luxS mutant strain had no effect on virulence but showed 
a growth defect in sulfur-limited defined medium. In S. pyogenes, the luxS/AI-2 signaling 
was shown to be involved in the regulation of pathogenicity and S-adenosylmethionine 
(SAM) utilization pathway. Mutation of luxS in an M6 serotype showed enhanced 
expression of sagA associated with enhanced haemolytic activity and reduction in SpeB 
protease proteolytic activity (Lyon et al., 2001). Marouni and Sela (2003) observed a  
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Table 4. LuxS mutant phenotypes in gram-positive bacteria (adapted from Maria Siller thesis) 
Bacterium Phenotype References 
Bacillus subtilis Decreased biofilm formation and 
swarming ability. 
Lombardia et al., 2006 
Clostridium perfringens Reduced toxin production; reduced 
pfo mRNA. 
Othani et al., 2002 
Listeria monocytogenes Cell attachment during biofilm 
formation affected. 
Challan Belval et al., 2005 
Porphyromonas gingivalis 
 
 
Reduced levels of Tlr (TonB-linked 
hemin binding protein) and the 
protease Kgp.  
Upregulatipon of HmuR (TonB-linked 
hemin binding protein) and hemin 
binding lipoprotein FetB, FeoB1 (a 
Fe2+ ion transporter protein) and 
ferritin (iron storage protein). 
Impaired hemin uptake in hemin-
depleted medium.  
Reduced TonB, excinuclease, 
hemin-regulated receptor. 
Increased hemin aquisition protein 
Rgp. Reduced Rgp and Kgp 
proteases,  
haemagglutinin levels. 
Failed to form biofilm with S. gordonii 
luxS mutant. 
James et al., 2006 
 
 
 
Chung et al., 2001 
Burgess et al., 2002 
 
McNab et al., 2003 
Staphylococcus aures Growth defect in sulfur limited 
defined media. 
Dohorty et al., 2006 
Straphylococcus epiderimidis Increased biofilm development and 
enhanced virulence. 
Genes involved in sugar, nucleotide, 
amino acid, and nitrogen 
metabolism, but also virulence-
associated genes coding for lipase 
and bacterial apoptosis proteins and 
the pro-inflammatory phenol-soluble 
modulin (PSM) peptides are altered 
by LuxS/AI-2 signaling system. 
Xu et al., 2006 
Li et al., 2008 
Streptococcus anginosus Increased susceptibility to 
erythromycin and ampicillin. 
Deficient in biofilm formation. 
Ahmed et al., 2007 
Petersen et al., 2006 
Streptococcus intermedius Decreased haemolytic actitiy. Pecharki et al., 2008 
Streptococcus gordonii Altered biofilm morphology. 
Failed to form biofilm with P. 
gingivalis luxS mutant. Decrease 
gtfG, fruA, lacD. 
Blehert et al., 2003 
McNab et al., 2003 
Streptococcus mutans Impaired bacteriocin mutacin I 
(mutA) and mutR (activator). 
Increased acid sensitivity; increased 
survival rate in the presence of 
hydrogen peroxide; downregulation 
of ffh, brpA, recA, smnA, nth. 
Meritt et al., 2005 
Wen and Burne, 2004 
Streptococcus oralis No mutualism with Actinomyces 
naeslundii; spare biofilm formation. 
Rickard et al., 2006 
Streptococcus pneumoniae Widened competence expression; 
increased autolysis in cultures 
entering stationary phase; 
Altered transcriptional profiles; 
attenuated in mouse. 
Altered proteome. 
Romao et al., 2006 
Joyce et al., 2004 
Stroeher et al., 2003 
Streptococcus pyogenes The mutant was internalized by Hep-
2 cells with higher efficiency than the 
wild-type. LuxS mutation reduced 
speB mRNA and increased emm3 
mRNA.  
Increased streptolysin S; increased 
sagA expression; decreased growth 
rate (media dependent); decreased 
SpeB activity. 
Marouni et al., 2003 
 
Lyon et al., 2001 
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Figure 12. V. harveyi  AI-2 regulates bioluminescence (Waters & Bassler, 2006) 
 
higher ability of a luxS mutant in an M3 serotype to be internalized in pharyngeal 
epithelial cells as well as an enhanced emm transcription and slightly enhanced covRS 
transcription.  
 
2.5 Bacteriophages and horizontal transfer of virulence factors in S. pyogenes 
 
Bacteriophages are typically divided into two groups on the basis of their life cycles. The 
lytic phages do not enter into an extended relationship with their host bacterium. These 
phages infect, replicate, assemble, rupture and release from the host cells. On the other 
hand temperate or lysogenic phages can integrate their DNA into the host bacterium’s 
chromosome and replicate with the host DNA thereby altering the host genomes by the 
introduction of novel genes into their host cells (Figure 13). Thus, bacteria can acquire 
genes from other strains by lateral gene transfer also referred as horizontal transfer of 
genes. Horizontal transfer of virulence factors is a major driving force in the emergence 
and evolution of pathogenic isolates (Boyd & Brussow, 2002). Newly recombinant 
bacteria can become more fit by gaining new alleles or genes such as immune evasion, 
antimicrobial agent’s resistance or virulence. Three main means for horizontal gene 
transfer are transformation, conjugation and transduction, which involve several mobile 
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elements like insertion sequences, plasmids and bacteriophages. As transformation and 
conjugation appear to play minor role in streptococci, thus bacteriophages are 
significantly responsible for horizontal gene transfers (Canchaya et al., 2003). 
 
Figure 13. Lytic and lysogenic life cycle of bacteriophages 
(http://www.bio.miami.edu/dana/pix/bacteriophage_life_cycle.jpg) 
 
Bacteriophage-encoding virulence factors can convert their bacterial host in a process 
known as phage lysogenic conversion, from a non-pathogenic strain to a virulent strain or 
a strain with increased virulence. GAS prophage sequences constitute 7-14% of the total 
genome of sequenced strains. It is a polylysogenic organism, containing many prophages 
or prophage like elements. The complete genome sequences of twelve GAS strains 
representing six different M serotypes confirm the presence of two to eight phages per 
genome (Table 5). Sequence alignments of the completely sequenced GAS genomes 
showed that ~90 percent of sequences are conserved, thus the significant source of 
genomic divergence is due to prophage sequences (Fischetti, 2007). All the prophages 
contain one or two proven or putative virulence factors like SPEs, DNAses, novel 
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phospholipase A2 (SlaA), efflux pump responsible for resistance to macrolide antibiotics 
and a novel cell wall anchored protein hypothesized to be an adhesin (Musser & DeLeo, 
2005). The gene order of prophages from lactic acid bacteria having low G+C ratio is as 
follows: left attachment site (attL), lysogeny, DNA replication, transcriptional regulation, 
DNA packaging, head-joining-tail-tail fiber, lysis modules, right attachment site (attR) 
(Canchaya et al., 2003). At one end of phage genome is the gene required for phage 
integration and on the other end between the attachment site and the gene for cell lysis is 
the toxin cassette. These toxin cassettes mostly encode GAS mitogens, like 
streptodornase or superantigens. Since many streptococcal SAgs-encoding genes are 
located on integrated phage genomes, it is now widely acknowledged that a favorable 
condition exists for genetic transfer among different GAS M types as well as other 
streptococcal species. GAS phages are therefore of highly mosaic nature, and exchange 
of virulence genes between phages seem to be a frequent event (Aziz et al., 2005). 
 
Table 5. Prophages in GAS sequenced strains (adapted from Beres et al., 2006) 
Strain M type Size (bp) CDS
a Prophage MLST
b GenBank accession no ATCC no. 
SF370 1 1,852,441 1,697 4 28 AE004092 700294 
MGAS5005 1 1,838,554 1,865 3 28 CP000017 BAA-947 
MGAS10270 2 1,928,252 1,987 5 55 CP000260 BAA-1063 
MGAS315 3 1,900,521 1,865 6 15 AE14074 BAA-595 
SSI-1 3 1,894,275 1,861 6 15 BA000034 — 
MGAS10750 4 1,937,111 1,979 4 39 CP000262 BAA-1066 
Manfredo 5 1,841,271 1,803 5 99 — — 
MGAS10394 6 1,899,877 1,886 8 382 CP000003 BAA-946 
MGAS2096 12 1,860,355 1,898 2 36 CP000261 BAA-1065 
MGAS9429 12 1,836,467 1,878 3 36 CP000259 BAA-1315 
MGAS8232 18 1,895,017 1,845 5 42 AE009949 BAA-572 
MGAS6180 28 1,897,573 1,894 4 52 CP000056 BAA-1064 
aCDS= coding sequence, bMLST= Multilocus sequence typing 
 
Since the mid 1980s, there is an unexplained resurgence of GAS infections observed with 
an occurrence of new and more severe infections. Particularly STSS caused by GAS was 
reported from Europe, USA and Japan (Cunningham, 2000; Stevens et al., 1989). Many 
theories have tried to explain this phenomenon. Some have focused on host cells factors 
while others on an increased virulence of strains with a high speculation that phages 
might play a significant role in the transfer of virulence determinants especially SAgs. 
Indeed, SPEs were found to be involved in the pathogenesis of the observed severe 
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streptococcal diseases. However the evidence for the later theory is mostly indirect based 
on the distribution patterns of superantigens throughout the GAS population or their 
association with prophage sequences (Broudy & Fischetti, 2003; Kapur et al., 1992; 
Musser et al., 1993). Besides this, there is also an old theory that M protein acts as a 
barrier for bacteriophage transfer from one M serotype to another one. This means that M 
protein would be preventing phage-mediated spread of virulence factor transfer among 
the GAS population (Cleary & Johnson, 1977; Spanier & Cleary, 1980).  
 
2.6 RNA regulators 
 
As bacteria are facing different environmental conditions in their life time, hence they 
need to adapt according to the changing environmental conditions. Bacteria have a 
number of virulence factors, which are needed to be activated or repressed according to 
the environmental or host signals. Up to recently, it was believed that bacteria regulate 
mainly their gene expression by means of repressor or activator proteins at the 
transcriptional level. However, it has been increasingly evident that RNA can control 
gene expression more commonly than previously anticipated. Some of the described 
RNAs provide house-keeping functions like RNaseP, tmRNA and 4.5S RNA, while 
others are regulators of gene expression. 
 
2.6.1 Regulatory RNAs: Definition and modes of action 
 
Many terms have been used for small RNAs like sRNAs (small RNAs), ncRNA 
(noncoding RNAs), snmRNAs (small non messenger RNAs), fRNA (functional RNAs), 
regulatory RNAs and riboregulators. sRNAs are mainly confined to control biological 
functions as bacterial accessory elements (Wagner et al., 2002). sRNAs have emerged as 
major regulators of adaptive responses and RNA-mediated regulation plays a main role in 
virulence. Most of the sRNAs are non essential i.e. their absence does not cause cell 
death. 
The most common mode of action of regulatory RNAs is by base pairing to mostly the 5' 
end of target mRNAs, via a so-called antisense mechanism, thus leading to down-
regulation or up-regulation of the gene expression at the post-transcriptional level (Figure 
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14). Binding of a sRNA to a target mRNA mostly inhibits translation or facilitates the 
decay of mRNA, however sometimes it can also activates the translation by conversion to 
a translationally active conformation (Storz et al., 2005). Regulatory RNAs can affect the 
expression of multiple target mRNA or a single target mRNA encoding a virulence 
factor. They can also inhibit or activate the expression of single target mRNAs, which 
decrease or increase the synthesis of single regulatory protein, in turn affecting the 
expression of a great number of downstream genes. The CsrA protein, regulator of 
carbon storage, adhesion, cell surface properties and virulence, interacts with target 
mRNAs and either facilitates their rapid degradation or activates translation (Liu et al., 
1997). The third mechanism involves binding of a metabolite to the nascent mRNA thus 
inducing a structural change to a terminator or a translationally inactive state, called 
riboswitch (Winkler & Breaker, 2005).  
 
Figure 14. Mechanisms of action of regulatory RNAs  (Storz et al., 2004) 
 
Regulatory antisense RNAs can be of two types: cis-encoded or trans-encoded. Cis-
encoded RNAs can bind to the genes downstream from the same locus and are fully 
complementary to their target RNAs. In contrast trans-encoded RNAs and their targets 
are encoded in separate loci and the regions of complementarity are generally short and 
often non-contagious (Altuvia & Wagner, 2000; Delihas, 1995). Most of the 
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chromosomally encoded antisense sRNAs belong to this class. In gram-negative bacteria, 
many sRNAs that form only a limited complementarity to their targets require the 
hexameric Sm-like protein Hfq (Valentin-Hansen et al., 2004). Hfq can help in 
stabilizing sRNAs by promoting antisense-target RNA pairing or by acting in an 
unfolding or playing chaperone role. Hfq can also act as an adapter between sRNAs and 
RNase E for degradation (Romby et al., 2006). Many of the sRNAs discovered are stable 
when induced, exhibiting a half life of 20-60 minutes. Many sRNAs are unprocessed 
primary transcripts e.g. DsrA, Spot42, MicF, OxyS, while several others are generated 
from longer precursors and are finally cleaved to their actual sizes e.g. 4.5S RNA, 
tmRNA, 6S RNA. 
Regulatory RNAs regulate gene expression in different growth conditions. For example, 
in Listeria monocytogenes, the transcriptional regulator PrfA is thermo-regulated i.e. its 
translation initiation only happens when temperature is increased to 37oC (Johansson et 
al., 2002). This occurs through a riboswitch-like mechanism. A typical non-coding sRNA 
can bind to several different targets, as it usually forms only a limited number of 
basepairs to its target mRNA. This limited complementarity not only allows single sRNA 
to act on multiple targets but also allows the sRNAs to be induced under different growth 
conditions, allowing multiple sRNAs to act on single targets (Romby et al., 2006). 
 
2.6.2 Small RNAs in bacterial pathogenicity 
 
More than 80 non-coding RNAs have been found in Escherichia coli. The majority of 
these RNAs are present in pathogenic strains and have a role in stress-response regulation 
and bacterial pathogenicity (Table 6). The first trans-encoded antisense RNA identified is 
MicF in E. coli (Andersen et al., 1987). Expression of MicF is induced by different 
environmental stresses like osmolarity and temperature (Delihas & Forst, 2001). MicF 
binds to the translation initiation region (TIR) of ompF mRNA, blocks the translation of 
the OmpF protein (porin protein) and induces rapid RNase E dependent ompF mRNA 
degradation (Rasmussen et al., 2005).  
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Table 6. Regulatory RNAs in bacterial pathogenicity (adapted from Maria Siller thesis) 
RNA (Species) 
 
Target genes 
 
Mechanism of action 
 
References 
CsrB 
(Salmonella 
typhimurium) 
UR: genes of the 
salmonella 
pathogenicity island 1 
Protein-targeting 
CsrB RNA functions as an antagonist of CsrA by sequestering 
this protein and preventing its action.  
Altier et al., 2000 
 
CsrB 
(Escherichia 
coli) 
UR: glgC (ADP-glucose 
pyrophosphorylase) 
Protein-targeting 
CsrB RNA functions as an antagonist of CsrA by sequestering 
this protein and preventing its action.  
Baker et al., 2002 
 
CsrB/C/D 
(Vibrio cholerae) 
 
Interact via CsrA with 
the expression of Qrr 
sRNAs. 
 
Protein-targeting 
The three sRNAs control the activity of CsrA, which interacts 
with the expression of Qrr sRNAs, therefore regulating the 
entiere quorum-sensing system.  
Lenz et al., 2005 
 
csRNA (1-5) 
(Streptococcus 
pneumoniae) 
DR: (csRNA4 and 
csRNA5) stationary-
phase autolysis 
Most likley inhibit initiation of transaltion by RNA-RNA base 
pairing. 
 
Halfmann et al., 2007 
 
DsrA 
(Escherichia 
coli) 
 
UR: rpoS 
DR: Global regulator H-
NS 
 
RNA-RNA basepairing 
Basepairing to the rpoS mRNA leader sequence, opens 
secondary structure formation so that translation can occur. 
Inhibits hnS mRNA translation by base pairing. 
Lease et al., 2004;  
Repoila and 
Gottesmann, 2001; 
Wassarman et al., 
1999 
fasX 
(Streptococcus 
pyogenes) 
UR: SLS, ska 
DR: mrp, fbp54, sagA 
unknown Kreikemeyer et al., 
2001 
gadY 
(Escherichia 
coli) 
UR: gadX, gadW  
(acid response genes) 
RNA-RNA basepairing 
Basepairing with the 3´end of the gadX mRNA leads to 
stabilization of the target transcript. 
Opdyke et al., 2004 
GcvB 
(Salmonella 
typhimurium) 
DR: Seven target 
mRNAs that encode 
periplasmic substarte-
binding proteins of ABC 
uptake systems for 
amino acids and 
peptides. 
RNA-RNA basepairing 
Represses target mRNAs by binding to extended C/A-rich 
enhancer motifs. In some cases GcvB maskes directly the S-D-
motif to prevent 30 S subunit binding. 
Sharma et al., 2007 
IstR1/ltsR2 
(Escherichia 
coli) 
DR: tisAB RNA-RNA basepairing 
Base pairing of lstR-1 to the tisAB mRNA promotes 
cleavage of the toxic transcript by RNAseIII. 
Vogel et al., 2004 
MicA, MicF, 
MicC 
(Escherichia 
coli) 
DR: ompA, ompF, 
ompC  
RNA-RNA basepairing 
MicA, MicC and MicF bind regions in their respective target 
mRNAs leading to repression of translation and induction of 
rapid RNase E-dependent mRNA decay. 
Vogel and Papenfort, 
2006 
MicX 
(Vibrio cholerae) 
DR: vc0972 
(uncharacterized OMP), 
vc0620 (ABC 
transporter) 
RNA-RNA basepairing 
Primary transcripts of MicX are processed in an RNase E- and 
Hfq-dependent fashion. Processed MicX downregulates 
transcripts of vc0972 and vc0620.  
Davis and Waldor, 
2007 
OmrA, OmrB 
(Escherichia 
coli) 
DR: several genes 
encoding outer 
membrane poteins, 
including cirA, fecA, 
fepA and ompT. 
RNA-RNA base pairing 
Because OmrA and OmrB bind Hfq, they were predicted that to 
act by pairing with their target mRNAs; thus changing stability 
and/or translation potential. 
Guillier and 
Gottesman, 2006 
OxyS  
(Escherichia 
coli) 
Represses translation of 
fhlA and  rpoS  
RNA-RNA basepairing 
Blocks translation of fhlA mRNA by binding across the  
S-D sequence. Mechanisms is Hfq dependent. 
Argaman et al., 2000; 
Wassarman et al., 
1999;  
Zhang et al., 1998 
pel 
(Streptococcus 
pyogenes) 
UR: emm, sic, nga,  
SpeB activity 
unknown Mangold et al., 2004 
PrfA 
(Listeria  
monocytogenes) 
Listeriolysin O,  
phospholipases PlcA 
and PlcB 
Thermosensor 
At low temperature the prfA-UTR forms a secondary structure 
wich masks the RBS. At higher temperature the structure melts, 
permitting binding to the ribosome. 
Johansson et al., 
2002 
PrrB 
(Pseudomonas 
fluorescens) 
UR: of 2, 4-
diacetylphloroglucinol 
(Phl) and 
hydrogencyanide HCN  
Protein targeting 
The structure is similar to the CsrB and RsmB regulatory RNAs 
in E. coli and E. carotovora. 
Aarons et al., 2002 
PrrF1 
PrrF2 
(Pseudomonas 
aeruginosa) 
DR: sodB (superoxide 
dismutase),  
sdh (succinate 
dehydrogenase), and 
bacterioferritin. 
RNA-RNA base pairing 
Functional homologs of RyhB in E. coli;  
Expression is regulated by iron. 
Wilderman et al., 2004 
Qrr1-4 
(Vibrio cholerae; 
Vibrio harveyi) 
DR: luxR/hapR RNA-RNA base pairing 
The sRNAs act downstram of LuxO-P to destabilize luxR/hapR 
mRNA and regulate quorum-sensing dependent gene 
Lenz et al., 2004 
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expression in V. harveyi and V. cholerae. 
RatA 
(Bacillus 
subtilis) 
DR: txpA (toxic peptide 
A) 
Toxin:antitoxin modul 
ratA is an antisense RNA that overlaps the txpA mRNA. 
Hybridisation results in degradation of the ds-RNA complex. 
Silvaggi et al., 2005 
RivX 
(Streptococcus  
pyogenes) 
UR: mga regulon unknown Roberts and Scott, 
2007 
RNAalpha 
(Vibrio 
anguillarum) 
DR: iron-uptake 
complex  
(fat operon) 
RNA-RNA basepairing 
The expression of fatA and fatB is repressed under iron-rich 
conditions, in which RNAalpha is induced. RNAalpha is 
homologous to two-thirds of the coding region of fatB. 
Waldbeser et al., 1995 
RNAIII 
(Staphylococcus 
aureus) 
UR: toxins and enzymes 
DR: surface proteins, 
spa, rot 
RNA-RNA basepairing 
Binding to the anti-S-D region of the hla mRNA leads to 
disruption of the intramolecular base-pairing, so that the 
ribosome can bind. 3´end of RNAIII binds to the spa mRNA, 
sequesters the RBS and further destabilizes the spa mRNA. 
Binding to rot mRNA S-D sequence inhibits translation, thus 
leading to rot mRNA procession. 
Geisinger et al., 2006; 
Huntzinger et al., 
2005;  
Morfeldt et al., 1995;  
Novick et al., 1993 
RprA 
(Escherichia 
coli) 
UR: rpoS RNA-RNA basepairing 
Translational regulation of the stationary phase sigma factor 
RpoS is mediated by the formation of a double-stranded RNA 
stem-loop structure in the upstream region of the rpoS mRNA, 
occluding the translation initiation site. 
Majdalani et al., 2001 
RsmB 
(Pseudomonas 
aeruginosa) 
UR: production of AHL 
C4-HSL  
and C6-HSL 
Protein-targeting 
AHL production increases when the RsmB RNA binds the 
repressor protein RsmA, which therfore becomes inactivated.  
Burrowes et al., 2005 
RsmB´ 
(Erwinia 
caratovora) 
UR: proteoloytic 
enzymes, proteases 
and cellulases 
Protein-targeting 
Inhibits target mRNA degradation by binding to the RNA binding 
protein RsmA. 
Johansson et al., 
2003;  
Liu et al., 1998 
RsmY, RsmZ 
(Pseudomonas 
fluoresecens) 
UR:  biocontrol traits Protein-targeting 
RsmZ sequesters the RNA-binding protein RsmA, a 
translational regulator of genes involved in biocontrol. Relieve 
RsmA-mediated regulation of secondary metabolism and 
biocontrol traits. 
Valverde et al., 2003 
RyaA/SgrS  
(Escherichia 
coli) 
DR: ptsG 
(encodes the glucose 
transporter of the 
phosphoenolpyruvate 
phosphotransferase 
system (PTS)) 
RNA-RNA base pairing 
RyaA is required for posttranscriptional regulation of 
ptsG in response to phosphoglucose stress. In addition, ryaA 
transcription is activated by YabN, the member of 
transcriptional regulators. 
Vanderpool et al., 
2004 
RyhB 
(Escherichia 
coli) 
DR: sodB (encoding 
superoxide dismutase), 
ftn and bfr (encoding 
ferritin and 
bacterioferritin), and 
several iron-sulfur 
cluster-containing TCA 
cycle enzyme genes, 
including the sdh 
operon (encoding 
succinate 
dehydrogenase)  
and acnA (encoding 
aconitase) 
RNA-RNA basepairing 
Base pairing between RyhB and its mRNA target and 
subsequent Rnase E-mediated degradation of the RyhB-mRNA 
duplex. Because RyhB is itself negatively regulated by Fur, the 
net effect is positive regulation of these genes under high-iron 
conditions.  
Afonyushkin et al., 
2005;  
Masse et al., 2002;  
Masse et al., 2003; 
Masse et al., 2005 
RyhB 
(Vibrio cholerae) 
DR: iron storage and 
utilization genes; 
motility, chemotaxis and 
biofilm formation. 
RNA-RNA basepairing 
V. cholerae may use a system analogous to the E. coli RyhB 
mechanism for regulating genes encoding iron-containing 
proteins and those involved in iron metabolism. 
Mey et al., 2005 
SR1 
(Bacillus 
subtilis) 
unknown RNA-RNA basepairing 
Glucose mediated repression of SR1 transcription; regulated by 
CcpN. 
Licht and Brantl, 2005 
SurA, SurC 
(Bacillus 
subtilis) 
yndL  
(involved in porulation) 
RNA-RNA basepairing 
Antisense sRNA to yndL mRNA. 
Silvaggi et al., 2006 
VR-RNA 
(Clostridium 
perfringens) 
UR: colA, plc, ptp, cpd 
DR: ycgJ, metB, cysK, 
ygaG 
unknown Shimizu et al., 2002 
UR: up-regulation 
DR: down-regulation 
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The most studied example of a regulatory RNA controlling bacterial virulence is the 512-
nucleotide long RNAIII of S. aureus, which affects both transcription and translation of 
virulence genes. It acts as multi-gene regulator, repressing the expression of cell surface 
proteins like protein A and fibronectin-binding proteins and activating the expression of 
extracellular toxins and proteases like α-toxin, β-haemolysin, TSST-1, enterotoxin B, 
leucocidin, staphylokinase, serine protease, metalloproteases (Janzon & Arvidson, 1990; 
Wolz et al., 1996). In totality, RNAIII regulates the expression of ~100 genes (Dunman 
et al., 2001). Consequently, the agr system functions as a switch from a localized 
infection to invasive and systemic dissemination (Novick & Muir, 1999). Apart from 
regulatory functions, RNAIII also acts as an mRNA encoding δ–hemolysin. Unlike most 
of the antisense RNAs, RNAIII can activate the expression of its target e.g. hla mRNA 
(Morfeldt et al., 1995) instead of inhibiting its expression. 
OxyS RNA of E. coli is yet another example of a multi-gene regulator, regulating the 
expression of ~40 genes. It has a role in defense against oxidative damage. It accumulates 
at high levels when bacteria are treated with hydrogen peroxide (Altuvia et al., 1997). 
OxyS negatively affects the expression of two target genes: fhlA (a transcriptional 
activator protein) and rpoS (stress/ stationary phase σ subunit of RNA polymerase). 
DsrA is a 87 nt long sRNA which affects polysaccharide capsule synthesis. It is induced 
at low temperature. mRNA encoding global transcriptional proteins RpoS and hns are 
targets of DsrA. One segment of nucleotides binds to the TIR of hns mRNA while 
another one basepairs to nucleotides near the 5' end of the rpoS mRNA (Lease & Belfort, 
2000). 
The RhyB sRNA, 90 nt long, is regulated by iron. At high iron concentration, it is 
repressed by the ferric uptake protein Fur. Fur dependent activation of sdh, genes 
required for growth on succinate, occurs by repression of RhyB transcription.  
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2.6.3 Small RNAs in S. pyogenes 
 
In S. pyogenes, so far, only three putative regulatory RNAs have been discovered: 
fasXRNA, pelRNA and rivXRNA. 
 
fasX RNA 
Fas stands for fibronectin / fibrinogen binding/ haemolytic activity / streptokinase 
regulator. Downstream of fasBCA is a small 200 nucleotide RNA fasX. The fas operon 
consists of two genes encoding histidine kinases, FasB and FasC and the single response 
regulator FasA. Presence of two sensor kinase genes might mean that the sensors are bind 
to different environmental stimuli. These genes were identified on the basis of homology 
to the S. aureus agr two-component system and S pneumoniae com operons, however a 
quorum-sensing driven regulation process was not demonstrated for fasX.  Rather, fasX 
controls the growth phase associated expression of GAS virulence factors. It regulates 
surface fibronectin and fibrinogen binding proteins and certain GAS virulence factors 
like mrp, fbp45, streptolysin A (pel) and streptokinase (ska) transcription (Figure 15). 
Both fasX RNA and the fasA response regulator have a similar regulatory effect on the 
transcription of virulence factors, however complementation studies showed that the 
small fasX RNA mainly controls virulence factor expression (Kreikemeyer et al., 2001). 
Another study shows that the wild-type strain adhered to and was internalized by Hep2 
cells at a higher degree compared to the fasX mutant. In addition, a fasX mutant showed 
reduced aggressiveness of strain as the mutant displayed decreased cytokine production, 
apoptosis induction and cytotoxicity. These results show that fasX expression is important 
for GAS in tissue colonization and intracellular persistence (Klenk et al., 2005). 
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Figure 15. The fas operon and fasX RNA (from Maria Siller thesis). P1 and P2: putative promoter 
sequence, TT: putative transcription terminator  
 
pel RNA 
pel stands for pleiotropic effect locus. It includes the sagA gene, structural gene for SLS, 
and functions as an effector of virulence factor expression (Nizet et al., 2000). 
Downstream of the sagA gene are sagB to sagl genes, which are involved in chemical 
modification, processing and secretion of SLS (Figure 16). Creation of isogenic sagBC, 
sagDEF and sagGHI-deficient strains and complementation studies proved that the 
phenotype is due to the pel locus and not due to polar effects of downstream genes. pel 
RNA regulates the expression of virulence factors like M protein, SpeB, Ska (Biswas et 
al., 2001; Li et al., 1999) and SIC (Mangold et al., 2004). pel RNA is regulated in a 
growth-phase dependent manner and is induced by condition media. TCSs or genes 
encoding signaling molecules have not been identified in the vicinity of the pel locus, 
however addition of conditioned media to early logarithmic cells induced transcription of 
pel. 
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Figure 16. The genetic locus for pel RNA and SLS production in S. pyogenes (M1 serotype) (from Maria 
Siller thesis). P1: transcriptional start, T1: putative transcriptional terminator 1, T2: putative transcriptional 
terminator 2  
 
rivX RNA 
RivR, a RofA-like protein, activates the expression of mga. RivX is a novel small RNA, 
encoded within an operon with rivR. rivX also activates the expression of the Mga 
regulon via a RivR-independent mechanism. rivX is conserved in all GAS genomes 
sequenced to date. Furthermore, RivRX is directly repressed by CovR (Roberts et al., 
2007). This shows a link between two major regulators of GAS virulence, Mga and 
CovR, where RivR and RivX play intermediaries in pathogenic regulatory circuits 
(Figure 17). A rivRX mutant in the covR deletion background was strongly attenuated for 
virulence in a murine model of invasive soft tissue infection (Roberts & Scott, 2007). 
rivRX-activated virulence factors include M protein, ScpA, Fba and Sic (Ashbaugh et al., 
2000; Lukomski et al., 2000; Okada et al., 1994; Terao et al., 2001). The rivRX locus 
does not autoregulate its own expression. Further, the analysis of rivX containing non 
sense mutations proved that the sRNA rivX itself, rather than a peptide encoded by rivX is 
responsible for rivX activity. However, rivX dependent mga-activated gene expression 
requires Mga protein. To note, the presence of rivX RNA was not demonstrated by 
Northern blot analysis but by RT-PCR analysis.  
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Figure 17. Model for regulation of virulence by RivR and rivX RNA (from Maria Siller thesis)  
 
2.7 Riboswitches 
 
Most of the riboregulator sRNAs function in trans while there is another class of 
regulatory RNAs, which are cis-acting RNA elements called riboswitches. To date more 
than a dozen classes of riboswitches are known (Barrick & Breaker, 2007). Although 
riboswitches were found in the genomes of archea, fungi and plants, most of them were 
identified in bacteria. Especially in Fermicutes (low G+C gram-positive) bacteria use 
extensively riboswitches (Table 7). As example, more than 70 cis-acting regulatory 
RNAs were described in Bacillus subtilis. In bacteria, the AdoCbl riboswitch is the most 
prevalent one but TPP, FMN and SAM-I riboswitches are also common in many groups 
(Barrick & Breaker, 2007). 
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Table 7. Distribution of riboswitches (Adapted from Winkler and breaker, 2005) 
Gram-positive bacteria Gram-negative bacteria 
B12 riboswitch (Cobalamin) 
Bacillus, Listeria, Enterococcus, Clostridium, 
Thermoanaerobacter 
Escherichia, Salmonella, Klebsiella, Yersinia, Vibrio, 
Pasteurella, Pseudomonas, Shewanella, Xanthomonas 
FMN riboswitch 
Bacillus, Oceanobacillus, Staphylococcus, Listeria, 
Enterococcus, Streptococcus, Lactococcus, Lactobacillus, 
Clostridium, Thermoanaerobacter 
Coxiella, Shewanella, Escherichia, Klebsiella, 
Pasteurella, Haemophilus, Vibrio, Xanthomonas, 
Salmonella, Yersinia, Shigella, Photorhabdus, 
Actinobacillus, Pseudomonas 
TPP riboswitch 
Bacillus, Listeria, Staphylococcus, Oceanobacillus, 
Enterococcus, Streptococcus, Lactococcus, Lactobacillus, 
Clostridium, Thermoanaerobacter 
Pasteurella, Haemophilus, Aeromonas, Coxiella, 
Shewanella, Vibrio, Xanthomonas, Thiocystis, 
Escherichia, Salmonella, Shigella, Erwinia, 
Photorhabdus, Yersinia, Pseudomonas 
Lysine riboswitch 
Bacillus, Staphylococcus, Oceanobacillus, Clostridium, 
Thermoanaerobacter 
Shewanella, Pasteurella, Haemophilus, Vibrio, 
Escherichia, Shigella 
SAM riboswitch 
Bacillus, Listeria, Staphylococcus, Oceanobacillus, 
Clostridium, Thermoanaerobacter 
Xanthomonas 
Purine riboswitch 
Bacillus, Listeria, Staphylococcus, Oceanobacillus, 
Geobacillus, Enterococcus, Streptococcus, Lactococcus, 
Clostridium, Thermoanaerobacter 
Vibrio, Bdellovibrio 
Glycine riboswitch 
Bacillus, Listeria, Staphylococcus, Oceanobacillus, 
Streptococcus, Clostridium 
Vibrio 
GlcN6P riboswitch 
Bacillus, Listeria, Staphylococcus, Oceanobacillus, 
Lactobacillus, Enterococcus, Clostridium, 
Thermoanaerobacter 
 
PreQ riboswitch 
Bacillus, Streptooccus, Lactococcus  
 
 
2.7.1 Riboswitches: Definition and modes of action 
 
Bacteria are able to sense and quantify intracellular metabolite concentration and regulate 
relevant gene expression accordingly. Riboswitches are RNAs that bind to cellular 
metabolites and by this leads to changing secondary or tertiary structures which then can 
modulate gene expression in cis without the involvement of protein factors. Nearly all of 
the riboswitches are cis-acting regulatory elements and are part of the 5’ UTRs of 
mRNAs. Riboswitches can bind to metabolites ranging from very simple amino acids to 
very complex vitamins (Montange & Batey, 2008). These metabolites are involved in 
fundamental biochemical processes like coenzyme B12, thiamine pyrophosphate (TPP), 
flavin mononucleotide (FMN), S-adenosylmethionine (SAM), lysine, guanine and 
adenine. Riboswitches are almost always located near the genes involved in biosynthesis 
or transport of their metabolites they sense. When a metabolite is present in the sufficient 
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quantity, most of the riboswitches function by inhibiting the biosynthesis or transport of a 
related gene, to avoid overproduction of the metabolites in the cell. Riboswitches show 
high specificity and affinity to their targets. Most riboswitches are composed of two 
functional domains. The first portion is the conserved “aptamer” domain, which binds to 
the metabolite and immediately downstream the second domain is called a “sequence 
element” or “expression platform”, which controls gene expression at the transcriptional 
or translational level. The aptamer domain size ranges from ~70 to ~200 nucleotides, 
while the expression platform varies greatly in size, sequence and structures (Winkler & 
Breaker, 2005).   
To date riboswitch mediated control of gene expression is exercised by four modes of 
actions. The most common mode of action is at the transcriptional level, where 
metabolite binding favours transcriptional termination or anti-termination conformation, 
leading to off or on gene expression respectively (Figure 18). Upon metabolite binding, 
GC-rich intrinsic terminator stems followed by polyuridine tracts are formed within the 
5’ UTR region of the riboswitch, which destabilizes the elongation complex (Winkler & 
Breaker, 2003; Yarnell & Roberts, 1999). Another common mode of gene control is at 
the translational level, where metabolite binding either sequester the ribosomal binding 
site or present it, thus making the gene either off or on, respectively (Figure 18). Hence 
riboswitches control gene expression by directly binding to metabolites and upon binding 
to their specific metabolite, they fluctuate among different conformations. Transcriptional 
attenuation is the most common mode of action in gram-positive bacteria while gram-
negative organisms mostly use translational attenuation (Vitreschak et al., 2004; Winkler 
& Breaker, 2003). The most common mode of gene expression control is by feedback 
repression; however there are examples where activation of gene expression is also 
observed.  
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Figure 18. Riboswitch mediated gene control (Nudler & Mironov, 2004) 
 
Alternative modes of riboswitch-mediated gene expression control are by cleavage of 
nascent RNA and alterations in mRNA stability or splicing (Montange & Batey, 2008). 
Unlike traditional riboswitches, GlcN6P riboswitch does not induce a conformational 
change upon binding to its ligand but rather it acts as a ribozyme, which self-cleaves its 
downstream glmS genes (Cochrane & Strobel, 2008). The glmS gene encodes the enzyme 
glutamine-fructose-6-phosphate amidotransferase. This enzyme produces glucosamine-6-
phosphate (GlcN6P) and this compound triggers the riboswitch function. For the 
downregulation of gene expression, ribozyme self-cleavage activity is necessary. The 
RNA cleavage site resides upstream of the glmS open reading frame.  
In some cases like in glycine riboswitch there are two aptamers followed by single 
expression platform (Mandal et al., 2004). Cooperative binding of metabolites to 
riboswitches helps bacteria to sense even small changes in the metabolite concentrations. 
Riboswitch from B subtilis activates transcription upon glycine exposure. Thus it is rare 
example of genetic on switch (Tucker & Breaker, 2005). 
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2.7.2 Riboswitches in S. pyogenes 
 
Although many riboswitches have been discovered in gram positive bacteria especially in 
B subtilis, but so far no information is available regarding riboswitches in S pyogenes.  
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3) AIMS OF THIS STUDY  
 
S. pyogenes (GAS) is a notorious human pathogen, causing a number of diseases world-
wide. It is a cause of great concern of human mortality and morbidity. A number of 
important questions related to S. pyogenes pathogenicity, virulence factor transfer and 
regulatory aspect still remains unanswered today. The knowledge about GAS 
pathogenesis and its control is necessary not only to help finding novel antimicrobial 
strategies to this pathogen but also to help understanding the molecular mechanisms that 
could explain the recent reemergence of severe infections caused by this pathogen. 
 
Project 1: Lysogenic transfer of Group A streptococcus superantigen gene among 
streptococci 
 
Since the mid-1980s there has been a significant reemergence of the severe forms of GAS 
infections worldwide, particularly necrotizing fasciitis and STSS. Apart from GAS, in the 
last few years, GCS and GGS, which are normally regarded as commensal organisms, 
have also been recovered from NF and STSS infections. Many hypotheses have emerged 
to explain this phenomenon, some focusing on the impaired host defenses to GAS while 
others focused on the emergence of more virulent strains. Bacteriophage-encoded 
virulence factors by lysogenic conversion can convert a non pathogenic strain into a 
pathogenic strain. As GAS is a polylysogenic organism, one can hypothesize that 
horizontal transfer of virulence factors may play a significant role in increased 
pathogenicity. On the other hand, a number of studies indicate that M protein can 
function as barrier to the horizontal gene transfer. 
In our lab we found a phage φ149 carrying the SSA superantigen-containing gene in M12 
GAS strain. We wanted to characterize φ149 and determine the broad host range of this 
phage to find out whether φ149 can convert a non-toxigenic strain to a toxigenic strain 
via lysogenic conversion. To facilitate the study, a kanamycin resistance cassette (aphIII) 
was inserted in the ssa coding sequence in phage φ149, thus generating the recombinant 
phage φ149::aphIII in strain EC516. Strain EC516 would be then used as a donor strain 
of phage φ149::aphIII in transfer experiments to other GAS strains of different M 
serotypes and to group C, G and S. pneumoniae strains using kanamycin resistance as a 
marker for phage transfer. This study would further allow the evaluation of the role of 
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bacteriophages in horizontal transfer of toxins and emergence of increased virulent 
strains. 
 
Project 2: A bioinformatic screen reveals novel small non-coding RNAs in 
Streptococcus pyogenes 
 
Bacteria need to control their gene expression according to changing environmental 
conditions. It has become increasingly evident now that apart from proteins, RNA can 
also control gene expression more commonly than previously anticipated. A number of 
small RNAs have been discovered in bacteria. However, only three putative regulatory 
RNAs have been discovered in S. pyogenes: fasXRNA, pelRNA and rivXRNA. 
The main goal of this study was to identify and characterize novel ncRNAs in S. 
pyogenes using a large scale bioinformatic approach. Four computational algorithms, 
‘QRNA’, ‘RNAz’, ‘Alifoldz’, ‘sRNAPredict2’ and the Rfam database would be used to 
predict sRNAs in intergenic regions of S. pyogenes M1 strain SF370. Selected predictions 
would be verified experimentally by Northern blot analysis and the interesting candidates 
would be characterized further.  
This is the first study aiming at uncovering ncRNAs in GAS in a genome-wide fashion. 
In a long-term perspective, this research would ultimately allow gaining information 
about the role of ncRNAs in the physiology, metabolism and virulence in GAS.  
 
Project 3: Functional analysis of the group A streptococcal luxS/AI-2 system in 
metabolism, adaptation to stress and interaction with host cells 
 
Bacteria have the ability to sense signaling molecules released by similar bacteria. These 
signaling molecules are extra-cellular, low molecular weight molecules called “auto-
inducers” (AIs). Recently, another autoinducing system has been discovered, which 
detects a furanone-like signaling molecule termed “autoinducer 2” (AI-2) in V. harveyi. 
AI-2 is synthesized by the luxS gene, which is found in over 55 gram-negative and gram-
positive bacterial species. AI-2 is proposed to have a role in interspecies communication. 
Knowledge about quorum sensing systems in S. pyogenes is very limited. Two putative 
quorum-sensing systems, sil and fasBCA, have been reported in GAS. The luxS 
homologue was found in S. pyogenes and shown to play a role in certain pathogenicity 
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aspects (Lyon et al., 2001; Marouni & Sela, 2003). Because of the dual metabolic and 
signaling function of luxS/ AI-2, which was reported in certain bacteria, we here were 
interested in the functional analysis of luxS in metabolism versus its implication in 
pathogenicity-linked aspects.  
 
Project 4: Group A Streptococcus activates type I interferon production and 
MyD88-dependent signalling without involvement of TLR2, TLR4 and  TLR9 
 
One of the mechanisms by which the innate immune system senses the invasion of 
pathogenic microorganisms is through the toll-like receptors (TLRs). TLRs recognize 
specific molecular patterns that are present in microbial components like peptidoglycan, 
flagellin, LPS etc. Stimulation of different TLRs induces distinct patterns of gene 
expression, which leads to the activation of innate immunity and also instructs the 
development of antigen-specific acquired immunity.  
Streptococcal invasins and protein toxins interact with mammalian blood and tissue 
components leading to host cell killing and provoke a damaging inflammatory response. 
S. pyogenes possesses two cytolysins: SLS and SLO. Previous data show that the gram-
positive pathogen Listeria monocytogenes produces listeriolysin O, which allow the 
bacteria to escape from the phagolysosome and leads to production of interferons. Here 
my aim was to find whether a similar mechanism of evasion from the immune system 
occurs in S. pyogenes and whether SLS or SLO is responsible for the production of 
interferons from infected macrophages. 
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4) RESULTS 
 
4.1 Project 1: Lysogenic transfer of Group A streptococcus superantigen gene 
among streptococci 
 
4.1.1 Summary 
 
Since the mid-1980s, there has been a significant re-emergence of severe forms of 
diseases (particularly necrotizing fasciitis and streptococcal toxic shock syndrome, STSS) 
caused by Group A Streptococcus (GAS) worldwide (Banks et al., 2002; Cunningham, 
2000). One hypothesis to explain this phenomenon has focused on changes in the 
virulence of the pathogen itself. With this respect, fluctuations in the severity and 
character of GAS virulence have been linked to the plasticity of the streptococcal genome 
involving mobile genetic elements. In GAS, prophages encode, in addition to their 
essential viral proteins, one or more putative or established virulence factors including 
superantigens (Banks et al., 2002; Brussow et al., 2004). Via lysogenic conversion, the 
toxin-encoding bacteriophages can convert their bacterial host from a non-pathogenic 
strain to a virulent strain or a strain with increased virulence (Brussow et al., 2004). 
Screening GAS clinical isolates for superantigen-encoding bacteriophage transfer 
revealed a clinical isolate of M12 serotype derived from a patient with STSS that carries 
a novel bacteriophage, φ149, encoding the streptococcal superantigen SSA (Igwe et al., 
2003; Reda et al., 1996) (allele ssa-3). Sequence analysis of the att-L proximal region of 
φ149 showed a mosaic nature of the phage, which shares characteristics with previously 
described GAS prophages. Release of φ149 from the bacterial chromosome was obtained 
after induction with the antibiotic and DNA damaging agent mitomycin C, hydrogen 
peroxide and UV treatment. Bacteriophage titer was estimated as 7 x 104 pfu/mL. 
Remarkably, lysogenic conversion of GAS clinical isolates of various M serotypes (M1, 
M3, M5, M12, M19, M28 and M94) as well as of Group C Streptococcus equisimilis 
(GCSE) clinical isolates via transfer of a recombinant phage φ149::Kmr was successfully 
obtained. φ149::Kmr from selected lysogenized GAS and GCSE strains could be 
transferred back to M12 GAS strains.  
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This is the first direct experimental evidence for toxigenic conversion via lysogeny across 
a diverse range of GAS clinical isolates of distinct M types and between GAS and GCSE. 
Our data indicate that horizontal transfer of lysogenic phage among GAS is not 
obligatory M-type restricted and provide further support for the concept of interspecies 
lysogenic toxin-conversion. Streptococci might employ this mechanism specifically to 
allow more efficient adaptation to changing host challenges, potentially leading to fitter 
and more virulent clones. 
My contribution to this study was the determination of bacteriophage titer, analysis of the 
inducibility of φ149 by mitomycin C, ultra-violet radiation and H2O2 using lysogenic 
infections as read-outs. Infection assays were performed to determine the host range of 
φ149 with 34 GAS, 10 GCS and 10 GGS. Retransfer experiments were done from 
selected M serotypes to M12 serotype and from GCS to GAS. All of the lysogens were 
checked by PCR and Southern blot analyses. 
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AgroupAStreptococcus (GAS)isolate, serotypeM12,recoveredfromapatientwithstreptococcal toxicshocksyndrome
was analyzed for superantigen-carrying prophages, revealing149, which encodes superantigen SSA. Sequence anal-
ysis of the att-L proximal region of 149 showed that the phage had a mosaic nature. Remarkably, we successfully
obtained lysogenic conversionofGASclinical isolates of variousMserotypes (M1,M3,M5,M12,M19,M28, andM94),
aswell as of groupCStreptococcus equisimilis (GCSE) clinical isolates, via transfer of a recombinant phage149::Kmr.
Phage149::Kmr fromselected lysogenizedGASandGCSE strains couldbe transferredback toM12GAS strains.Our
data indicate that horizontal transfer of lysogenic phages among GAS can occur across theM-type barrier; these data
alsoprovidefurthersupport for thehypothesis that toxigenicconversioncanoccurvia lysogenybetweenspecies.Strep-
tococci might employ thismechanism specifically to allowmore efficient adaptation to changing host challenges, po-
tentially leading to fitter andmore virulent clones.
Streptococcus pyogenes, or-hemolytic group A Streptococ-
cus (GAS), is a notorious human pathogen, responsible for
a number of different infections that range frommild skin
diseases to fulminant, severe, invasive syndromes. Since the
mid-1980s, a remarkable increase in the incidence of the
severe forms of GAS infections (in particular, necrotizing
fasciitis and streptococcal toxic shock syndrome [STSS])
hasbeenobservedworldwide [1, 2].Manyhypotheseshave
emerged to explain this phenomenon; some focus on im-
paired host defense against specific strains or specific viru-
lence determinants (e.g., immunogenetic background or
predisposing factors), whereas others focus on changes in
bacterial virulence itself [3–5].
Fluctuations in the severity and character of streptococ-
cal virulence have also been linked to the plasticity of the
streptococcal genome. Mobile genetic elements, including
lysogenicbacteriophages, thathave integrated into theGAS
genome over time were found to be almost exclusively re-
sponsible for the genetic differences among strains [6–11].
Recent genomic analyses indicate that GAS is a polylyso-
genic organism in which prophage sequences constitute
10%of the total genome [1, 3, 7, 12]. InGAS, prophages
encode 1 ormore putative or established virulence factors,
including phospholipases, streptodornases, and superanti-
gens, in addition to their essential viral proteins [1, 12]. It is
nowwidely acknowledged that virulence gene transfermay
occur among GASwhen favorable conditions are encoun-
tered in the human host [13–18]. By means of lysogenic
conversion, the toxin-encoding bacteriophages can con-
vert their bacterial host from a nonpathogenic strain to a
virulent strain or a strain with increased virulence [12, 13,
19].Along these lines, prophageshavebeen shown toplay a
key role in subclone diversification and to be largely re-
sponsible for the uniqueness of clinical isolates [3]. Conse-
quently, GAS prophages play a critical role in determining
the distinct disease pathologies associated with otherwise
similar strains [1].
The critical role of superantigens in severe GAS infec-
tion underlines the clinical relevance of prophages [2,
20, 21]. In GAS, the majority of superantigen genes are
located on prophage genomes. Experimental ex vivo
toxigenic conversion by lysogeny has been demonstrated
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Table 1. Bacterial strains and plasmids used in this study.
Strain or plasmid Relevant characteristic(s)
Source or
reference
Strain
E. coli Host strain for cloning Lab collection
DH5-
TOP10 Host strain for cloning Lab collection
S. pyogenes
RDN149 M12, 149 donor, ssa, speH [29]
EC516 RDN149 (149::Kmr) This study
RDN151 M12, indicator strain for 149, ssa, speH [29]
EC627 RDN151 (pMSP3535) This study
EC496 RDN151 lysogenized with 149 This study
EC497 RDN151 lysogenized with 149 This study
CS112 M12, CS112 donor, speC [38]
CS24 M12, indicator strain for CS112 and 149, speC,
ssa, speH [38]
RDN313 CS24 lysogenized with CS112 This study
RDN312 CS24 lysogenized with 149 This study
EC500 CS24 lysogenized with 149 This study
RDN1 M1, clinical isolate Lab collection
RDN2 M19, clinical isolate, recipient for 149 Lab collection
RDN3 M1, clinical isolate Lab collection
RDN4 M49, clinical isolate Lab collection
RDN5 M3, clinical isolate, recipient for 149 Lab collection
RDN6 M3, clinical isolate, recipient for 149 Lab collection
RDN8 M1, clinical isolate, recipient for 149 Lab collection
RDN27 M12, clinical isolate, recipient for 149 Lab collection
RDN29 M1, clinical isolate Lab collection
RDN57 M49, clinical isolate Lab collection
RDN60 M5, clinical isolate, recipient for 149 Lab collection
RDN74 M89, clinical isolate Lab collection
RDN78 M3, clinical isolate Lab collection
RDN83 M89, clinical isolate Lab collection
RDN86 M1, clinical isolate Lab collection
RDN89 M3, clinical isolate Lab collection
RDN100 M83, clinical isolate Lab collection
RDN104 M81, clinical isolate Lab collection
RDN106 M94, clinical isolate, recipient for 149 Lab collection
RDN107 M1, clinical isolate Lab collection
RDN114 M3, clinical isolate Lab collection
RDN116 M94, clinical isolate, recipient for 149 Lab collection
RDN119 M1, clinical isolate Lab collection
RDN138 M12, clinical isolate, recipient for 149 Lab collection
RDN139 M28, clinical isolate Lab collection
RDN144 M28, clinical isolate, recipient for 149 Lab collection
RDN145 M12, clinical isolate, recipient for 149 Lab collection
RDN146 M12, clinical isolate, recipient for 149 Lab collection
RDN147 M12, clinical isolate, recipient for 149 Lab collection
RDN148 M12, clinical isolate, recipient for 149 Lab collection
RDN152 M22, clinical isolate Lab collection
RDN156 M28, clinical isolate, recipient for 149 Lab collection
EC1091 RDN148 lysogenized with 149::Kmr This study
EC1092 RDN148 lysogenized with 149::Kmr This study
(continued)
only for speA and speC and almost exclusively among strains be-
longing to the same M serotype. The suggested bacteriophage-
mediated transfer of other superantigens is based only on indirect
evidence: for example, their association with prophage sequences,
their distribution pattern throughout the streptococcal population,
or the inducible character of prophages carrying the respective
genes [13, 15, 22–25]. Further, a number of studies indicate thatM
proteins could function, directly or indirectly, as barriers to hori-
zontal gene exchange. A phenotypic correlation between resis-
tance to bacteriophage infection andM-protein surface expression
has been described [26, 27]. Nonrandom associations between
exotoxin alleles and emmpatternswere also observed, thus suggest-
ing some direct or indirect biological interactions between
M-protein surface structures andbacteriophage-associatedproper-
ties [28–30]. In this study,we focus on themobility of superantigen
SSA, which has been associated with GAS isolated from patients
with STSS and which has highly potent superantigenic activity that
has been proven experimentally [31–33]. Presence of the ssa gene
has been detected across the GAS population, as well as in clinical
isolates of group C (GCS) and group G (GGS) streptococci (Strep-
tococcus dysgalactiae subspecies equisimilis GCSE and GGSE, re-
spectively), thus suggesting the possibility of interspecies ssa gene
transfer [14, 29, 30, 34–36].
We report here the characterization of an inducible chimeric
prophage,149, carrying the superantigen-encoding ssa-3 allele
from a GAS clinical isolate of serotype M12, RDN149. We de-
scribe the host range of this phage by investigating its transfer-
ability to GAS strains of various M types, as well as to GCSE and
GGSE. This study experimentally confirms previous indications
that lysogenic toxin conversion can occur across theM-type bar-
rier in GAS and between GAS and GCSE.
MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. Streptococcal
strains (table 1; [29, 37, 38]) were grown at 37°C with 5% CO2
without agitation in Todd-Hewitt broth either with or without
0.2%yeast extract supplementation and on tryptic soy agar supple-
mentedwith3%sheepbloodorTHYagar.TransformationofEsch-
erichia coli and S. pyogenes with plasmid DNA was performed as
described elsewhere [39, 40]. Whenever required, antibiotics were
added to the media: erythromycin at 3 g/mL for S. pyogenes; and
kanamycin at 25g/mL forE. coli andat 300g/mL for streptococ-
cal strains.
General DNA manipulation and analysis. Isolation of
streptococcal DNA (genomic and phage) and general DNAma-
nipulations were performed as described elsewhere [16, 39],
with minor modifications. VBC-Biotech Services supplied the
primers used in this study (table 2) and performed sequencing
reactions. General sequence analysis was performed by use of the
DNA* (DNAStar) software package and the Basic Local Align-
ment Search Tool (BLAST) algorithm.
Construction of 149::Kmr. A kanamycin-resistance (Kmr)
cassette, aphIII, was inserted into the ssa gene of phage 149 in
strain RDN149, thus generating strain EC516, which carried re-
combinantphage149::Kmr. For thispurpose, an856-bp fragment
upstream of ssa and a 569-bp fragment downstream of ssa were
amplified by use of RDN149 genomic DNA and primers (contain-
ing flanking restriction sites) OLEC154/OLEC155 and OLEC153/
OLEC159, respectively. After digestionwith appropriate restriction
enzymes, fragments were ligated and cloned into pEC61, a suicide
plasmid for GAS. The resulting plasmid, pEC97, was digested with
ScaI (which interrupts the ampicillin-resistance cassette) and used
to transform electrocompetent RDN149. Kmr clones were then se-
Table 1. (Continued.)
Strain or plasmid Relevant characteristic(s)
Source or
reference
EC1093 RDN148 lysogenized with 149::Kmr This study
EC749 RDN156 lysogenized with 149::Kmr This study
EC917 RDN156 lysogenized with 149::Kmr This study
EC727 RDN116 lysogenized with 149::Kmr This study
EC1083 RDN116 lysogenized with 149::Kmr This study
S. dysgalactiae
subsp. equisimilis
EC783 Clinical isolate Lab collection
EC788 Clinical isolate Lab collection
Plasmid
pUC19 ColE1ori, Ampr, lacZ Lab collection
pMSP3535 ermB, repDEG-pAM-1, nisRK, ColE1ori, PnisA [37]
pEC61 pUC19aphIII This study
pEC96 pEC61ssa-up This study
pEC97 pEC96ssa-down This study
NOTE. Lab, laboratory.
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lected and analyzed by polymerase chain reaction (PCR) and
Southern blot analyses. This ensured that the recombination event
by double crossoverwas correct anddidnot affect theDNAregions
located upstream and downstream of ssa.
Phage induction by mitomycin C treatment. Mitomycin C
(Sigma) was added (0.2g/mL) to cultures grown to early–mid-
logarithmic phase [24, 41]. After incubation for 3 h at 37°C, cells
were removed by centrifugation and supernatants were sterile-
filtered through 0.45-m pores (Iwaki Glass). Possible bacterial
contamination of filtrates was excluded by inoculating an ali-
quot of the filtrates in liquid and on solid media.
Detection of phage release in mitomycin C–treated bacte-
rial cultures. Two approaches were used. (1) A phage indicator
strain culture grown tomid-logarithmicphasewasmixedwith ster-
ile water, poured over THY agar plates, and allowed to sediment.
Superfluous bacterial suspension was carefully removed and plates
were left to dry. Supernatants ofmitomycinC–treatedphage donor
cultures were then spotted on the indicator lawn. (2) Supernatants
ofmitomycinC–treatedphagedonor culturesweremixedwith cul-
tures of phage indicator strain and added to molten top agar. The
mixture was then poured over THY agar plates and allowed to dry.
In both approaches, the final stepwas to incubate the plates at 37°C
until plaques were observed.
Lysogenization of recipient strains with phage 149. By
use of the first approach described above, secondary growth col-
onies were recovered from the areas of lysis and analyzed for
sensitivity to phage infection. Lysogenized strains for which no
lysis was observed were then selected and analyzed by PCR and
Southern blot analysis for the presence of the phage.
Determination of the host range of149::Kmr. Supernatants
ofmitomycin C–treated EC516 cultures weremixed with recipient
cultures grown to early–mid-logarithmic phase and further incu-
bated for 3 hours at 37°C. Aliquots of themixture were then plated
on tryptic soy agar that contained kanamycin. Selected Kmr-
Table 2. Oligonucleotides used in this study.
Oligonucleotide Direction Sequence (5' to 3' direction) Specific gene target
oliRN70 F GCTATTTTTTGACTTACTGGG aphIII
oliRN69 R TCCGTATCTTTTACGCAGCGG aphIII
oliRN110 F CGCTGCGTAAAAGATACG aphIII
oliRN111 R AATGGAGTGTCTTCTTCC aphIII
oliRN133 F TATTCGCTTAGAAAATTAA emm
oliRN134 R GCAAGTTCTTCAGCTTGTTT emm
oliRN39 F AAAAATGACATTGCTTGGGC hki
oliRN40 R TTTAGTAGATATACTTTATTGGC hki
oliRN233 F AGATTGGATATCACAGG speH
oliRN234 R CTATTCTCTCGTTATTGG speH
oliRN237 F GTGTAGAATTGAGGTAATTG ssa
oliRN238 R TAATATAGCCTGTCTCGTAC ssa
OLEC141 F AACAAGTCACTGTTCAAG ssa
OLEC142 R GCTACAACGAGTATTCTT ssa
OLEC166 F GTACGAGACAGGCTATAT ssa
OLEC211 F TGCACAATTATTATCGATTAG ssa
OLEC153 F TAACTTGGATCCGTTCAATAGTAAAGATTTAGCTGC Insertion of aphIII into ss
OLEC154 R TTCTTACTGCAGGCTGACCTGTGGATCTTACATTAG Insertion of aphIII into ss
OLEC155 F AAGTAAGCATGCACCCAATATTTTTCGTTAGTGAAG Insertion of aphIII into ss
OLEC159 R TATGAAGGTACCTTAACTAGTATCATGGATTTGATAC Insertion of aphIII into ss
OLEC179 F TTGCTCATGCGCAATTCG Spy1278
OLEC497 R AATATTGGGTGTTTTAGAAGCC Spy1278
OLEC178 R ATCGCTTGCTTAAACTCG prx
OLEC395 F ATGGAGAAGTTGTGACTAAGG prx
OLEC396 F TGACAATGGATATATCGCAGG prx
OLEC156 R TTAACTAGTATCATGGAT Intergenic ssa-prx
OLEC167 R CAATTACCTCAATTCTAC Intergenic ssa-Spy1278
OLEC267 R AAGAACCTTGTCGCTATC Intergenic attR-Spy1275
OLEC325 R GATGACTGACCATTATAG Intergenic attR-Spy1275
OLEC324 R GCTACAAAATAACGAAAC Intergenic attR-prx
OLEC500 F AGAAGCAACTGAATTGA Spy1329
NOTE. The underlined sequences indicate restriction sites. Spy1275, Spy1278, and Spy1329 refer to annotated open reading
frames in strain MGAS10750F. F, forward; prx, paratox gene; R, reverse.
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positive colonies were analyzed by PCR and Southern blot analysis
to determine whether the recombinant phage was present. Lysog-
enization was confirmed for 2–3 independent lysogens per infec-
tion experiment. Lysogenization experiments were performed in-
dependently 3–4 times.
RESULTS
Phage release after mitomycin C treatment of an M12 clinical
isolate. The analysis of a type M12 clinical GAS isolate,
RDN149, recovered from a patient with STSS, revealed the su-
perantigen genes ssa and speH (table 1). Subsequent treatment of
a bacterial culture of RDN149 with mitomycin C resulted in the
release of phage particles in the culture supernatant, which could
be demonstrated by plaque detection with the phage indicator
strains CS24 and RDN151 (M12 types). The plaques obtained
with both indicator strainswere turbid,2mm in diameter, and
the bacteriophage titer was estimated at 7  104 pfu/mL (data
not shown). The presence of phage particles in the supernatant
of mitomycin C–induced RDN149 cultures was further confirmed
by isolation of phage DNA. In contrast, no phage DNA could be
detected in the supernatant of cultures that were not subjected to
mitomycinC treatment (data not shown). Further characterization
of the released prophage(s) by PCR analysis indicated the possible
presence of 2 phages in the supernatant (figure 1A).
Ex vivo lysogeny of phage 149 associated with ssa-toxigenic
conversion. To investigate whether phage(s) released from strain
Figure 1. Gel electrophoresis patterns demonstrating ex vivo lysogenic transfer of ssa-3–carrying phage 149 to group A Streptococcus (GAS)
clinical isolates of type M12. A, Results of polymerase chain reaction analysis of isolated phage DNA from strain RDN149 and genomic DNA from phage
donor strain RDN149, phage indicator strain CS24, and lysogenized strain RDN312 with primers specific to the ssa gene (lane 1), the speH gene (lane
2) and the hki gene (lane 3). hki encoding a putative histidine kinase served as positive control for GAS genomic DNA. M, 1-kb DNA ladder (Fermentas
Life Sciences). The 709-, 681-, and 416-bp DNA fragments correspond to the ssa-, hki-, and speH-specific amplified products, respectively. B, Results
of Southern blot analysis of HindIII-digested genomic DNA of phage donor strain RDN149; phage indicator strains RDN151 and CS24; and lysogenized
strains EC496, EC497, RDN312, and EC500, with -32P labeled DNA probes specific to the ssa, speH, and hki genes. The approximate sizes of the
hybridizing fragments are indicated in bp.
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RDN149 could convert speH-negative and ssa-negative strains into
speH-positive and/or ssa-positive strains, lysogenization experi-
ments involving the phage indicator strain CS24 with mitomycin
C–induced supernatants of RDN149 were conducted. Each lysog-
enization experiment performed was positively controlled with
CS112 lysogenization of recipient strain CS24 with strain CS112
used as phage donor [24]. Lysogenic clones were obtained success-
fully and further analyzed for transfer of the superantigen genes.
PCR analysis of genomic DNA from the phage donor strain
(RDN149), phage indicator strain (CS24), and lysogenized CS24
strains (RDN312 and EC500), as well as purified phage DNA from
RDN149, showed that only ssa, not speH, was transferred to the
phage indicator strain (figure 1A).
These results, confirmed by Southern blot analysis, suggested
that in RDN149, speH and ssa are encoded on 2 distinct pro-
phages (figure 1B). The transferable, lysogenic, ssa-carrying ph-
age was designated 149. To further verify that lysogeny was
responsible for the observed ssa-toxigenic conversion, we re-
peated the experiments with the second phage indicator strain,
RDN151. Toxigenic conversion of RDN151 with 149 was also
observed (figure 1). Thus, we have identified ssa-carrying phage
149 in strain RDN149, which can convert ssa-negative clinical
strains of type M12 to ssa-positive strains via lysogenization.
Characterization of the ssa-carrying phage 149. The su-
perantigen SSA shares considerable homology with the S. aureus
enterotoxins SEB and SEC [33, 42]. Three alleles of ssa have
already been identified in natural GAS populations [35]. The
alleles ssa-1 and ssa-3 differ by a single synonymous substitution
in codon 94, and both encode SSA-1. The ssa-2 allele is identical
to ssa-3 at codon 94, but has a nonsynonymous substitution at
codon 28, which changes the second amino acid of the mature
protein from serine to arginine [35]. PCR amplification of the
ssa coding sequence in RDN149 with primers oliRN237 and
OLEC156, followed by sequencing, revealed the ssa-3 allele. To
determine the attachment site of 149 and its location on the
chromosome of strain RDN149, we took advantage of the fact
that, in all GAS prophages, the genes encoding virulence factors
are located at one extremity of the prophage, between the phage
lysis cassette and the phage attachment site [12]. At the time of
the study, 2 GAS prophages, 315.2 (strain MGAS315 [M3
type]) and SPsP6 (strain SSI-1 [M3 type]), had already been
described that carried the ssa gene (ssa-1 allele) [7, 10].
Southern blot analysis of HindIII-digested genomic DNA of
strain RDN149 revealed an ssa-hybridizing DNA fragment, the
size of which (2700 bp) was different from that expected in
strains MGAS315 and SSI-1 (5090 bp) (figure 1). There are sev-
eral possible explanations for this result: (1) 149 is identical to
315.2 orSPsP6 but is integrated at a different attachment site;
(2)149 is identical to315.2 orSPsP6 and is integrated at the
same attachment site, but the chromosomal region surrounding
the attachment sites differs among strains; or (3)149 is a novel
GAS prophage that has not yet been characterized.
We performed inverse PCR using religated, HindIII-digested
genomic fragments of strain RDN149 as DNA templates and
ssa-specific outward primers OLEC141 and OLEC142 (table 2;
figure 2). The PCR fragment obtained was purified and used as a
DNA template in PCR reactions with embedded primers
OLEC166 and OLEC167 (table 2; figure 2). Sequence analysis of
the resulting PCR fragment indicated that 149 consisted of a
chimeric GAS prophage. The downstream region of the ssa cod-
Figure 2. Comparison of the att-L proximal region of ssa-3–carrying phage 149 with the att-L proximal regions of ssa-1–carrying phages 315.2
(MGAS315; M3) and SPsP6 (SSI-1, M3) and mf3-carrying phages 315.3 (MGAS315; M3), SPsP4 (SSI-1; M3), 370.2 (SF370; M1), and 370.2-like
(MGAS8232; M18). The shaded areas indicate the regions of similarity with the percentage of nucleotide identity given. The 34 bp IS1239-related
sequence located 103 bp upstream of the ssa coding sequence is shown. Annotated open reading frames refer to the genomes of MGAS315 strain
(315.2) and SF370 (370.2). Small, black arrows, positions of primers.
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ing sequence, which includes a hypothetical phage protein re-
ferred to as paratox, the left 149 attachment site, and the adja-
cent sequence on the bacterial chromosome showed identity to
the DNA region upstream of the streptodornase gene (mf3) in 4
GAS prophages that have already been described:370.2 (SF370
[M1]), SPsP4 (SSI-1 [M3]), 315.3 (MGAS315 [M3]), and
370.2-like prophage (MGAS8232 [M18]) (figure 2) [7, 8, 10, 11].
All 4 prophages, and therefore also149, are integrated into the
GAS bacterial genome at the same attachment site, which is located
341 bp upstream of a putative heavy metal–transporting, ATPase-
encoding gene. Nucleotide sequence analysis of the upstream re-
gion of ssa-3 in 149 revealed 99% identity with the upstream re-
gion of ssa-1 in 315.2 (MGAS315 [M3]) and SPsP6 (SSI-1
[M3]). The difference consists of a 34-bp insertion located 103 bp
upstreamof the ssa-3 start codon, which is not present upstreamof
ssa-1.This 34-bp insertion comprises a 26-bp insertion element (5'-
CTCTTTTAAAATTAAAACATTGATTT-3'), which doubles the
sequence 5'-AATTTTAT-3'. The 26-bp insertion element was pre-
viously identified upstream of the insertion sequence IS1239 and,
on this basis, it was suggested that it may function as a target se-
quence [42]. It was shown to be more frequently associated with
ssa-3 than with ssa-1 or ssa-2 [35]. In addition, the presence of
IS1239 associated with the 26-bp insertion element was identified
upstream of ssa-3 in several serotypes—M4, M15, M23, M33 and
M41—leading to the suggestion that IS1239 might have contrib-
uted to the horizontal transfer of ssa among GAS [35]. Taken to-
gether, these observations suggest that recombination events may
have taken place, leading to the mosaic nature of149.
Determination of host range of 149 among clinical iso-
lates of GAS. We were interested in the possibility that 149
could be transferred ex vivo to clinical isolates of GAS. As de-
scribed above, we showed transfer of149 from the donor strain
RDN149 (type M12) to the phage indicator strains CS24 and
RDN151 (type M12). To facilitate the detection of toxin-
converted strains, a selective marker (the kanamycin-resistance
cassette, apiII) was inserted into the ssa-3 coding sequence of
149, thus creating strain EC516. Strain EC516 was then used as
a donor strain of 149::Kmr in infection experiments involving
other GAS clinical isolates of various M serotypes. Lysogenic
strains were selected on the basis of their Kmr phenotype, which
was verified by PCR scoring for the presence of the Kmr cassette
flanked by the interrupted ssa-3 sequence and further verified by
subsequent Southern blot analysis. In this study, 34 clinical iso-
lates, which represented 12M types, were analyzed for lysogenic
conversion. A total of 17 strains that comprised 7 different M
types and were classified as pattern A-C/SOF- strains (M1, M3,
M5, M12, and M19) and pattern E/SOF strains (M28 and
M94) [43, 44] were successfully lysogenized (table 3; figure 3).
Further, the transfer of 149::Kmr from selected M1, M12, and
M94 lysogens back to clinical isolates of typeM12 (RDN151 and
RDN138) was obtained. This indicated that the recombinant
phage was still functional once inserted in the chromosome of
the lysogenic strains. In addition, infection experiments with
UV-induced and hydrogen peroxide (H2O2)–induced EC516
culture supernatants led successfully to lysogenic clones among
M12 strains (data not shown).
Ex vivo lysogenic transfer 149 to other streptococcal
species. Several studies report the presence of ssa-3 among the
emerging human pathogens GCSE and GGSE, thus suggesting a
temporal dynamic for ssa-3 exchange across streptococcal spe-
cies [14]. Here, we asked whether 149 could be lysogenically
transferred ex vivo from GAS to other streptococcal species. In-
fection experiments were conducted that used the 149::Kmr
phage donor strain EC516 and 10 GCSE clinical isolates and 10
GGSE clinical isolates as recipient strains, by use of the same
approach described above. Two GCSE strains were successfully
lysogenized (table 3). 149::Kmr was also transferred from se-
lected GCSE lysogens back to clinical isolates of type M12
(RDN151 and RDN138). Taken together, the ability of 149::
Kmr to lysogenize GAS strains of different clonal lineages and
different M types as well as GCSE isolates indicate that phage
transfer most probably played a critical role in mediating the
spread of ssa across the streptococcal population.
DISCUSSION
The recent reemergence of severe, invasive GAS diseases observed
during themid-1980s has encouragedmany researchers to investi-
gate this phenomenon. Some studies questionedwhether enhanced
virulence could be associated with a particular M type or with cer-
Table 3. Ex vivo lysogenic transfer of 149::Kmr between
streptococcal species.
Group, M type
Clinical
isolates,
no.
Serum
opacity
factor
Lysogenizationa
with 149::Kmr
Positive Negative
Group A Streptococcus
M1 7  1 6
M3 5  2 3
M5 1  1 0
M12 8  8 0
M19 1  1 0
M22 1  0 1
M28 3  2 1
M49 2  0 2
M81 1  0 1
M83 1  0 1
M89 2  0 2
M94 2  2 0
Group C Streptococcus 10 . . . 2 8
Group G Streptococcus 10 . . . 0 10
a Each lysogenization experiment was performed at least 3 times indepen-
dently. Lysogens were analyzed by polymerase chain reaction and Southern
blot analysis for the presence of the recombinant phage.
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tain virulence factors. Reports show the existence of particular vir-
ulent and invasive clones that have successfully spread worldwide
[3, 4, 7, 45]. However, despite the dominance of certain M types,
such asM1,M3,M12, andM28, among endemic and invasiveGAS
isolates, no exclusive link between M type and specific diseases
could be demonstrated.Only certainM types seem to exhibit a cor-
relation with invasive diseases (e.g., M1 andM3) or postinfectious
sequelae from superficial GAS infection (e.g.,M18) [11, 29, 30, 45].
Furthermore, invasiveGAS isolates donot seem tobe characterized
by a common toxin-gene profile. Although reports show the dom-
inanceof1or2 toxin-geneprofiles inallMtypes, strains thatdidnot
share thepredominantprofile still showednonrandomdistribution
of key toxin genes that were characteristic of theM type [29].
Among bacterial factors that can determine enhanced viru-
lence are superantigen-carrying bacteriophages that can, via ly-
sogenic transfer, convert a nontoxinogenic strain to a toxin-
producing strain [19]. In this study, the analysis of a clinical GAS
isolate, type M12, to determine its superantigen-encoding bac-
teriophage profile uncovered prophage 149, which carried the
allele ssa-3 that encodes the streptococcal superantigen SSA. Se-
quence analysis of the att-L proximal region of 149 indicated
that the phage was amosaic prophage that shared characteristics
Figure 3. Analysis of the broad host range of recombinant phage 149::Kmr. A, Representative restriction map of the att-L proximal region of
149::Kmr. Genes are drawn to scale. Small, black arrows, positions of primers. Sizes of PCR and hybridizing restriction fragments are indicated in bp.
B, Results of polymerase chain reaction analysis of genomic DNA from 149 donor strain RDN149, 149::Kmr donor strain EC516, recipient strain
RDN156 (M28), and lysogenized strains EC749 and EC917, with primers OLEC178 and oliRN70 (top), oliRN69 and OLEC179 (middle), and oliRN111 and
oliRN110 (bottom). M, 1-kb DNA ladder (Fermentas Life Sciences). C, Results of Southern blot analysis of HindIII-digested genomic DNA from 149::Kmr
donor strain EC516, phage recipient strain RDN156 (M28) and corresponding lysogenized strains EC749 and EC917, phage recipient strain RDN116 (M94)
and corresponding lysogenized strains EC727 and EC1083 with -32P labelled DNA probes specific to the ssa upstream fragment (ssaup), aphIII gene,
and ssa downstream fragment (ssadw).
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of 2 different types of prophages: 370.2, SPsP4, 315.3, and
370.2–like phages (already identified in M1, M3, and M18
strains) and 315.2 and SPsP6 phages (M3 strains). This indi-
cates that phage genomic rearrangements occurred, leading to
genetic mosaicism in 149. Recently, the complete genome se-
quence of an M4-type strain, MGAS10750, revealed that the
strain harbors an ssa-3–carrying prophage, 10750.3 [46],
whose att-L proximal region is 100% identical to that of 149
(figure 2). The contribution that the genetic mosaicism of GAS
prophages makes to the emergence and diversification of the
globally disseminated clonalM1T1 strain has already been dem-
onstrated, indicating the exchange of genetic material among
GAS prophages [1, 3, 12].
Superantigen SSA produced by GAS shares greater homology
with staphylococcal enterotoxins SEB and SEC than it does with
streptococcal superantigens. Several studies during the past de-
cade have further documented the presence of the ssa gene
among GAS isolates of different M types, as well as in emerging
clinical isolates of GCSE and GGSE [14, 29, 30, 32–35]. In our
study, we performed infection experiments on GAS clinical iso-
lates of various M types, as well as experiments on GCSE and
GGSE clinical isolates usingmitomycin C–induced cell-free cul-
ture supernatants of strain EC516 harboring the selective recom-
binant phage 149::Kmr. Our results show the ability of 149:
Kmr to lysogenize GAS clinical isolates of 7 different M types
(M1, M3, M5, M12, M19, M28, and M94), as well as the GCSE
clinical isolates. To our knowledge, this is the first direct exper-
imental evidence for toxigenic conversion via lysogeny across a
diverse range of strains of distinctM types and betweenGAS and
GCSE. However, no lysogenic conversion of GGSE clinical iso-
lates could be observed. We hypothesize that such events could
take place, but the experimental conditions in our study might
have limited their detection.
Although some studies indicate that M proteins could func-
tion as barriers to horizontal gene exchange, recent genomic se-
quence analysis strongly suggests that extensive lateral gene
transfer occurred among GAS isolates of different M types [1].
Along these lines, lysogenic conversion of 1 T25-type strain with
SpeC toxin originating from anM12-type isolate was described;
however, the lysogenic transfer eventwas not confirmedbyDNA
analysis [31]. Reports on intergroup streptococcal bacterio-
phage transfer remain limited. Intergroup transduction of
markers for streptomycin and bacitracin resistance between
GCS and GAS using A-25 lytic phage and propagation of a tem-
perate phage isolated fromGGSon eitherGAS orGCShave been
reported [47, 48]. GCSE and GGSE, although generally consid-
ered to be commensal organisms, have also been isolated from
infections in humans that had clinical manifestations similar to
those caused by GAS. In particular, reports of GCSE and GGSE
isolates recovered from patients with severe forms of infection
and of the presence of superantigen genes in these isolates have
increased in recent years [49]. Our data strongly support the
hypothesis that the emergence of superantigen genes in GCSE
and GGSEmay occur by means of horizontal transfer fromGAS
via temperate phage. Accordingly, it has been suggested that
housekeeping genes are exchanged among GCSE, GGSE, and
GAS via lateral transfer with a strong net directionality of gene
movement from GAS donors to GCS and GGS recipients, but
only on the basis of phylogenetic studies [50]. Our experimental
findings raise questions about the extent to which M type and
streptococcal species are barriers to the horizontal transfer of
lysogenic phages, as well as questions about the assumption of
phage specificity within a given streptococcal group.
Given the critical role of temperate bacteriophages in toxi-
genic conversion and in the mediation of strain diversity and
evolution in GAS, it will be important to obtain additional
knowledge of the molecular mechanisms underlying these
events [19, 23]. Further investigation is also needed to unravel
the complex interplay between strain genotype, in vivo toxin-
gene transfer, regulation of toxin expression, and host factors
(i.e., genetics and underlying conditions) that is responsible for
the development of severe streptococcal disease.
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4.2 Project 2: A bioinformatic screen reveals novel small non-coding RNAs in 
Streptococcus pyogenes 
 
4.2.1 Summary 
 
Small non-coding RNAs (sRNAs) define a novel class of molecules with regulatory 
functions in basic house-holding, metabolism and virulence of bacteria. Knowledge of 
sRNAs in the human GAS pathogen remains limited. To date, only three such sRNAs 
have been described in the human pathogen S. pyogenes: fasXRNA, pelRNA and 
rivXRNA, all of which RNAs have a role in virulence gene expression in GAS. 
The objective of the study was to identify novel sRNAs in this species using a large-scale 
computational approach. Four different algorithms ‘QRNA’, ‘RNAz’, ‘Alifoldz’, 
‘sRNAPredict2’ and the Rfam database were used to identify intergenic regions (IGRs) 
likely to encode sRNAs in the genome of M1 strain SF370. Expression of sRNA 
candidates was validated using Northern blot analysis. Characterization of expressed 
sRNAs was done by studying their expression pattern in different M-types throughout 
growth and under stress conditions, determining their intracellular metabolic stability, 
mapping of 5’ and 3’ extremities and analyzing their putative secondary structure. In total, 
218 individual predictions were summarised into 178 loci, of which 90 were further 
analyzed. Under normal growth conditions, 29 (32%) sRNAs were expressed, of which 
five were predicted riboswitches, six were leader elements, four were functional RNAs, 
eight were predicted T-boxes and five were novel sRNAs of unknown function. Three of 
these novel sRNAs were determined to be 5’UTR-derived, whereas one novel sRNA was 
3’UTR-derived. One IGR encoded three novel sRNAs ending at the same rho-independent 
terminator. Several predictions next to scpA, a gene encoding the virulence factor C5a 
peptidase, resulted in the mapping of an sRNA originating from the 5’UTR of the scpA 
mRNA through a transcription termination mechanism.  
Two sRNAs are located in the 5’ UTRs of Spy_0373 and Spy_1016 predicted as 
riboflavin and tryptophan transporters, respectively. Remarkably, S. pyogenes lacks the 
riboflavin synthetic genes and the terminal tryptophan biosynthetic pathway, and therefore 
bacterial growth depends strictly on uptake of the metabolites from the environment, 
which shows an essentiality of Spy_0373 and Spy_1016. Northern blot and RT-PCR 
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analyses showed that the expression of Spy_0373 and Spy_1016 was dependent on the 
absence of riboflavin and tryptophan, respectively, from the growth medium. Our data 
suggest a direct or indirect effect of these metabolites on the expression of the downstream 
genes via transcriptional termination or translational attenuation mechanisms involving the 
5’ UTR-located sRNAs. Thus, vital components in the regulation of expression of these 
important genes reside in the 5’UTRs, indicating the importance of riboswitches and 
leader elements in gene regulation. 
This study allowed the identification and characterization of five novel sRNAs and is the 
first report of riboswitches, T-boxes and functional RNAs in S. pyogenes, some of which 
are currently being further investigated in our laboratory. We also conclude that 
algorithms need further development to selectively identify trans-acting sRNAs in S. 
pyogenes. 
For the above-mentioned results, we worked in a team and my contribution was to 
analyze a number of predictions by Northern blot analysis in 4 M serotypes under normal 
growth conditions and stress conditions (pH, salt and temperature) and determining their 
stability. I also performed the studies to describe the expression of FMN and tryptophan 
sRNA elements versus that of the FMN and tryptophan transporters in different growth 
conditions by Northern blot analysis and semi quantitative RT-PCRs. 
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4.2.3 Additional data  
 
Introduction 
Several studies described a number of small RNAs (sRNAs) regulating gene expression 
in bacteria. Many of these play role in the pathogenicity of bacteria. However, 
information regarding regulatory RNAs in S. pyogenes is rather limited. So far only three 
sRNAs have been discovered, i.e. pel RNA, fasX RNA and rivX RNA.  
In our lab, a bioinformatic approach to search for novel sRNAs in S. pyogenes revealed 5 
novel sRNAs. Three of the novel sRNAs are in the 5’ UTR, one in the 3’ UTR and only 
one candidate was found truly in the intergenic region i.e. SpyRNA049. We chose to 
characterize further SpyRNA049 on the following basis: 1) SpyRNA049 has a stable half 
life as most of the regulatory RNAs described so far have a long half life, 2) It was truly 
located in the intergenic region as seen in many regulatory RNAs functioning in trans 
and 3) bioinformatic tools predicted cfa mRNA a likely target for SpyRNA049. Thus it 
was interesting to investigate the potential regulatory role of SpyRNA049 in different 
aspects of pathogenicity. The following questions were asked: 
 
• Verification of SpyRNA049 computational predictions 
• Expression analysis of SpyRNA049  
• Conservation and alignment of SpyRNA049 in all M serotypes 
• Role of SpyRNA049 in regulating cfa mRNA  
• Role of SpyRNA049 in host cell interaction 
• Role of SpyRNA049 in the expression of virulence factors 
• Role of SpyRNA049 in other pathogenicity aspects 
 
Materials and Methods 
 
Computational prediction of SpyRNA049  
SpyRNA049 in the genome of M1 S. pyogenes strain SF370 (AE004092) was predicted 
by two different programmes, QRNA (Rivas & Eddy, 2001) and sRNA Predict 2 
(personal communication, Hanah Margalet). 
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Secondary structure predictions of SpyRNA049 
Predictions of RNA secondary structure were done using Mfold (Zuker, 2003) default 
parameters at the Rensselaer Polytechnic Institute server 
(http://frontend.bioinfo.rpi.edu/applications/mfold/cgi-bin/rna-form1.cgi). In addition, 
RNAfold (Hofacker et al., 1994) of the Vienna RNA package was used. 
 
DNA manipulations and cloning  
Unless specified otherwise, DNA manipulations (restriction enzyme digestion, gel 
electrophoresis, PCR reaction, DNA purification, ligation) were done according to 
standard techniques (Sambrook et al., 1990). Genomic DNA of S. pyogenes was prepared 
according to a previously described protocol (Caparon & Scott, 1991). PCR reactions 
were done using Pwo Polymerase (Roche), primers listed in Table 1 and S. pyogenes 
SF370 (Table 2) genomic DNA as template. PCR product purification and plasmid 
preparations were done using commercial kits (Qiagen or PeqLab Biotechnologie 
GmbH). Sequencing reactions were done at VBC-Biotech and results were viewed using 
Chromas v.2.31. 
 
Bacterial strains and growth conditions 
Please refer to manuscript 4.2.2.  
Whenever required, suitable antibiotics were added to the medium at the following final 
concentrations: kanamycin 300 µg/ml for S. pyogenes and 25 µg/ml for E. coli.  
 
5’ and 3’ end mapping 
Please refer to manuscript 4.2.2.  
 
Computational prediction of mRNA targets for the novel sRNAs 
Please refer to manuscript 4.2.2.  
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Construction of SpyRNA049-deficient mutant  
E. coli TOP10 was used as host for cloning. S. pyogenes serotype M1 (SF370) was used 
as wild-type. The isogenic SpyRNA049-deficient mutants were constructed using a 
thermo-sensitive strategy described previously (Mangold et al., 2004). First, using wild-
type genomic DNA as template and primers containing flanking restriction sites, a 864 
bp-SpyRNA049-upstream fragment (primers OLEC823/OLEC824) and a 1074 bp-
SpyRNA049-downstream fragment (primers OLEC821/OLEC822) were amplified. After 
digestion with the respective restriction enzymes, the upstream and downstream 
fragments were cloned into the thermo-sensitive plasmid pEC214. After introduction of 
the recombinant plasmid into S. pyogenes SF370, a series of temperature shifts with 
appropriate antibiotic selection was performed thus leading to the final deficient mutant 
(Table 2) in which the entire SpyRNA049 sequence was deleted in a non-polar fashion. 
The correct deletion event in the mutants was verified by PCR, Southern blot and 
sequencing analyses.  
 
Preparation of RNA and Northern blot analysis 
Please refer to manuscript 4.2.2.  
 
RNA stability 
Please refer to manuscript 4.2.2.  
 
CAMP test 
Strains were analyzed for CAMP activity using a conventional diffusion test with minor 
modifications (Gase et al., 1999). Briefly, strains including group B streptococcus as 
positive control, were streaked on 5% sheep blood agar plates perpendicular to, but not 
touching, a streak of the beta-toxin-producing strain S. aureus RN450. After 12 to 20 h of 
incubation at 30°C, streptococcal strains were inspected for CAMP hemolysis. 
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Bacterial aggregation 
Bacterial aggregation was determined as described by (Manetti et al., 2007). S. pyogenes 
strains were grown under agitation in THY at 37°C to stationary phase. Tubes were then 
incubated without agitation and the sedimentation rate was determined by measuring the 
OD at 620 nm from the upper part of the tubes at regular time intervals during 2 h. 
 
Bacterial adhesion, internalization and survival assays in host cells 
HEp-2 cells and RAW 264.7 mouse macrophages were maintained in RPMI medium 
(HEp-2 cells) or Dulbecco's modified Eagle's medium (D-MEM, Gibco) (RAW 264.7 
cells) supplemented with 10% foetal bovine serum (Gibco), penicillin (100 µg/ml) and 
streptomycin (100 µg/ml), and grown at 37°C in an atmosphere containing 5% CO2. Prior 
the infection assay, the cells were cultured overnight to semi-confluency (1.5 x 105 cells 
per well for HEp-2 cells and 2 x 105 cells per well for RAW264.7 cells) in 24-well tissue 
culture plates containing medium without antibiotic. GAS strains were grown to the same 
OD at 620 nm corresponding to late-logarithmic phase (HEp-2 cells) and mid-logarithmic 
phase (RAW 264.7 cells), washed with PBS, suspended in fresh cell culture medium and 
added to the semi confluent host cell monolayer at a multiplicity of infection (MOI) of 
5:1 (HEp-2) and 100:1 (RAW 264.7) in triplicate. Times of incubation were 1 h 
(adhesion, HEp-2 cells), 2 h (internalization, HEp-2 cells) and 30 min (RAW 264.7 cells). 
For adhesion assays (HEp-2 cells), infected monolayers were washed extensively with 
PBS before lysing. For internalization assays (RAW 264.7 cells), extracellularly adhered 
bacteria were killed by incubation with fresh medium containing either 100 µg/ml 
gentamicin and 5 µg/ml penicillin (HEp-2 cells) or 60 µg/ml penicillin (RAW 264.7 
cells). At indicated time points, the infected monolayers were washed extensively with 
PBS to remove the antibiotics. Cells were then lysed with chilled sterile distilled water. 
The number of viable intracellular bacteria released from the lysed cells was determined 
by plating appropriate dilutions of the lysates on TSA blood plates in triplicates followed 
by 24 h incubation at 37°C. The number of bacteria that survived intracellularly was 
calculated using the following equation: average number of bacteria recovered (cfu/ml) 
per well (triplicate) at designated time point/inoculated number of bacteria (cfu/ml)) x 
100. Average values were plotted. 
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In vitro transcription 
Primers containing a T7 promoter were designed in order to amplify the 5’ region of cfa 
(primers OLEC1168/OLEC1169) and the 3’ region of SpyRNA049 (primers 
OLEC1171/OLEC1173, Table 1). PCR was done using wild-type GAS (EC904) genomic 
DNA as template and the primers. In vitro transcription was done using the Epicentre kit 
(Epicentre Biotechnologies). 
 
Gel-mobility shift assays 
RNA-RNA band-shift assays were done as described by Sorger-Domenigg et al., 2007 
(Sorger-Domenigg et al., 2007) with minor modifications. Briefly, in vitro transcribed 
SpyRNA049 and cfa RNA were gel purified. Gel-purified RNAs were 5′-end labelled 
with [γ-32P]-ATP (Amersham) and re-purified on a 10% polyacrylamide-8 M urea gel. 
Labelled SpyRNA049 (0.15 pmol) was first incubated at room temperature for 5 min to 
refold, then for 15 min with purified cfa (0.75, 1.5 and 2.25 pmol) in 10 μl VD buffer 
(10 mM Tris, pH 7.4, 60 mM NH4Cl, 6 mM β-mercaptoethanol, and 2 M Mg-acetate). 
Immediately before loading, the samples were mixed with 4 μl of loading dye (75% 
glycerol, 0.01% xylencyanol, 0.01% bromphenol blue), and loaded on a native 4% 
polyacrylamide gel. Electrophoresis was performed in TAE buffer at 50 V for 1-2 h. The 
radioactively labelled bands were visualized with a PhosphorImager (Molecular 
Dynamics). 
 
Exoprotein precipitation 
S. pyogenes culture supernatants were collected at early-logarithmic, mid-logarithmic and 
late-logarithmic time points, filter sterilized (0.45 μm filter), incubated on ice for 30 min 
with 1/10 volume 4% (w/v) DOC in TCA and centrifuged for 10 min at 14000 g at 4°C. 
The pellet was resuspended in 1 ml of ice-cold acetone and incubated on ice for 15 min. 
The acetone-extraction step was repeated two more times and finally the pellet was 
resuspended in 100 ml of 1 M Tris/HCl, pH 8.0 (Mangold et al., 2004). 
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Results 
 
Identification of SpyRNA049 by computational prediction 
One prediction from QRNA and two predictions from sRNAPredict2 identified the 479 
bp IGR between the hypothetical proteins encoding genes SPy1044 and SPy1046 as a 
putative non-coding sRNA locus.  
 
SpyRNA049 consists of three sRNAs 
Using total RNA from the M1 strain SF370 in Northern blot analysis, three transcripts of 
approximately 180, 80 and 60 nt were revealed (Fig. 1 A). Detection using a riboprobe 
clearly showed that all three sRNAs were derived from the negative strand (data not 
shown). The 5’ and 3’ ends of the sRNAs were mapped by self-ligation and primer 
extension. The data showed that the three sRNAs are 171, 89 and 76 nt in size and end at 
the same RIT, differing at their 5’ ends (Fig. 1A; 2A, B, C). BPROM predicted a 
promoter only for the 89 nt transcript, the TransTerm RIT prediction had a region of 
confidence of 100. Rifampicin assays showed that the 171 nt sRNA was stable (t1/2 >30 
min), whereas the 89 nt sRNA was unstable (t1/2 <5 min) and the 76 nt sRNA of 
intermediate stability (t1/2 ~15 min) (Fig. 1B, C). The best mfe Mfold and RNAfold 
secondary structure predictions were nearly identical. Two main structure variants could 
be distinguished, the 171 nt sRNA with one long and two short stem loops and the two 
shorter sRNAs, with two stem loops of approximately equal length (Fig. 3). All three 
sRNA structures have two stem loops with an ‘AGU’ motif (Fig. 3). The RNAfold dot 
plots showed alternative pairing probabilities for all three sRNAs (data not shown), 
indicating that the mfe structures are likely to change conformation to structures with 
larger free energy values. 
 
SpyRNA049 is not conserved in all M serotypes 
The IGR is 100% conserved in M1, M2, M4, M12 and M28 strains of S. pyogenes, all 
other S. pyogenes strains with an available complete genome sequence contain only the 
first 167 nt of the IGR. This is either due to a different genomic location of the 
downstream gene (M3 and M4 strains) or its complete absence from the genome (M5, 
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M6 and M18; Fig. 4A, B). A homologous stretch corresponding to 81 nt of the 171 nt 
sRNA in M1 strain SF370 is present in the sequenced M5 strain Manfredo (position 
996726-996646, 3 mismatches). Northern blot analysis using total RNA of M3, M5 and 
M49 strains (Table 1) and a PCR-derived probe corresponding to the entire IGR in SF370 
failed to detect sRNA expression in these strains. To confirm sRNA expression in other 
strains, which contain the entire IGR, M1 strain MGAS5005 and M12 strain RDN151 
(Table 1) were analyzed. In both strains, the three sRNAs were detected with a similar 
expression profile as seen in M1 strain SF370 (Fig. 1A). There was no differential 
expression of the SpyRNA049 sRNA in any of the stress conditions analyzed.  
 
Is cfa an mRNA target of SpyRNA049? 
The mRNA target analysis returned the same results for the three sRNAs, with only one 
true outlier (Fig. 5A). According to this prediction, the 5’UTR of the CAMP factor gene 
(cfa) mRNA is the most likely target of SpyRNA049 (Fig. 5B, C). The cfa gene is of 
particular interest, as several studies provide evidence for a role of the CAMP protein in 
pathogenicity, such as in group B streptococci (GBS, Streptococcus agalactiae) 
(Bernheimer et al., 1979; Jürgens et al., 1987). The predicted interaction (S-score: 340) 
involves 51 bases (position 1050538-1050588, SF370 genome) of the cfa 5’UTR and 54 
bases of SypRNA049 (position 854384-854437, SF370 genome).  
To investigate whether cfa is the target for SypRNA049, we deleted SypRNA049 in M1 
SF370 GAS strain from +1 to the terminator including all three RNAs. To examine 
whether the CAMP activity was affected in the SpyRNA049 mutant, CAMP test was 
done with mutant and wild type GAS strains. But CAMP factor activity analysis showed 
no difference between the SpyRNA049 mutant and wild type strains (Fig. 6). To check 
whether SypRNA049 affects cfa expression at the transcriptional level, Northern blot 
analysis was done. However, no significant difference in the expression of cfa mRNA 
from early logarithmic to stationary phase was observed comparing the SpyRNA049-
deficient and wild type strains (Fig. 7A). We then analyzed the possibility that 
SpyRNA049 could bind to cfa mRNA and affects its stability. Therefore, the stability of 
cfa mRNA was analyzed in SpyRNA049-deficient and wild-type strains. Similarly, the 
half life of cfa mRNA was ~5 minutes in both SpyRNA049-deficient and wild-type 
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strains (Fig. 7B). Furthermore, band shift assays were done to analyze a possible binding 
of cfa mRNA with SpyRNA049. But the band shift assays also failed to show any shift in 
the band when the 5’ end of cfa and the 3’ end of SpyRNA049 were allowed to bind with 
each other (Fig. 8). All of these results indicate that most likely the cfa mRNA is not the 
target for SpyRNA049.  
 
Phenotypic assays 
To investigate a possible role of SpyRNA049 in pathogenic aspects of S. pyogenes, some 
phenotypic assays were undertaken. The growth curve of the SpyRNA049-deficient 
strains (EC1417 and EC1418) was compared to that of the wild-type in rich THY 
medium. SpyRNA049 was not found to be essential for the growth of GAS as no growth 
defects were observed. Interestingly the SpyRNA049-deficient strains were growing 
slightly faster, reaching a higher OD at 620 nm when compared to the wild-type strain 
(Fig. 9). 
Then a bacterial aggregation/sedimentation assay was done comparing wild-type and 
SpyRNA049-deficient strains (Fig. 10). First, we observed a variation in sedimentation in 
two SpyRNA049-deficient strains (EC1417 and EC1500). The first mutant EC1417 and 
its corresponding wild-type partner after temperature shifts EC1420 were not aggregating 
for 2 h whereas the wild-type EC904 was aggregating. On the other hand, we did not 
observe any difference in the aggregation when comparing the second mutant EC1500, 
its corresponding wild-type partner after temperature shifts EC1502 and wild-type 
EC904. 
 
Does SpyRNA049 have a role in host cell interaction? 
In order to investigate the role of SpyRNA049 in infection, we conducted adhesion, 
internalization and survival assays with pharyngeal epithelial HEp-2 cells and RAW 
macrophages comparing the SpyRNA049-deficient and wild type strains. However, we 
could not see a significant difference in adhesion and internalization rates between the 
two strains (Fig. 11A, B, C).  
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Does SpyRNA049 have a role in the expression of virulence factors? 
SDS-PAGE analysis of intracellular, cell-associated and exoproteins was done to 
examine the effect of SpyRNA049 on virulence factors. Thus far, we could not observe a 
striking difference in protein patterns when comparing the SpyRNA049-deficient and 
wild type strain grown in rich medium. This would have to be repeated and analyzed in 
conditions of growth in minimal medium. 
 
Discussion 
A previous in silico study conducted in our lab revealed 5 novel sRNA candidates. We 
chose one of the interesting candidates SpyRNA049 to describe further. Our 
investigations revealed that SpyRNA049 is not conserved in all M serotypes of S. 
pyogenes and expressed only in M1 and M12 serotypes. Moreover, our data indicated 
that SpyRNA049 consists of three independent sRNAs varying in size, stability and 
secondary RNA structures. Expression of three different sRNAs but having a same 3’ end 
might be using a novel mechanism of gene expression control. It would be interesting to 
find its mechanism of action. 
In silico mRNA target analysis showed the CAMP factor gene (cfa) mRNA as the most 
likely target of SpyRNA049. CAMP factor is an extracellular protein involved in 
erythrocyte lysis. In order to analyze cfa maRNA as target of SpyRNA049 we compared 
SpyRNA049-deficient and wild-type strains for cfa expression, stability and CAMP test, 
but none of these experiments showed a significant difference. Moreover to analyze a 
possible binding of SpyRNA049 with cfa mRNA band shift assay was done, but no 
binding was observed. Thus our data do not verify the in silico prediction i.e. cfa mRNA 
is a possible target of SpyRNA049.  
Our data indicated that SpyRNA049 is not essential for GAS as SpyRNA049-deficient 
mutant had no growth defects. In contrast, the mutants were growing faster and reaching 
a higher OD when compared to the wild-type strain. If this could be confirmed it would 
indicate that sRNAs might play a role in GAS to render the pathogen fitter for infection. 
Therefore, to investigate the possible role of SpyRNA049 in infection, we performed 
adhesion, internalization and survival assays with pharyngeal epithelial cells and 
macrophages. However, no significant difference was observed when SpyRNA049-
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deficient and wild-type strains were compared. To investigate the role of SpyRNA049 in 
virulence factor expression, SpyRNA049-deficient and wild-type strains were compared 
for intracellular, cell-associated and exoproteins, however no difference could be 
observed thus far. These experiments need to be repeated to confirm the data.  
To further investigate the role of SpyRNA049 in different aspects of pathogenity, a 
sedimentation assay was done. We found a striking difference between SpyRNA049-
deficient and wild-type strains but the wild-type after temperature shifts was also 
behaving like the mutant. In order to verify whether the sedimation phenotype was linked 
to SpyRNA049, we constructed a fresh SpyRNA049-deficient strain. Therafter, we did 
not observe any difference in SpyRNA049-deficient, wild-type and wild-type after 
temperature shift strains. Thus it still remains an open question what is the role of 
SpyRNA049. Do all three sRNAs expressed from the same locus have similar role or 
distinct functions? 
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FIGURE LEGENDS 
Figure 1. SpyRNA049 expression profile and stability. (A) Northern blot analysis of 
total RNA isolated from M1 serotype S. pyogenes (SF370 – EC904). Total RNA samples 
prepared from cell grown in THY were separated on 8% denaturating PAA (10 µg/lane) 
and submitted to Northern blot analysis. RNAs were hybridized with a radiolabelled PCR 
generated SpyRNA049 probe. 5S rRNA was used as loading control. EL: early log; ML: 
mid log; LL: late log; ES early stationary; S: stationary; LS: late stationary phase of 
growth. (B) Northern blot analysis of RNA prepared from rifampicin-treated cells. 
Treated RNAs (10 µg/lane) were hybridized with a PCR generated probe specific to 
SpyRNA049. (C) Half-life calculation of the three transcripts derived from the 
SpyRNA049 locus. Before rifampicin addition, the amount of the transcript is 100%. 
Over the time, decreasing amounts of RNA are normalized with 5S rRNA amounts in the 
cells. The half-life is defined as the point at which 50% of the RNA was degraded. 
 
Figure 2. SpyRNA049 mapping. (A) Primer extension analysis of SpyRNA049. A, C, 
G, T: sequencing reactions. OLEC703: primer extension reaction done with primer 
OLEC703 and 8 µg of TP2 RNA from EC904. Alternative 5’ ends are underlined in the 
sequencing and with arrows aside the primer extension. Only one 5’ end was confirmed 
by self ligation (SL). (B) SpyRNA049 sequence. (C) SpyRNA049 locus Panel A: 
Genomic organization of SpyRNA049 locus. SpyRNA049 is pictured in red, encoded on 
the (-1) strand of SF370 genome. Locus tag is given above the grey arrows representing 
the ORFs; start position of these ORFs is annotated underneath. Zoom is made on 
SpyRNA049. The position of the three 5’ ends, the rho-independent terminator and the 
size of the three RNAs are given. The sequence of SpyRNA049 is from SF370 sequenced 
genome [NC_002737], position: 854376 to 854546. Putative promoter regions are 
underlined in blue; 5’ends are underlined in red; *: primer extension result; °: self-
circularization result; Putative translational start (TTG) is underlined in black; Rho-
independent terminator is underlined in green. Panel B: SpyRNA049 locus annotations. 
Annotations to NC_002737 of the NCBI database. Hypothetical proteins annotation was 
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further checked for orthology using the KEGG database [http://www.genome.jp/kegg/] 
and by Blast analysis [http://blast.ncbi.nlm.nih.gov/Blast.cgi]. 
 
Figure 3. SpyRNA049 predicted structure. Structure predictions for the three 
transcripts expressed from SpyRNA049 locus using the RNAfold, contrafold and RNA 
structure algorithm. Panel A: SpyRNA049-76 Panel B: SpyRNA049-89 Panel C: 
SpyRNA049-171. 
 
Figure 4. (A) GeneDoc alignment of SPyRNA049 locus (coordinates M1 SF370 
NC_002737: 854279 – 854756, complementary strand).  Blue: putative transcriptional 
promoters; red: alternative 5’ ends; green: putative rho-independent terminator (RIT); 
grey: sequence variation. The serotype of the different sequenced genome is given. M49 
serotype is not fully sequenced yet. IGR is not conserved in M5, M6 and M18 seotypes. 
(B) SpyRNA049 Blast analysis Panel A: Sequence query used for the Blast analysis. 
SpyRNA049-171 sequence (from +1 to RIT) has been taken as template. Panel B: Blast 
results. Numbers refer to panel C. Panel C: Blast partners. Accession numbers of each 
Blast partner is given. 
 
Figure 5. mRNA target predictions for SpyRNA049. Panel A: S-scores for potential 
interaction between 3’ UTRs (grey) and 5’ UTRs (red) with SpyRNA049. Panel B: 
RNAcofold predicted duplex structure of SpyRNA049 and the upstream region of the cfa 
gene. SpyRNA049: red. Panel C: RNAfold predicted interaction between full length 
SpyRNA049 (76 nt) and cfa transcript (#150 nt). Yellow: SpyRNA049; Green: cfa 
mRNA 5’end; Blue: cfa mRNA AUG; grey: linker; interaction site: red. 
 
Figure 6. CAMP test. S. aureus strain RN450 (EC16) was streaked vertically and 
SpyRNA049-deficient mutant (EC1417) and SF370 WT (EC904) GAS strains were 
streaked at right angles. GBS (EC770) was streaked as a positive control of CAMP 
reaction. SF370 WT (EC904) GAS strain and SpyRNA049-deficient mutant (EC1417) 
are CAMP negative, while GBS (EC770) gives CAMP positive reaction.  
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Figure 7. (A) Northern blot analysis of total RNA of wild-type strain EC904 and its 
isogenic SpyRNA049 mutant EC1417. Specific DNA probes were used for cfa. The 
probe for tmRNA acted as loading control. (B) Determination of mRNA half-lives in 
EC904 (wild-type) and EC1417 (SpyRNA049 mutant) by inhibiting mRNA synthesis 
with the addition of rifampicin. Estimation of mRNA decay is based on Northern blot 
analysis. Total RNA of mid-logarithmic cells was harvested at the indicated time points 
(min) after addition of rifampicin (250μg/ml). The blot was hybridized with cfa-specific 
probe and with tmRNA-probe acting as loading control. 
 
Figure 8. Band shift assay. Labelled SpyRNA049 (0.15 pmol) was incubated with 
unlabelled cfa RNA in increasing molar ratio as indicated.  
 
Figure 9. Growth curve in THY. Growth curve was done using SpyRNA049-deficient 
strains (EC1417 and EC1418) and SF370 WT (EC904) GAS strains in THY. 
SpyRNA049-deficient strains reached stationary phase at higher OD (0.59), while SF370 
WT reached stationary phase at lower OD (0.49) when monitored at 620 nm.  
 
Figure 10. Aggregation/ sedimentation assay. Aggregation assay was done using 
SpyRNA049-deficient strains (EC1417 and EC1418) and SF370 WT (EC904) GAS 
strains in Thy.  Strains were grown till stationary phase with shaking and then OD was 
noted every 30 minutes without shaking tubes. SF370 WT (EC904) GAS strain was 
aggregating in 30 minutes while SpyRNA049-deficient strains were not aggregating even 
till 3 hours. 
 
Figure 11. (A) Adhesion assay. Adhesion assay was done using SpyRNA049-deficient 
strain (EC1417) and SF370 WT (EC904) GAS strains in Hep2 cells. GAS were grown to 
late-logarithmic phase and added to monolayers at MOI 5:1 in triplicate. After incubation 
for 1 hour, infected monolayers were washed extensively with PBS before lysing with 
chilled sterile distilled water. The number of viable bacteria was counted by plating 
appropriate dilutions of the lysates on TSA-blood plates. Adherence of WT strain was 
30% while adherence of SpyRNA049-deficient strain was 39%. (B) Internalization 
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assay with Hep2 cells. Internalization assay was done using SpyRNA049-deficient strain 
(EC1417) and SF370 WT (EC904) GAS strains in Hep2 cells. GAS were grown to late-
logarithmic phase and added to monolayers at MOI 5:1 in triplicate. After incubation for 
2 hours, extracellularly adhered bacteria were killed by incubation with medium 
containing 100 µg/ml gentamicin and 5 µg/ml penicillin for 2 hours. Infected monolayers 
were washed with PBS before lysing with chilled sterile distilled water. The number of 
viable bacteria was counted by plating appropriate dilutions of the lysates on TSA-blood 
plates. Internalization of WT strain was 3.5% while internalization of SpyRNA049-
deficient strain was 4.1%. (C) Internalization assay with RAW cells. Internalization 
assay was done using SpyRNA049-deficient strain (EC1417) and SF370 WT (EC904) 
GAS strains in RAW cells. RAW 264.7 GAS were grown to mid-logarithmic phase and 
added to monolayers at MOI 100:1 in triplicate. After infection for 30 minutes, 
extracellularly adhered bacteria were killed by incubation with medium containing 60 
µg/ml penicillin for 30 minutes and 1 hour. Infected monolayers were washed with PBS 
before lysing with chilled sterile distilled water. The number of viable bacteria was 
counted by appropriate dilutions of the lysates on TSA-blood plates. Internalization of 
WT strain was 1.9 % while internalization of SpyRNA049-deficient strain was 1.5% at 0 
h and 1.5% and 1.1% at 1 hour.  
The percent intracellular invasion represents the average CFU/mL number of viable 
intracellular bacteria recovered at different times following addition of antibiotics versus 
the average CFU/mL number of inoculated bacteria x 100. The average values and 
standard deviations are shown. 
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Figure 2A 
 
 
 
 
 
Figure 2B 
SpyRNA049-171 
 
AGUAUUAAGUAUUGUUUUAUGGCUGAUAAAUUUCUUUGAAUUUCUCCUUGAUUAUUUGUU
AUAAAAGUUAUAAAAUAAUCUUGUUGGAACCAUUCAAAACAGCAUAGCAAGUUAAAAUAA
GGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUUUUU 
 
SpyRNA049-89 
 
GUUGGAACCAUUCAAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGA
AAAAGUGGCACCGAGUCGGUGCUUUUUUU 
 
SpyRNA049-76 
 
AAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCG
AGUCGGUGCUUUUUUU 
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Figure 2C 
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Figure 3 
Panel A: SpyRNA049- 76 
Panel B: SpyRNA049- 89 
Panel C: SpyRNA049- 171 
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Figure 4A 
GenDoc multiple sequence alignment 
 
SF370-M1        TTTTTGCCTCCTAAAATAAAAAGTTTAAATTAAATCCATAATGAGTTTGATGATTTCAAT 
MGAS5005-M1     TTTTTGCCTCCTAAAATAAAAAGTTTAAATTAAATCCATAATGAGTTTGATGATTTCAAT 
MGAS10270-M2    TTTTTGCCTCCTAAAATAAAAAGTTTAAATTAAATCCATAATGAGTTTGATGATTTCAAT 
MGAS10750-M4    TTTTTGCCTCCTAAAATAAAAAGTTTAAATTAAATCCATAATGAGTTTGATGATTTCACT 
MGAS2096-M12    --TTTGCCTCCTAAAATAAAAAGTTTAAATTAAATCCATAATGAGTTTGATGATTTCACT 
MGAS9429-M12    TTTTTGCCTCCTAAAATAAAAAGTTTAAATTAAATCCATAATGAGTTTGATGATTTCACT 
MGAS6180-M28    TTTTTGCCTCCTAAAATAAAAAGTTTAAATTAAATCCATAATGAGTTTGATGATTTCACT 
SSI-1-M3        TTTTTGTCTCCTAAAATAAAAAGTTTAAATTAAATCCATAATGAGTTTGATGATTTCACT 
MGAS315-M3      TTTTTGTCTCCTAAAATAAAAAGTTTAAATTAAATCCATAATGAGTTTGATGATTTCACT 
Manfredo-M5     ------------------------------------------------------------ 
MGAS10394-M6    ------------------------------------------------------------ 
MGAS8232-M18    ------------------------------------------------------------ 
 
SF370-M1        AATAGTTTTAATGACCTCCGAAATTAGTTTAATATGCTTTAATTTTTCTTTTTCAAAATA 
MGAS5005-M1     AATAGTTTTAATGACCTCCGAAATTAGTTTAATATGCTTTAATTTTTCTTTTTCAAAATA 
MGAS10270-M2    AATAGTTTTAATGACCTCCGAAATTAGTTTAATATGCTTTAATTTTTCTTTTTCAAAATA 
MGAS10750-M4    AATAGTTTTAATGACCTCCGAAATTAGTTTAATATGCTTTAATTTTTCTTTTTCAAAATA 
MGAS2096-M12    AATAGTTTTAATGACCTCCGAAATTGGTTTAATATGCTTTAATTTTTCTTTTTCAAAATA 
MGAS9429-M12    AATAGTTTTAATGACCTCCGAAATTGGTTTAATATGCTTTAATTTTTCTTTTTCAAAATA 
MGAS6180-M28    AATAGTTTTAATGACCTCCGAAATTGGTTTAATATGCTTTAATTTTTCTTTTTCAAAATA 
SSI-1-M3        AATAGTTTTAATGACCTCCGAAATTAGTTTAATATGCTTTAATTTTTC------------ 
MGAS315-M3      AATAGTTTTAATGACCTCCGAAATTAGTTTAATATGCTTTAATTTTTC------------ 
Manfredo-M5     ------------------------------------------------------------ 
MGAS10394-M6    ------------------------------------------------------------ 
MGAS8232-M18    ------------------------------------------------------------ 
 
SF370-M1        TCTCTTCAAAAAATATTACCCAATACTTAATAATAAATAGATTATAACACAAAATTCTTT 
MGAS5005-M1     TCTCTTCAAAAAATATTACCCAATACTTAATAATAAATAGATTATAACACAAAATTCTTT 
MGAS10270-M2    TCTCTTCAAAAAATATTACCCAATACTTAATAATAAATAGATTATAACACAAAATTCTTT 
MGAS10750-M4    TCTCTTCAAAAAATATTACCTAATACTTAATAATGAATAAATTATAACACAAAATCCTTT 
MGAS2096-M12    TCTCTTCAAAAAATATTACCCAATACTTAATAATAAATAGATTATAACACAAAATTCTTT 
MGAS9429-M12    TCTCTTCAAAAAATATTACCCAATACTTAATAATAAATAGATTATAACACAAAATTCTTT 
MGAS6180-M28    TCTCTTCAAAAAATATTACCCAATACTTAATAATAAATAGATTATAACACAAAATTCTTT 
SSI-1-M3        ------------------------------------------------------------ 
MGAS315-M3      ------------------------------------------------------------ 
Manfredo-M5     ------------------------------------------------------------ 
MGAS10394-M6    ------------------------------------------------------------ 
MGAS8232-M18    ------------------------------------------------------------ 
       -10      +1 +1 
SF370-M1        TAAAAAGTAGTTTATTTTGTTATCATTCTATAGTATTAAGTATTGTTTTATGGCTGATAA 
MGAS5005-M1     TAAAAAGTAGTTTATTTTGTTATCATTCTATAGTATTAAGTATTGTTTTATGGCTGATAA 
MGAS10270-M2    TAAAAAGTAGTTTATTTTGTTATCATTCTATAGTATTAAGTATTGTTTTATGGCTGATAA 
MGAS10750-M4    TAAAAAGTAGTTTATTTTGTTATCATTCTATAGTATTAAGTATTGTTTTATGGCTGATAA 
MGAS2096-M12    TAAAAAGTAGTTTATTTTGTTATCATTCTATAGTATTAAGTATTGTTTTATGGCTGATAA 
MGAS9429-M12    TAAAAAGTAGTTTATTTTGTTATCATTCTATAGTATTAAGTATTGTTTTATGGCTGATAA 
MGAS6180-M28    TAAAAAGTAGTTTATTTTGTTATCATTCTATAGTATTAAGTATTGTTTTATGGCTGATAA 
SSI-1-M3        ------------------------------------------------------------ 
MGAS315-M3      ------------------------------------------------------------ 
Manfredo-M5     ------------------------------------------------------------ 
MGAS10394-M6    ------------------------------------------------------------ 
MGAS8232-M18    ------------------------------------------------------------ 
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                                 -35         -10                   +1 
SF370-M1        ATTTCTTTGAATTTCTCCTTGATTATTTGTTATAAAAGTTATAAAATAATCTTGTTGGAA 
MGAS5005-M1     ATTTCTTTGAATTTCTCCTTGATTATTTGTTATAAAAGTTATAAAATAATCTTGTTGGAA 
MGAS10270-M2    ATTTCTTTGAATTTCTCCTTGATTATTTGTTATAAAAGTTATAAAATAATCTTGTTGGAA 
MGAS10750-M4    ATTTCTTTGAATTTCTCCTTGATTATTTGTTATAAAAGTTATAAAATAATCTTGTTGGAA 
MGAS2096-M12    ATTTCTTTGAATTTCTCCTTGATTATTTGTTATAAAAGTTATAAAATAATCTTGTTGGAA 
MGAS9429-M12    ATTTCTTTGAATTTCTCCTTGATTATTTGTTATAAAAGTTATAAAATAATCTTGTTGGAA 
MGAS6180-M28    ATTTCTTTGAATTTCTCCTTGATTATTTGTTATAAAAGTTATAAAATAATCTTGTTGGAA 
SSI-1-M3        ------------------------------------------------------------ 
MGAS315-M3      ------------------------------------------------------------ 
Manfredo-M5     --------------------------------------------------------GAGA 
MGAS10394-M6    ------------------------------------------------------TGGAGA 
MGAS8232-M18    ------------------------------------------------------TTGGGA 
 
                    +1                
………………RIT……………. 
SF370-M1        CCATTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTG 
MGAS5005-M1     CCATTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTG 
MGAS10270-M2    CCATTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTG 
MGAS10750-M4    CCATTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTG 
MGAS2096-M12    CCATTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTG 
MGAS9429-M12    CCATTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTG 
MGAS6180-M28    CCATTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTG 
SSI-1-M3        TTTTTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTG 
MGAS315-M3      TTTTTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTG 
Manfredo-M5     CCATTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATTAACTTGAAAAAGTG 
MGAS10394-M6    CCATTCAAAACAGCATAGCCAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTG 
MGAS8232-M18    CCATTCAAAACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTG 
 
    ………………………RIT………………………… 
SF370-M1        GCACCGAGTCGGTGCTTTTTTT-GATACTTCTATTCTACTCTGACTGCAAACCAAAAAAA 
MGAS5005-M1     GCACCGAGTCGGTGCTTTTTTT-GATACTTCTATTCTACTCTGACTGCAAACCAAAAAAA 
MGAS10270-M2    GCACCGAGTCGGTGCTTTTTTT-GATACTTCTATTCTACTCTGACTGCAAACTAAAAAA- 
MGAS10750-M4    GCACCGAGTCGGTGCTTTTTTT-GATACTTCTATTCTACTCTGACTGCAAACTAAAAAA- 
MGAS2096-M12    GCACCGAGTCGGTGCTTTTTTTTGATACTTCTATTCTACTCTGACTGCAAACTAAAAAA- 
MGAS9429-M12    GCACCGAGTCGGTGCTTTTTTTTGATACTTCTATTCTACTCTGACTGCAAACTAAAAAA- 
MGAS6180-M28    GCACCGAGTCGGTGCTTTTTTTTGATACTTCTATTCTACTCTGACTGCAAACTAAAAAA- 
SSI-1-M3        GCACCGAGTCGGTGCTTTTTTT-GATACTTCTATTCTACTCTGACTGCAAACTAAAAAA- 
MGAS315-M3      GCACCGAGTCGGTGCTTTTTTT-GATACTTCTATTCTACTCTGACTGCAAACTAAAAAA- 
Manfredo-M5     GCACCGATTCGGTGCTTTTTTT-GATACTTCTATTCTACTCTGACTGCAAACTAAAAAA- 
MGAS10394-M6    GCACCGAGTCGGTGCTTTTTTT-GATACTTCTATTCTACTCTGACTGCAAACCCAAAAAA 
MGAS8232-M18    GCACCGAGTCGGTGCTTTTTTT-GATACTTCTATTCTACTCTGACTGCAAACCGAAAAA- 
 
 
SF370-M1        CAAGCGCTTTCAAAACGCTTGTTTTATCATTTTTAGGGAAATTAATCTCTTAATCCTTTT 
MGAS5005-M1     CAAGCGCTTTCAAAACGCTTGTTTTATCATTTTTAGGGAAATTAATCTCTTAATCCTTTT 
MGAS10270-M2    CAAGCGCTTTCAAAACGCTTGTTCTATCATTTTTAGGGAAATTAATCTCTTAATCCTTTT 
MGAS10750-M4    CAAGCGCTTTCAAAACGCTTGTTTTATCATTTTTAGGGAAATTAATCTCTTAATCCTTTT 
MGAS2096-M12    CAAGCGCTTTCAAAACGCTTGTTTTATCATT----------------------------- 
MGAS9429-M12    CAAGCGCTTTCAAAACGCTTGTTTTATCATT----------------------------- 
MGAS6180-M28    CAAGCGCTTTCAAAACGCTTGTTTTATCATT----------------------------- 
SSI-1-M3        CAAGCGCTTTCAAAACGCTTGTTTTATCATTTTTAGGGAAATTAATCTCTTAATCCTTTT 
MGAS315-M3      CAAGCGCTTTCAAAACGCTTGTTTTATCATTTTTAGGGAAATTAATCTCTTAATCCTTTT 
Manfredo-M5     CAAGCGCTTTCAAAACGCTTGTTTTATCATTTTTAGGGAAATTAATCTCTTAATCCTTTT 
MGAS10394-M6    CAAGCGCTTTCAAAACGCTTGTTTTATCATTTTTAGGGAAATTAATCTCTTAATCCTTTT 
MGAS8232-M18    CAAGCGCTTTCAAAACGCTTGTTTTATCATTTTTAGGGAAATTAATCTCTTAATCCTTTT 
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Figure 4B 
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Figure 5 
A. 
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C. 
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Figure 6 
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Figure 7B 
 
Figure 8 
Serial  1 2 3 4 
Ratio - 5 10 15 
SpyRNA049  2.3 µL 2.3 µL 2.3 µL 2.3 µL 
Cfa   2.2 µL 4.4 µL 6.6 µL 
VD 7.7 µL 5.5 µL 3.3 µL 1.1 µL 
 
 
 
 
Labelled SpyRNA049 (84nt)           +        +         +          + 
 
Unlabelled Cfa (164nt) molar ratio -        5         10        15         
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Figure 9 
Growth curve in THY
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Figure 10 
Aggregation assay
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Figure 11A 
 
 
 
 
 
 
 
 
Figure 11B 
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Figure 11C 
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TABLES 
 
Table 1 Bacterial strains and plasmids used in this study 
 
Strains Relevant characteristics Source 
 
Streptococcus pyogenes 
EC904 M1 SF370 wild-type ATCC 700294 
MGAS5005 M1 wild-type ATCC BAA-947 
RDN57 M49 wild-type Lab collection 
RDN60 M5 wild-type Lab collection 
RDN151 M12 wild-type Lab collection 
EC905 M3 wild-type Lab collection 
EC1417 Isogenic SpyRNA049-deficient mutant of M1 SF370 This study 
EC1500 Isogenic SpyRNA049-deficient mutant of M1 SF370 This study 
EC1420 M1 wild-type after temperature shifts This study 
EC1502 M1 wild-type after temperature shifts This study 
EC1412 EC904 (pEC264) This study 
EC1414 EC904 (pEC264, integrated) This study 
Escherichia coli 
DH5α Host for cloning Lab collection 
TOP10 Host for cloning Invitrogen 
EC1254 Top10 (pEC262) This study 
EC1409 Top10 (pEC264) This study 
EC1438 Top10 (pEC268, for complementation of 179 bp fragment) This study 
EC1441 Top10 (pEC269, for complementation of 89 bp fragment) This study 
Plasmids 
pEC264 pEC214ΩSpyRNA049up-SpyRNA049dw This study 
pEC262 pEC214ΩSpyRNA049up This study 
pEC268 pEC85ΩSpyRNA049 (179bp fragment) This study 
pEC269 pEC85ΩSpyRNA049 (89bp fragment) This study 
 
Table 2 Oligonucleotides used in this study 
 
Oligo 
 
aF/R Sequence 5’-3’ Specificity 
 
OLEC486
OLEC487 
F 
R 
TAAAACAAGCGTTTTGAAAGC 
TTAATGACCTCCGAAATTAGT  
SpyRNA049 
OLEC673 
OLEC674 
F 
R 
TGTTGGAACCATTCAAAACAG 
ATTCAAAGAAATTTATCAGCCA 
OLEC702 
OLEC703 
F 
R 
ATACTTCTATTCTACTCTGAC 
CGACTCGGTGCCACTTTTTCA 
OLEC740 
OLEC741 
F 
R 
AGTAGTTTATTTTGTTATCA 
TGTGTTATAATCTATTTATTA 
primers used for RT-PCR 
of self-circularized RNA to 
amplify 5’ and 3’ ligated 
ends of SpyRNA049 
OLEC821 
OLEC822 
F 
R 
GACAGCGAGCTCATAGAATGATAACAAAATAAA 
AAG TGCGAATTCATCAGCATATTGATCTCCAAT 
SpyRNA049-downstream 
fragment 
OLEC823 
OLEC824 
F 
R 
TAGACTCTGCAGGACTGATATCATGGCAGGTAT 
CTGTAAGAGCTCTTCTATTCTACTCTGACTGCA 
SpyRNA049-upstream 
fragment 
OLEC997 
OLEC996 
F 
R 
GCGTCGGGATCCTTAATGACCTCCGAAATTAGT 
TGCAGTCAGAGTAGAATAGAA 
Complementation of 
SpyRNA049 (179bp) 
OLEC998 
OLEC996 
F 
R 
CGAGCGGGATCCGAATTTCTCCTTGATTATTTG 
TGCAGTCAGAGTAGAATAGAA 
Complementation of 
SpyRNA049 (89bp) 
OLEC287
OLEC288 
F 
R 
AGTTAAGTGACGATAGCCTAG 
CTAAGCGACTACCTTATCTCA 
5S rRNA 
oliRN242 
oliRN243 
F 
R 
CGGTAACTAACCAGAAAGGG 
CGTTGTACCAACCATTGTAGC 
16S rRNA 
 
a F, forward; R, reverse. Underlined sequences indicate restriction sites. 
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4.3 Project 3: Functional analysis of the group A streptococcal luxS/AI-2 system in 
metabolism, adaptation to stress and interaction with host cells 
 
4.3.1 Summary 
Quorum sensing mechanism helps bacteria to sense their own number (quorum) in the 
environment by producing and releasing signaling molecules and then detecting and 
responding to them. As auto-inducers (AIs) are specific to their sensors so the sensing is 
restricted within the same species. Recently, a second autoinducing system has been 
discovered, which detects a furanone-like signaling molecule termed “autoinducer 2” 
(AI-2) in V. harveyi. AI-2 is synthesized by the luxS gene, which is found in over 55 
gram-negative and gram-positive bacterial species. AI-2 is proposed to have a role in 
interspecies communication. Knowledge about quorum sensing systems in S. pyogenes is 
very limited. Two putative quorum-sensing systems, sil and fasBCA, have been reported 
in GAS. No signaling peptide could be identified within the fasBCA locus, but the 
putative pheromone peptide SilCR from the sil operon was shown to regulate DNA 
uptake and the ability of GAS to cause invasive infection.  
Apart from bioluminescence, luxS/AI-2 signaling is hypothesized to be involved in the 
regulation of pathogenicity and S-adenosylmethionine (SAM) utilization pathway. In an 
M6 serotype, Lyon et al (2001) observed an enhanced expression of sagA associated with 
enhanced haemolytic activity and a reduction in SpeB protease proteolytic activity in a 
luxS mutant. In an M6 serotype, Marouni and Sela (2003) observed higher ability to be 
internalized in pharyngeal epithelial cells and an enhanced emm transcription in a luxS 
mutant compared to the wild-type. Further they observed that luxS expression is under the 
control of the CsrR regulator.  
To investigate the role of luxS in AI-2 like activity, our data showed that at late-
logarithimic phase AI-2 like activity peaked, but luxS transcript levels rapidly decreased, 
hence luxS expression and production of AI-2 like activity are shifted out of phase. 
Furthermore, an auto-regulatory function of AI-2 like activity on luxS expression could 
not be observed in GAS using conditioned medium. To investigate the role of luxS 
enzyme in AMC metabolism, the growth rates of wild-type and luxS-deficient strains in 
sulfur-limited CDM were analyzed. Overall the growth rates and yields were similar 
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when wild-type strains were compared to the luxS-deficient mutants. These results 
indicate that luxS does not have an essential AMC-related metabolic role in GAS.  
The role of luxS in adaptation to stress conditions, which bacteria can encounter during 
the infection was investigated. Exposure of bacterial cultures to acidic conditions 
revealed a profound increase in acid tolerance in the luxS-deficient strains. Exposing 
cultures to low pH led to reduced expression of luxS, thus suggesting a correlation 
between reduced luxS expression and survival under acidic conditions. Accordingly, CM 
from these cultures showed reduced AI-2 like activity. We observed reduced luxS 
expression at the transcriptional level in wild-type cultures grown in RPMI medium 
compared to cultures grown in the nutrient rich THY medium. Furthermore, AI-2 activity 
in CM from wild-type cultures grown in RPMI was reduced to a level similar to CM from 
luxS-deficient cultures. This indicates that under host cell environment mimicking 
medium (acidic conditions and in vivo-like environment), there is an advantage for GAS 
to lower the expression of luxS and the production of AI-2 like activity. 
We investigated further whether lowering the expression of luxS would be beneficial for 
bacteria in intracellular host environments. Results from internalization assays showed 
that the internalization and survival rates of the luxS mutant strains of both M1 and M19 
serotypes in HEp-2 lung epithelial cells were about 5-fold higher to those of wild-type 
strains. The luxS deficient mutants showed also significantly higher survival rates in 
macrophages of 2 to 3 fold compared to the wild-type strains. With both serotypes and in 
both epithelial and macrophages cells, complementing the mutant strains with the luxS 
allele in trans restored the intracellular survival rates to wild-type levels. These data 
indicate that lowering the expression of luxS provides GAS an advantage to survive the 
harsh conditions encountered in host cells. In addition, virulence gene expression in luxS 
mutants showed that luxS negatively affects the fasX transcript while it positively affects 
the sibA transcript. 
Our data indicate a limited role of luxS in AMC-related metabolism. However it has a 
role in adaptation to stress responses and by down-regulation of the expression of luxS, S. 
pyogenes has an advantage to survive in a host environment. Hence, luxS/AI-2 has an 
important function in host cell infection. 
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My contribution to this study was to do the adhesion and internalization assays with HEp-
2 and RAW cells, also the internalization assays with the mixed cultures and to check the 
effect of alkaline pH on luxS expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 102
4.3.2 Manuscript 3 
 
Functional analysis of the group A streptococcal luxS/AI-2 system in metabolism, 
adaptation to stress and interaction with host cells 
 
Published manuscript: BMC Microbiology (2008) 30(8), 188 
 
Authors: 
 
Maria Siller, Rajendra Prasad Janapatla, Zaid Ahmed Pirzada, Christine Hassler, 
Daniela Zinkl and Emmanuelle Charpentier 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BioMed CentralBMC Microbiology
ssOpen AcceResearch article
Functional analysis of the group A streptococcal luxS/AI-2 system in 
metabolism, adaptation to stress and interaction with host cells
Maria Siller†1, Rajendra P Janapatla†1, Zaid A Pirzada1, Christine Hassler1, 
Daniela Zinkl1 and Emmanuelle Charpentier*1,2
Address: 1Max F. Perutz Laboratories, University of Vienna, Department of Microbiology and Immunobiology, 1030 Vienna, Austria and 2The 
Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, S-90187 Umeå, Sweden
Email: Maria Siller - maria.siller@univie.ac.at; Rajendra P Janapatla - rajanjan@yahoo.com; Zaid A Pirzada - zaid.ahmed.pirzada@univie.ac.at; 
Christine Hassler - hasslerc@gmx.de; Daniela Zinkl - Daniela.Zinkl@gmx.at; Emmanuelle Charpentier* - emmanuelle.charpentier@univie.ac.at
* Corresponding author    †Equal contributors
Abstract
Background: The luxS/AI-2 signaling pathway has been reported to interfere with important
physiological and pathogenic functions in a variety of bacteria. In the present study, we investigated
the functional role of the streptococcal luxS/AI-2 system in metabolism and diverse aspects of
pathogenicity including the adaptation of the organism to stress conditions using two serotypes of
Streptococcus pyogenes, M1 and M19.
Results: Exposing wild-type and isogenic luxS-deficient strains to sulfur-limited media suggested a
limited role for luxS in streptococcal activated methyl cycle metabolism. Interestingly, loss of luxS
led to an increased acid tolerance in both serotypes. Accordingly, luxS expression and AI-2
production were reduced at lower pH, thus linking the luxS/AI-2 system to stress adaptation in S.
pyogenes. luxS expression and AI-2 production also decreased when cells were grown in RPMI
medium supplemented with 10% serum, considered to be a host environment-mimicking medium.
Furthermore, interaction analysis with epithelial cells and macrophages showed a clear advantage
of the luxS-deficient mutants to be internalized and survive intracellularly in the host cells compared
to the wild-type parents. In addition, our data revealed that luxS influences the expression of two
virulence-associated factors, the fasX regulatory RNA and the virulence gene sibA (psp).
Conclusion: Here, we suggest that the group A streptococcal luxS/AI-2 system is not only
involved in the regulation of virulence factor expression but in addition low level of luxS expression
seems to provide an advantage for bacterial survival in conditions that can be encountered during
infections.
Background
Bacterial cell density-dependent signaling, also termed
"quorum sensing", is used by bacteria to collectively mod-
ulate gene expression in response to changes in the popu-
lation density [1-6]. Although signaling can be achieved
through a variety of regulatory mechanisms, all systems
described to date involve the production, secretion and
detection of extracellular low-molecular-weight signaling
molecules called "autoinducers" [1,3,7,8]. Due to the spe-
cificity of their respective sensors, recognition of acylated
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and peptide autoinducers (gram-positive bacteria) is
restricted for communication within the same species.
More recently, a novel quorum sensing system involving
a furanone-like signaling molecule termed "autoinducer
2" (AI-2) was described to regulate bioluminescence in
Vibrio harveyi [9,10]. AI-2 is synthesized by the luxS gene
product, which has been identified in the genome of over
55 gram-negative and gram-positive bacterial species
[1,11,12]. Since culture supernatants of several bacterial
species had a complementary effect on luxS-deficient V.
harveyi, AI-2 has been proposed to function as a "univer-
sal" signaling molecule for interspecies communication
[1,9,10]. In addition to controlling bioluminescence,
recent studies show that the luxS/AI-2 signaling is
involved in the regulation of pathogenicity in several
organisms [5,12].
Apart from its role in quorum sensing, the enzyme LuxS is
tightly coupled to the S-adenosylmethionine (SAM) utili-
zation pathway [11-13]. SAM is an essential donor of
methyl groups for DNA, RNA and other methylation reac-
tions. Its utilization by methyl transferases yields S-adeno-
sylhomocysteine (SAH), which is toxic for the cells and is
eliminated through hydrolysis by the nucleosidase Pfs to
produce S-ribosylhomocysteine (SRH) and adenine.
Finally, LuxS cleaves SRH into homocysteine and 4,5-
dihydroxy-2,3-pentanedione (DPD). DPD spontaneously
forms the cyclic pro-AI-2 molecule, which in V. harveyi
reacts with borate to form a stable cyclic furanosyl borate
diester [1,11,13].
Knowledge about quorum-sensing systems in the gram-
positive human pathogen Streptococcus pyogenes is rather
limited. S. pyogenes (Group A Streptococcus, GAS) is
responsible for a broad range of diseases including mild
illnesses such as pharyngitis, impetigo and scarlet fever
and more severe invasive infections such as necrotizing
fasciitis, streptococcal toxic shock syndrome and post-
infectious rheumatic fever [14,15]. In GAS, like in other
bacteria, pathogenicity is multifactorial and requires the
coordinated temporal regulation of virulence factor
expression in response to changing environmental condi-
tions and cell population density [14,16,17]. Studies have
confirmed that expression of several GAS virulence genes
is temporal and dependent on growth phase [16-20]. Fur-
thermore, a number of specific regulators (e.g. two-com-
ponent systems and response regulators) modulate
virulence gene expression in a growth phase dependent
manner [16,21-24]. Based on similarities with previously
described peptide signaling regulons of S. pneumoniae
(com system) and S. aureus (agr system), two putative quo-
rum-sensing systems, sil and fasBCA, have been reported
in GAS [21,25]. Although no signaling peptide could be
identified within the fasBCA locus, the putative pherom-
one peptide SilCR from the sil operon was shown to regu-
late DNA uptake and the ability of GAS to cause invasive
infection [21,25]. In addition, the observation of a luxS
homologue in the GAS genome suggested that quorum
sensing via the luxS/AI-2 signaling could have a relevant
function in the pathogenesis of this organism [26,27].
Two recent studies report a role of luxS/AI-2 in the regula-
tion of virulence gene expression in M3 and M6 serotypes
[26,27]. However, the role of the luxS/AI-2 in the AMC-
related metabolism and adaptation to stress conditions in
GAS remains unknown.
Here, we were interested in investigating further the func-
tion of the luxS/AI-2 system in GAS serotypes M1 and
M19. Expression of luxS in connection with production of
AI-2 like activity was analyzed. The metabolic role of luxS
in the activated methyl cycle (AMC) in GAS was exam-
ined. Wild-type and isogenic luxS-deficient strains were
compared in regard to their adaptation to diverse growth
and stress conditions as well as diverse aspects of patho-
genicity including interaction with epithelial cells and
macrophages. In summary, our data suggest an important
function of the luxS/AI-2 system in survival and growth of
GAS under conditions that are relevant during infections.
Results
Construction of luxS-deficient mutants
As reported previously, GAS possesses a luxS homolog
(coding sequence: 483 bp), the predicted translational
product of which shares 36% identity with the LuxS pro-
tein from V. harveyi [26]. Analysis of the luxS coding
sequences in clinical isolates of two different serotypes,
RDN29 (M1 type) and RDN02 (M19 type), revealed
100% amino acid sequence identity. In a previous study,
a GAS strain of serotype M6 (JRS4) was shown to contain
in its genome the insertion element, IS 1239, inserted 111
bp upstream of the luxS translational start codon [26].
This insertion was assumed to have an influence on luxS
expression [26]. Further analysis of the sequence up to
300 bp upstream of the luxS coding sequence in RDN29
and RDN02 did not reveal the presence of IS 1239 (data
not shown). To analyze the function of the luxS/AI-2 sys-
tem in GAS, we deleted the luxS gene in RDN29 and
RDN02, thus creating EC478 and RDN306, respectively
(Table 1).
Temporal luxS expression and production of AI-2 like 
activity
First, we investigated luxS expression at the transcriptional
level. Northern blot analysis of RNA extracts from wild-
type strains revealed a monocistronic luxS-specific tran-
script of approximately 650 bases in size (Fig. 1A). In both
strains, the luxS transcript levels were abundant from lag
to early-logarithmic phase, after which gradual decrease of
the signal intensity towards stationary phase was observedPage 2 of 17
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transcription initiation site (+1) as a guanine located 20
nucleotides upstream of the translation start codon (ATG)
(Fig. 1B). Then, we investigated whether the growth
phase-dependent expression of luxS transcripts correlated
with production of AI-2 like activity. Analysis of condi-
tioned media (CM) from the luxS-deficient mutants dem-
onstrated a loss of AI-2 like activity production in a
bioluminescence reporter assay described earlier [9]. In
contrast, CM from the wild-type parental strains induced
luminescence in the AI-1 sensor defective reporter V. har-
veyi strain BB170 with AI-2 like activity peaking at late-log-
arithmic phase (Fig. 2A, B). CM prepared from the
complemented luxS-deficient strains restored lumines-
cence production in the reporter V. harveyi strain to a level
comparable to that of wild-type CM (Fig. 2A). Further-
more, we showed that the S. pyogenes luxS gene comple-
mented successfully the lack of AI-2 production in E. coli
DH5-α (data not shown), thus confirming that the luxS
homologue in both M1 and M19 strains is required for
production of AI-2 like activity. We then addressed the
question whether CM with AI-2 like activity has an auto-
regulatory effect on luxS expression in S. pyogenes. CM
from wild-type and luxS-deficient cultures grown to differ-
ent phases was added to early-logarithmic wild-type cul-
tures. No significant differences in the intensity of the luxS
transcript signal were observed by Northern blot analysis
when comparing induction with CM from both wild-type
and mutant strains and control media (data not shown).
Taken together, our data demonstrate that luxS transcrip-
tion and production of AI-2 like activity are shifted out of
phase. AI-2 like activity peaked at a time point – late-log-
arithmic phase – when luxS transcript levels rapidly
decreased. Importantly, an auto-regulatory function of AI-
2 like activity containing CM on luxS expression could not
be observed in GAS.
Role of luxS in growth and metabolism
Growth rates and yields, colony and chain morphology of
wild-type and luxS-deficient strains in complex THY
medium, THY medium supplemented with 10% fetal
bovine serum, C-medium and CDM were similar (data
not shown). In addition, wild-type and luxS-deficient
strains did not significantly differ in their ability to form
primary adhesion to uncoated polystyrene surfaces (ini-
tial step in biofilm formation) when grown in THY or
CDM (data not shown). To investigate whether inactiva-
tion of luxS and therefore disruption of the AMC would
lead to a metabolic burden that might influence growth or
fitness, we analyzed the growth rates of wild-type and
luxS-deficient strains in sulfur-limited CDM (CDM-S1 and
CDM-S2). Although overall growth rates and yields were
significantly reduced in the restricted media compared to
those in CDM, they were similar when wild-type strains
Table 1: Bacterial strains and plasmids used in this study
Strain/plasmid Relevant characteristics Source
Streptococcus pyogenes
RDN29 M1 type ATCC 700294
RDN02 M19 type Lab strain collection
EC478 Isogenic luxS-deficient mutant of RDN29 This study
RDN306 Isogenic luxS-deficient mutant of RDN02 This study
EC460 RDN29 (pEC82) This study
EC489 EC478 (pEC82) This study
EC490 EC478 (pEC83) This study
EC480 RDN02 (pEC82) This study
EC481 RDN306 (pEC82) This study
EC482 RDN306 (pEC83) This study
Escherichia coli
DH5α Host for cloning; AI-2 deficient (contains a frame-shift mutation in luxS) Lab strain collection
TOP10 Host for cloning Invitrogen
EC467 DH5α (pEC82) This study
EC464 DH5α (pEC83) This study
Vibrio harveyi
BB170 AI-1 sensor deficient, AI-2 sensor positive [9]
Plasmids
pAT21 Apr Kmr; pBR322Ω 1.5-kb pJH1 ClaI (aphIII) [61]
pUC19 ColE1ori, Ampr, lacZ New England Biolabs
pEC131 pUC19ΩluxSup-aphIII-luxSdown This study
pEC82 repDEG-pAMβ1, ermAM/B, ColE1ori This study
pEC83 pEC82ΩPluxS-luxS-TT This studyPage 3 of 17
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Analysis of the luxS transcript in S. pyogenesFigure 1
Analysis of the luxS transcript in S. pyogenes. (A) Temporal analysis of luxS expression. Northern blot analysis of total 
RNA isolated from RDN29 (wild-type M1 strain) and EC478 (isogenic luxS-deficient mutant) cultures at (1) lag, (2) early-loga-
rithmic, (3) mid-logarithmic, (4) mid-late-logarithmic, (5) late-logarithmic, (6) early-stationary and (7) stationary (O/N) phase of 
growth. Blots were hybridized with probes specific to luxS and rRNA16S (acting as loading control). The estimated sizes of 
transcripts are indicated. The blots shown are representative of four independent experiments. Identical luxS expression pro-
files were observed in RDN02 (wild-type M19 strain) and RDN306 (isogenic luxS-deficient mutant). (B) Determination of the 
transcriptional start site of luxS. Left: Primer extension analysis using total RNA isolated from RDN29 wild-type cultures at lag 
(lag) and early-logarithmic (el) phase and the γ-32P-radiolabelled reverse primer oliRN250. As a reference ladder, a DNA 
sequencing reaction using plasmid pEC83 as template and reverse primer oliRN250 is shown (lanes TGCA). The complemen-
tary base (C*) of the transcriptional start site (G), located 20 nucleotides upstream of the translational start codon (ATG), is 
indicated. The picture shown is representative of three independent experiments. Right: Sequence of the 5' part of the luxS 
locus. The putative -35 and -10 promoter regions and +1 transcriptional start site are represented in bold. The putative ribos-
omal binding site (RBS) and translational start codon (ATG) are underlined. The arrow indicates the direction of primer 
oliRN250, which was used for primer extension. An inverted repeat sequence located 97 bp downstream of the translation 
stop codon could serve as a rho-independent transcriptional terminator (not shown).
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BMC Microbiology 2008, 8:188 http://www.biomedcentral.com/1471-2180/8/188were compared to the luxS-deficient mutants (data not
shown). These results indicate that luxS does not have an
essential AMC-related metabolic role in GAS.
Role of luxS in adaptation to host-induced stress condi-
tions. Further, we investigated whether luxS is involved in
the adaptation of S. pyogenes to stress conditions that can
be encountered during infection. Oxidative, acid and salt
stresses, which have been shown to interfere with viru-
lence factor expression in GAS [28-30], were studied.
Challenging wild-type and luxS-deficient strains with
hydrogen peroxide (4 mM) and high salt concentrations
(150 and 650 mM NaCl) did not induce any significant
change in survival rate (data not shown). However, expo-
sure of bacterial cultures to acidic conditions (pH 4) for 2,
4 and 6 h revealed a profound increase in acid tolerance
in the luxS-deficient strains (Fig. 3A). Complementing the
luxS-deficient strains with luxS in trans resulted in restora-
tion of acid sensitivity to a wild-type level (Fig. 3A, shown
only for the 6 h time point), clearly linking luxS to the
observed phenotype. Importantly, we could show that
exposing S. pyogenes cultures to low pH led to reduced
expression of luxS (Fig. 3B), thus suggesting a correlation
between reduced luxS expression and survival under
acidic conditions. Accordingly, CM from these cultures
showed reduced AI-2 like activity (Fig. 3C).
Then, we analyzed the role of the luxS/AI-2 system in
adaptation to an environment that resembles in vivo con-
ditions by using RPMI medium (used for culturing
eukaryotic cells) and 10% serum. We observed reduced
luxS expression at the transcriptional level in wild-type
cultures grown in RPMI medium compared to cultures
grown in the nutrient rich THY medium (Fig. 4A). Fur-
thermore, AI-2 activity in CM from wild-type cultures
grown in RPMI was reduced to a level similar to CM from
luxS-deficient cultures (Fig. 4B). During growth in RPMI,
due to the presence of buffer salts and cultivation in the
presence of CO2, no acidification occurs. Therefore, under
this growth condition, regulation of luxS expression can-
not be attributed to low pH. Since low concentration of
iron in the RPMI medium could be responsible for the
observed phenotype, we supplemented RPMI medium
with iron and depleted THY medium from iron. In both
cases, no change in luxS expression could be observed
(data not shown). Our data thus indicate that under spe-
cific conditions encountered in the host (acidic condi-
tions and in vivo-like environment), there is an advantage
for GAS to lower the expression of luxS and the produc-
tion of AI-2 like activity.
Role of luxS in internalization and survival in human epi-
thelial cells and macrophages. These results prompted us
to determine whether a lack of luxS expression gives a ben-
eficial advantage for GAS to survive in an intracellular
environment. Interactions of wild-type and luxS-deficient
strains of both serotypes M1 and M19 with monolayers of
human pharyngeal epithelial cells were analyzed. No dif-
ferences in the number of bacteria adhering to the epithe-
lial cells (30 min, 1 h and 2 h after infection) were
observed when comparing wild-type and mutant strains
(data not shown). Using an antibiotic protection assay,
the internalization and survival rates of the luxS mutant
strains of both M1 and M19 serotypes were significantly
higher (about 5-fold) at 2 h and 5 h after the addition of
antibiotics compared to those of wild-type strains (Fig.
5A). Analyzing the number of bacteria that survived intra-
cellularly in macrophages led to the same results. The luxS
deficient mutants showed significantly higher internaliza-
tion and survival rates (about 2.5-fold) in macrophages at
0 h, 1 h and 2 h after the addition of antibiotics compared
to the wild-type parents (Fig. 5B). With both serotypes
and in both epithelial and macrophage cells, comple-
menting the mutant strains with the luxS allele in trans
restored the intracellular survival rates to almost wild-type
levels. Since the role of luxS in the AMC-related metabolic
pathway seems limited, we analyzed the possibility of a
signalling function of the luxS/AI-2 system in GAS survival
in host cells. Antibiotic protection assays were performed
with mixed cultures of wild-type and luxS-deficient cells
(ratio 1:1) comparing with non-mixed wild-type and luxS-
deficient cultures. The survival rates of the mixed culture
in both eukaryotic cell types were almost identical to
those of the wild-type strain (data not shown), thus sug-
gesting a potential complementation effect of the luxS-
deficient cells by the wild-type parent cells possibly by AI-
2 production and signaling. In summary, the data indicate
that lowering the expression of luxS provides GAS an
advantage to survive the harsh conditions encountered in
host cells.
Virulence gene expression in luxS mutants
We also studied whether luxS had regulatory effects on
pathogenicity functions other than those already
described (e.g. effect on cysteine protease, SLS and
hyaluronic acid production) [26,27]. Expression of a
number of genes encoding virulence factors and their reg-
ulators [16,21,28,31-36] was then studied by Northern
blot analysis throughout the entire growth phase (Table
2). A consistent decrease in the fasX (encoding the effector
molecule of the fasBCA regulatory system [21]) transcript
and a consistent enhancement of the sibA (psp) (encoding
a secreted immunoglobulin binding protein [32]) tran-
script were detected in the luxS-deficient RDN02 (M19)
strain compared to the wild-type parent, however not in
the M1 background (Fig. 6A, B). This finding does not
only add fasX and sibA to the list of genes being influenced
by luxS but underlines the fact that regulatory pathways
linking the luxS/AI-2 pathway to virulence-associatedPage 5 of 17
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Induction of luminescence in V. harveyi by CM from S. pyogenesFig re 2
Induction of luminescence in V. harveyi by CM from S. pyogenes. (A) Induction of luminescence in V. harveyi reporter 
strain BB170 by CM of wild-type and luxS-deficient mutants. RDN29: wild-type M1 strain, EC460: RDN29 (pEC82), EC478: iso-
genic luxS-deficient mutant, EC489: EC478 (pEC82), EC490: EC478 complemented with pEC83. THY medium and CM of DH5-
α (AI-2 deficient) were used as negative controls; CM of BB170 was used as positive control. CM were prepared from cultures 
at late-logarithmic phase of growth. The luminescence values expressed in specific light units (SLU = RLU (relative light units)/
OD620 nm) (y axis) are plotted versus time (h) (x axis). Data shown are representative of three independent experiments. Simi-
lar data were obtained with CM of the RDN02 (M19 serotype) derivative strains. (B) Fold induction of V. harveyi BB170 lumi-
nescence by CM of RDN29 and EC478. CM was prepared from cultures at mid-logarithmic (ML), late-logarithmic (LL), early-
stationary (ST-1) and stationary phase (ST-2) of growth. Fold induction corresponds to the SLU values obtained with the CM 
of the analyzed strains versus those obtained with the CM of the negative control THY. Fold induction was calculated after ~4 
h of induction when the cell density begins to rise. Induction of luminescence with late-logarithmic CM from the luxS-deficient 
mutant was ~60 fold lower compared to CM from the parent wild-type strain. The average values and standard deviations of 
three independent experiments are shown. Similar data were obtained with CM of the RDN02 derivative strains.
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BMC Microbiology 2008, 8:188 http://www.biomedcentral.com/1471-2180/8/188gene expression can differ among different GAS strains or
serotypes.
Discussion
Among the quorum sensing systems described to date, the
luxS/AI-2 pathway has been shown to be involved in the
regulation of virulence in a number of gram-negative and
gram-positive bacteria [1,5,11,12]. In this study, we ana-
lyzed the expression of the streptococcal luxS/AI-2 system,
its possible role in the AMC metabolic pathway and its
function in adaptation to diverse host-induced stress con-
ditions in two GAS clinical isolates of serotypes M1 and
M19.
Expression analysis of luxS indicated that the luxS tran-
script is monocistronic (644 bases) in GAS serotypes M1
and M19. In a previous report, which was based on
sequence analysis, the luxS transcript in GAS (M6 strain)
was predicted to be polycistronic as a distal member of the
fatty acid metabolism operon [26]. In our study, Northern
blot analysis of luxS expression did not reveal any addi-
tional transcript of higher size. Furthermore, we showed
that the monocistronic transcript is expressed in a growth
phase-dependent manner, a finding already reported for
bacterial species like Streptococcus bovis, whereas transcrip-
tion of luxS in species like Salmonella typhimurium and
Vibrio fischeri has been shown to be constitutive [37-39].
Accordingly, production of AI-2 like activity occurred in a
temporal fashion in the serotypes analyzed, however,
shifted out of phase compared to luxS expression. AI-2 like
activity peaked at late-logarithmic phase when the luxS
transcript had already declined being just above the
detectable expression level. We also investigated the pos-
sibility of an auto-regulation mechanism of luxS expres-
sion in GAS. Induction experiments by Northern blot
analysis failed to show a regulation of luxS expression by
AI-2 dependent CM. These findings are in accordance with
previous work in S. typhimurium, where AI-2 production
and luxS transcription were not in phase either, also sug-
gesting that luxS expression was not regulated by AI-2
[38].
Despite intensive research on luxS and AI-2 during the last
years, a clear separation of the possible metabolic func-
tion of AI-2 from its possible signaling activity could not
be achieved. A recent comparative genomic and phyloge-
netic analysis of synthesis and signal transduction path-
ways showed that S. pyogenes contains the two-step
enzymatic pathway catalyzed by the Pfs and LuxS
enzymes to detoxify SAH leading to AI-2 production
[13,40]. Interestingly, in S. pyogenes the AMC is incom-
plete as it lacks the homocysteine methyltransferases
(MetE or MetH) that convert the SAH-derived metabolic
product homocysteine to methionine. Nevertheless, S.
pyogenes encodes the SAM synthetase ortholog (MetK) that
permits conversion of methionine to SAM [40]. Therefore,
either GAS cannot recycle homocysteine to methionine
(as it has been described in Borrelia burgdorferi [41]) or
recycling occurs through other types of methyltrans-
ferases. In the former case of a de novo methionine synthe-
sis defect, bacterial growth would exclusively depend on
sulfur provided from external sources. In our study,
decreasing media concentrations of cysteine and methio-
nine reduced to a similar extent bacterial growth and
yields in both wild-type and luxS-deficient strains. These
data indicate that GAS, as a poly-auxotrophic organism, is
unable to recycle homocysteine to methionine. Moreover,
we showed that inactivation of luxS does not lead to a
metabolic burden that would influence growth or fitness.
Although AI-2 can certainly be considered as a metabolite,
the viability and lack of growth defects of the investigated
luxS-deficient mutants in various media including mini-
mal media depleted of sulfur sources argues against an
essential role of luxS in AMC-related metabolism.
The previously described regulatory role of luxS in the pro-
duction of virulence factors in GAS [26,27] prompted us
to investigate the role of the luxS/AI-2 system in the adap-
tation to host-induced stress conditions. During an on-
going infection, bacteria often have to face challenging
conditions in particular niches of the host, including
changes in pH, and therefore are forced to develop quickly
an adaptive response, which requires fine-tuning of path-
ogenicity gene expression. Although we could not identify
a possible involvement of the GAS luxS system in adapta-
tion to oxidative and salt stress, we showed an increased
survival of S. pyogenes under acidic conditions when the
luxS/AI-2 system was down-regulated. This is in accord-
ance with luxS expression and AI-2 production being sig-
nificantly lowered when GAS cells were grown in low pH
conditions. Interestingly, previous studies in S. mutans
showed that acid sensitivity was enhanced in luxS defi-
cient mutants [42,43] and that luxS expression was
increased at low pH [44,45]. These reverse effects of luxS
on tolerance to acidic conditions in S. pyogenes and S.
mutans need to be considered in regard to their different
living habitats and pathogenesis. Thus, our data reveal a
link between the S. pyogenes luxS/AI-2 system and path-
ways involved in adaptation of the organism to stress
[46,47]. In addition, we also observed a reduction of luxS
expression and AI-2 like activity in GAS cells grown in
serum enriched RPMI, a medium with a composition sim-
ilar to that of human plasma. In a previous study,
Marouni et al. reported that in an M6 serotype, the sur-
vival of a luxS-deficient mutant in epithelial cells at 4 h
after infection was higher compared to the wild-type par-
ent [27]. Here we analyzed further the role of luxS in inter-
action of S. pyogenes with host cells. No differences in
adhesion rates to human pharyngeal epithelial cells were
observed when comparing wild-type and luxS-deficientPage 7 of 17
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(A) Acid tolerance assayFigure 3
(A) Acid tolerance assay. The ability of RDN02 (wild-type M19 strain), RDN306 (isogenic luxS-deficient mutant), EC480 
(RDN02 (pEC82)), EC481 (RDN306 (pEC82)) and EC482 (RDN306 (pEC83)) to survive an acid challenge (pH 4) is shown as 
survival in percent (y axis) at the 6 h time point. The average % survival values and standard deviations of three independent 
experiments are shown. The asterisk indicates that the difference in survival rates between the luxS-deficient mutant and the 
wild-type strain was statistically significant (P < 0.05). Similar data were obtained with the RDN29 (M1 type) derivative strains. 
(B) Effect of low pH on luxS expression. Northern blot analysis was performed with total RNA isolated from RDN02 cultures 
grown to early-logarithmic phase and then incubated for 90 min with THY medium at pH 5.5, 6.0 and 7.5. Blots were hybrid-
ized with probes specific to luxS and rRNA16S (acting as loading control). The estimated sizes of transcripts are indicated. Pixel 
rates of signals (pixel counts obtained with the luxS probe versus pixel counts obtained with the rRNA16S probe) are shown. 
The blot shown is representative of three independent experiments. Similar data were obtained with the RDN29 strain. (C) 
Induction of luminescence in V. harveyi reporter strain BB170 by CM of RDN02. CM was prepared from RDN02 cultures 
grown to early-logarithmic phase and then incubated for 90 min with THY medium at pH 5.5 (RDN02-pH 5.5), 6.0 (RDN02-
pH 6.0) and 7.5 (RDN02-pH 7.5) for 90 min. THY medium at pH 7.5, 6.0 and 5.5 and CM of DH5-α (AI-2 deficient) were used 
as negative controls; CM of BB170 was used as positive control. The luminescence values expressed in specific light units (SLU 
= RLU (relative light units)/OD620 nm) (y axis) are plotted versus time (h) (x axis). Data shown are representative of three inde-
pendent experiments. Similar data were obtained with CM of the RDN29 derivative strains.
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luxS-deficient mutants had a significant advantage to sur-
vive intracellularly in both epithelial cells (over a period
of 7 h after infection) and macrophages (over a period of
3 h after infection). Taken together, we show that low
level of luxS and AI-2 expression seems to provide a com-
petitive advantage for GAS survival under specific condi-
tions encountered during infection.
With luxS being linked to stress and adaptation to the
host, we were interested in investigating additional effects
of luxS on virulence factor expression in GAS. In an M6
serotype, luxS was shown to regulate streptolysin S (SLS)
expression at the transcriptional level and SpeB cysteine
protease activity [26]. In an M3 serotype, luxS was
reported to regulate expression of SpeB and M protein at
the transcriptional level and hyaluronic acid capsule at the
post-transcriptional level [27]. In our report, we show that
luxS had a positive effect on fasX expression and a negative
effect on sibA (psp) expression at the transcriptional level.
fasX is a small RNA molecule, effector of the fasBCA
operon, which has regulatory functions on virulence fac-
tor expression. fasX was also suggested to be involved in
local tissue destruction and general bacterial aggressive-
ness towards host cells [21,48]. sibA (psp) is a virulence
gene encoding a secreted immunoglobulin binding pro-
tein [32]. Remarkably, the above described regulatory
effects were only observed in the M19 strain, thus suggest-
ing a strain or serotype dependent effect of luxS on the
expression of these two targets. The strain- or serotype-
dependent effect of luxS observed in this study empha-
sizes differences in regulatory pathways among different
GAS isolates. Along these lines, previous reports demon-
strated that mutations in GAS regulators might alter dis-
ease progression [49,50]. This is well illustrated with the
two-component regulatory system CovRS where muta-
tions in the sensor encoding gene covS have been shown
to correlate with human disease severity [51,52]. Muta-
tions in this gene can occur under selective pressure
encountered in the host and can generate hypervirulent
GAS variants with increased risk of systemic dissemina-
tion [51,52]. In the case of luxS, strain specificity manifes-
tation of virulence-associated gene regulation by luxS has
been reported previously in Neisseria meningitidis and Ser-
ratia marcescens [53,54]. Additionally, Marouni et al.
attributed the dissimilar results of the effect of luxS on
bacterial growth and the level of SpeB regulation in GAS
to a possible strain-specific effect [27]. The finding that
luxS can affect the expression of fasX RNA also provides an
additional evidence for the notion that small RNAs have
the ability to integrate cell density signals together with
other environmental stimuli to affect gene expression
[55].
Conclusion
Our data together with previous reports suggest a complex
role of the luxS/AI-2 system in S. pyogenes. Here, we
showed that expression of both luxS and AI-2 occurs in a
temporal fashion but AI-2 like activity does not seem to
have a regulatory effect on luxS expression. Analysis of the
role of luxS in metabolism demonstrated a limited role of
luxS in the AMC-related metabolism. However, studying
the possible function of the luxS/AI-2 system in adapta-
tion to stress revealed that a down-regulation of luxS
expression provides an advantage for S. pyogenes to toler-
ate acidic conditions and grow in a host environment-
mimicking medium. Accordingly, there was an increased
ability of the luxS-deficient mutants to survive intracellu-
larly in both epithelial cells and macrophages. Altogether,
our data suggest an important function for the luxS/AI-2
system in survival and growth of GAS under conditions
that are relevant during infections. Based on the data out-
lined in this article, it is tempting to speculate that in GAS,
luxS is not exclusively a key part of a detoxification path-
way but rather modulation of luxS expression levels
would allow adjusting bacterial fitness in response to
changing host conditions. Finally, our study revealed two
novel virulence-associated targets of luxS in S. pyogenes:
the regulator fasX RNA and the virulence gene sibA.
Methods
Bacterial strains and growth conditions
Bacterial strains and plasmids used in this study are listed
in Table 1. S. pyogenes was routinely cultured in Todd
Hewitt Broth (THB, Bacto, Becton Dickinson) supple-
mented with 0.2% yeast extract (Oxoid) (THY) without
agitation or on trypticase soy agar supplemented with 3%
sheep blood (TSA, BBL, Becton Dickinson). C-medium
(peptide rich and carbohydrate poor), THY or RPMI
medium supplemented with 10% foetal bovine serum
(Gibco), metal ion-restricted medium, chemically defined
medium (CDM) and sulfur-restricted CDM (CDM-S)
were used in specific experiments [56,57]. For the eukary-
otic-like environment, RPMI 1640 (PAA) was supple-
mented with 10% foetal bovine serum (Gibco) or 10%
foetal bovine serum and 50 μM FeCl3. For metal-ion
restricted medium, THY was treated overnight with 30 g of
chelating resin Chelex 100 (Sigma)/liter, supplemented
with 1 mM MgCl2 or 1 mM MgCl2and 1 mM FeCl3. Sulfur-
restricted CDM (CDM-S) consisted of CDM with sulfur
containing salts replaced with their chloride equivalents
[58]. CDM contained L-methionine (670 μM), L-cysteine
(4,125 μM) and L-cystine (208 μM). In sulfur-limiting
conditions, L-cystine was eliminated and only L-cysteine
(10 μM or 350 μM) and L-methionine (1 μM or 100 μM)
were provided as sulfur source. All S. pyogenes cultures
were incubated at 37°C in an atmosphere supplemented
with 5% CO2. Escherichia coli was grown aerobically at
37°C in Luria-Bertani (LB) medium either in liquid withPage 9 of 17
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(A) Analysis of luxS expression in RPMI mediumFigure 4
(A) Analysis of luxS expression in RPMI medium. Northern blot analysis of total RNA isolated from RDN02 (wild-type 
M19 strain) cultures at early-logarithmic (EL), mid-logarithmic (ML) and late-logarithmic (LL) phase of growth. Blots were 
hybridized with probes specific to luxS with 5S rRNA as loading control. The estimated sizes of transcripts are indicated. The 
blots shown are representative of three independent experiments. Identical luxS expression profiles were observed with 
RDN29 (wild-type M1 strain). (B) Induction of luminescence in V. harveyi reporter strain BB170 by CM of S. pyogenes. RDN02: 
M19 wild-type, RDN306: isogenic luxS-deficient mutant. RPMI medium and CM of DH5-α (AI-2 deficient) were used as nega-
tive controls; CM of BB170 was used as positive control. CM was prepared from cultures at late-logarithmic phase of growth 
in RPMI medium. The luminescence values expressed in specific light units (SLU = RLU (relative light units)/OD620 nm) (y axis) 
are plotted versus time (h) (x axis). Data shown are representative of three independent experiments. Similar data were 
obtained with CM of derivative strains of the RDN29 background.
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BMC Microbiology 2008, 8:188 http://www.biomedcentral.com/1471-2180/8/188shaking or on agar plates. V. harveyi was cultured aerobi-
cally at 28°C in an Autoinducer Bioassay (AB) medium
[9]. Transformation of E. coli and S. pyogenes was per-
formed as previously described [59,60]. Whenever
required, suitable antibiotics were added to the medium
to the following final concentrations: erythromycin 300
μg/ml for E. coli and 3 μg/ml for S. pyogenes; kanamycin 25
μg/ml for E. coli and 300 μg/ml for S. pyogenes. Bacterial
cell growth was monitored periodically by measuring the
optical density of culture aliquots at 620 nm using a
microplate reader (SLT Spectra Reader).
DNA manipulations
DNA manipulations including DNA preparation, amplifi-
cation, digestion, ligation, purification, agarose gel elec-
trophoresis and Southern blot analysis were performed
according to standard techniques [60]. Synthetic oligonu-
cleotides used as primers in this study (Table 2) were sup-
plied by VBC-Biotech Services GmbH. Sequencing
reactions were performed at VBC-Biotech Services GmbH.
Construction of the luxS-deficient mutants
Replacement of the luxS coding sequence with a kanamy-
cin resistance cassette, aphIII [61], was performed select-
ing for a double cross-over event. For this purpose, a 1209
bp fragment upstream of luxS (luxS-up) and a 1107 bp
fragment downstream of luxS (luxS-down) were amplified
using wild-type genomic DNA as template and primers
(containing flanking restriction sites) oliRN22/oliRN21
and oliRN20/oliRN19, respectively. The aphIII cassette
was amplified using plasmid pAT21 as template and
primers oliRN23/oliRN24. After digestion with the
respective restriction enzymes, the three fragments were
ligated and cloned into pUC19 (suicide vector for S. pyo-
genes). The resulting plasmid pEC131 was purified, linear-
ized with the restriction enzyme ScaI (which cuts within
the ampicillin resistance cassette) and used to transform
electro-competent wild-type S. pyogenes. Kanamycin resist-
ant clones were selected and the correct replacement event
was checked by PCR analysis using combinations of prim-
ers oliRN267 and oliRN268 derived from flanking regions
upstream and downstream of the luxS-up and luxS-down
fragments and primers oliRN69 and oliRN70 specific to
the aphIII cassette. Southern blot analysis was done to fur-
ther confirm that the recombination events had not
affected the DNA regions located upstream and down-
stream of luxS. The S. pyogenes mutants were grown in liq-
uid medium without antibiotic unless otherwise
specified.
Construction of plasmids for complementation studies
Plasmid pEC82 contains repDEG-pAMβ1 (the origin of
replication of pAMβ1), ermAM (an erythromycin resist-
ance gene with its own promoter and transcriptional ter-
minator), ColE1 (a pUC19-based ColE1 origin of
replication for E. coli) and an expanded MCS (multiple
cloning site). To create the pEC83 luxS-complementation
vector, a 1152 bp large DNA fragment (PluxS-luxS-TT)
containing the luxS coding sequence, its putative pro-
moter region and putative transcriptional terminator, was
amplified from wild-type genomic DNA using primers
(containing flanking restriction sites) oliRN205/
oliRN280 and cloned into pEC82. Plasmids pEC82 and
pEC83 were introduced in competent E. coli and S. pyo-
genes strains selecting for erythromycin resistant clones.
RNA analysis
Total RNA was prepared from culture samples harvested at
different time points during growth and further processed
for normalization and Northern blot analysis as previ-
ously described [62] with minor modifications. Specific
α-32P-dATP labeled DNA probes corresponding to inter-
nal fragments of genes were created by amplification of
wild-type genomic DNA using primers described in Table
2. Primer extension analysis of the luxS transcript and
DNA sequencing reactions were carried out according to
standard protocols [60].
Phenotypical studies
Assays for bioluminescence, acid killing, hydrogen perox-
ide killing, salt stress and biofilm formation were per-
formed as described previously [9,28,29,43,63] with
some minor modifications. For the acid tolerance assay,
mid-logarithmic phase bacterial cultures were harvested
by centrifugation and washed once with 0.1 M glycine
buffer (pH 7.0). Culture aliquots were removed for CFU
determination and the remaining cultures were subjected
to killing by incubating the cells in 0.1 M glycine buffer
(pH 4) for 6 h. The number of viable bacteria was deter-
mined by plating appropriate dilutions in triplicate on
TSA media. For each individual experiment, the ability of
strains to survive the acid challenge was reported as sur-
vival in percent, defined by the ratio of average CFU/ml
(triplicate measurements) recovered after challenge versus
the average number of CFU/ml (triplicate measurements)
present immediately before challenge × 100.
Preparation of conditioned medium for induction assays
Conditioned medium (CM) was prepared from bacterial
cultures grown in THY buffered with 0.1 M HEPES
(Sigma) (pH 7.5) to early-, mid- and late-logarithmic
phase. Culture supernatants were separated from bacterial
pellets by centrifugation at 9,500 × g for 30 min at 4°C,
filter sterilized (0.45 μm) and stored at -20°C. For induc-
tion assays, early-logarithmic wild-type cultures were
induced for 60 and 90 min with THY adjusted to pH 7.5,
6.0 and 5.0 or with CM of wild-type and luxS-deficient
cultures from early-, mid- and late-logarithmic growth
phase and then subjected to Northern blot analysis.Page 11 of 17
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Internalization assays of S. pyogenes in epithelial cells and macrophagesFigure 5
Internalization assays of S. pyogenes in epithelial cells and macrophages. RDN29 (wild-type strain), EC478 (isogenic 
luxS-deficient mutant) and EC490 (RDN29 (pEC85)); RDN02 (wild-type strain), RDN306 (isogenic luxS-deficient mutant) and 
EC482 (RDN29 (pEC85)). Bacterial cultures were used to infect (A) HEp-2 human pharyngeal epithelial cells and (B) RAW 
264.7 macrophages in an antibiotic protection assay. For this, bacterial cultures were grown to mid-logarithmic (RAW 264.7) 
and late-logarithmic (HEp-2) phases, growth time points showing optimal internalization rates in RAW 264.7 and HEp-2, 
respectively. The percent intracellular invasion represents the average CFU/ml number of viable intracellular bacteria recov-
ered at different times following addition of antibiotics versus the average CFU/ml number of inoculated bacteria × 100. The 
average values and standard deviations of three independent assays are shown. The asterisks indicate that the differences in 
survival rates between the luxS-deficient mutants and the wild-type strains were statistically significant (P < 0.01 for Hep-2 epi-
thelial cells, P < 0.05 for RAW 264.7 macrophages). Similar data were obtained for both M1 and M19 serotypes.
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Transcriptional expression of virulence-associated genes in RDN02 (wild-type M19 strain) and RDN306 (isogenic luxS-deficient mutant)Figure 6
Transcriptional expression of virulence-associated genes in RDN02 (wild-type M19 strain) and RDN306 (iso-
genic luxS-deficient mutant). Northern blot analysis was performed with total RNA isolated from strains grown to (1) lag, 
(2) early-logarithmic, (3) mid-logarithmic, (4) mid-late-logarithmic, (5) late-logarithmic, (6) early-stationary and (7) stationary 
phase (O/N). Blots were hybridized with probes specific to fasX (A) and sibA (psp) (B) with a probe specific to 16S rRNA as 
loading control. The estimated sizes of transcripts are indicated. Pixel rates of signals (pixel counts obtained with probe of 
interest versus pixel counts obtained with the 16S rRNA probe) are shown for the different time points during growth. The 
blots shown are representative of three independent experiments.
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Oligo aF/R Sequence 5'-3' bSpecificity
oliRN110 F CGCTGCGTAAAAGATACG aphIII
oliRN111 R AATGGAGTGTCTTCTTCC
oliRN130 F TTGAAATGACAAAAGAAGTT luxS
oliRN129 R AAAGAGGCTATGATCCTTAT
OLEC287OLEC288 F AGTTAAGTGACGATAGCCTAG 5S rRNA
R CTAAGCGACTACCTTATCTCA
oliRN242 F CGGTAACTAACCAGAAAGGG 16S rRNA
oliRN243 R CGTTGTACCAACCATTGTAGC
Virulence genes
OLEC137 F GACCTACTCAGGCAAATC fbp54
OLEC138 R CTTGTCTAAGGCAATCTC
oliRN204oliRN203 F TGGTAAAAATGCCTATACCC isp2
R GACCTCGTGAAAACTTAGCC
oliRN248 F AGGAATAAATTGGTCCTCTT nga
oliRN249 R GGCAGTTTCAATAAACTCAT
OLEC268 F AAGAGATCGAAGAAAGTCTT scl
OLEC269 R TTTGGTTAGCTTCTTTGTCA
oliRN202oliRN201 F AGTTAAGGCACAAGAACAGG sibA (psp)
oliRN246 R TACTTGAGGCACTTTGAACC
oliRN247 F ACTAGGAGCTACACAACCAG sic
oliRN263 R TACCCTGTACCTAATGCTTC
oliRN264 F ACATCTCAAGAATTACTAGC ska
oliRN279 R TTGTTGTAGAGTAGTTTAGC
oliRN50 F ATGGAAAATATTCTGATATCTTAG slo
oliRN47 R CCCAAAGGATTTCATATTGAGC
F CATAATTACAGTCACTGATT speC
oliRN48 R ATCGAAATGACTAAAGTTCTTCAT
oliRN55 F TTTTCAATGGTAGCTCTTG speF (mf)
oliRN56 R TTCTTGAGCTCTTTGTTCG
Stand-alone regulators
OLEC274 F ATAGCCTAGAAACAGAATTA codY
OLEC275 R TTCTGAATAAGAAAGCGTAT
oliRN170 F TAAGTAAGTTGTTTACAAGTCAAC AGTGGAG mga
oliRN136 R AAAGGCGTAGATCAATTGG
OLEC337 F ATGACGCCTAATAAAGAAGA mtsR
OLEC338 R CTGTGACATAAAGTTGCTTA
OLEC315 F TGGACATTCATTCACATCAG perR (spf)
OLEC316 R ATCAGGTTGGTCTTTTGCTT
oliRN73 F AAATACTTGGAATCATCAATCG rofA
oliRN74 R TTTTCTTGAGCTAATGCAACCG
OLEC278 F TAGACAACTTGAATGTCAAT ropB
OLEC279 R AAGCTTTATCATACTCTTGT
OLEC276 F ACATTTTGCAACGGTATATT srv
OLEC277 R AATAGGGTCATTAAGTCATA
Two-component systems
oliRN175 F CTGCTTGACTTAATGTTACC covR (CovRS)
oliRN176 R TTTGACAATAATTCTTCACG
OLEC182 F GAGCAATAACATTTTAGG fasX (effector molecule, FasBCA)
OLEC183 R TTACAATCAGCTGATGTG
OLEC270 F ATTCGAAAGACATCAGATGT Irr (Ihk/Irr)
OLEC271 R CATATGTCATCCATCAATTGPage 14 of 17
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host cells. HEp-2 cells and RAW 264.7 mouse macro-
phages were maintained in RPMI medium (HEp-2 cells)
or Dulbecco's modified Eagle's medium (D-MEM, Gibco)
(RAW 264.7 cells) supplemented with 10% foetal bovine
serum (Gibco), penicillin (100 μg/ml) and streptomycin
(100 μg/ml), and grown at 37°C in an atmosphere con-
taining 5% CO2. Prior the infection assay, the cells were
cultured overnight to semi-confluency (1.5 × 105 cells per
well for HEp-2 cells and 2 × 105 cells per well for
RAW264.7 cells) in 24-well tissue culture plates contain-
ing medium without antibiotic. GAS strains were grown
to the same OD620 nm corresponding to mid-logarithmic
(RAW 264.7) or late-logarithmic (HEp-2) phase, washed
with PBS, suspended in fresh cell culture medium and
added to the semi-confluent host cell monolayers at a
multiplicity of infection (MOI) of 5:1 (HEp-2) or 100:1
(RAW 264.7) in triplicate. Times of incubation were 30
min, 1 h and 2 h (adhesion, HEp-2 cells), 2 h (internali-
zation, HEp-2 cells) and 30 min (RAW 264.7 cells). For
adhesion assays (HEp-2 cells), infected monolayers were
washed extensively with PBS before lysing. For internali-
zation assays (RAW 264.7 cells), extracellularly adhered
bacteria were killed by incubation with fresh medium
containing either 100 μg/ml gentamicin and 5 μg/ml pen-
icillin (HEp-2 cells) or 60 μg/ml penicillin (RAW 264.7
cells). At indicated time points, the infected monolayers
were washed extensively with PBS to remove the antibiot-
ics. Cells were then lysed with chilled sterile distilled
water. The number of viable intracellular bacteria released
from the lysed cells was determined by plating appropri-
ate dilutions of the lysates on TSA-blood plates in tripli-
cates followed by 24 h incubation at 37°C. The number of
bacteria that survived intracellularly was calculated using
the following equation: average number of bacteria recov-
ered (cfu/ml) per well (triplicate) at designated time
point/inoculated number of bacteria (cfu/ml)) × 100.
Average values were plotted.
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4.4 Project 4: Group A Streptococcus activates type I interferon production and 
MyD88-dependent signalling without involvement of TLR2, TLR4 and  TLR9 
 
4.4.1 Summary 
One of the mechanisms by which the innate immune system senses the invasion of 
pathogenic micro-organisms is through the toll-like receptors (TLRs). TLRs have a 
crucial role in early host defence against invading pathogens. Pathogen-associated 
molecular patterns (PAMPs) in bacteria are recognized by host cell-encoded pattern-
recognition receptors (PRRs) to develop immune responses. TLRs are the best studied 
PRRs. Stimulation of different TLRs induces distinct patterns of gene expression, which 
leads to the activation of innate immunity and also instructs the development of antigen-
specific acquired immunity. All pathogenic bacteria are recognized by one or more TLRs. 
TLR4 is critical for LPS recognition, TLR2 for lipoteichoic acids, TLR5 for flagellin and 
TLR9 recognizes bacterial DNA containing unmethylated CpG sequences. The MAP 
kinase cascade is an evolutionary conserved signaling pathway. There are three major 
groups of MAP kinases: the extracellular signal-regulated protein kinases (ERK), the p38 
MAP kinases and the c-Jun NH2-terminal kinases (JNK). After ligand mediated 
dimerization, TLR recruits an adapter protein MyD88 (Myeloid differentiation factor 88). 
MyD88 then assembles a signalosome containing IRAK (interleukin receptor associated 
kinase), TRAF6 (tumor-necrosis-factor-receptor associated factor 6) and ECSIT. 
Together they mediate activation of NF-kB and MAP kinases like p38 and JNK, which 
leads to the production of inflammatory cytokines such as TNFα,IL-1 and IL-2.  
 
In this study the activation of p38MAPK and NF-κB in WT and TLR2-/- BMDMs was 
compared, since many gram-positive pathogens are recognized by this receptor. The data 
demonstrate that TLR2 was not required for GAS-induced signalling. Other TLRs 
frequently engaged by bacteria are TLR4 and TLR9. To examine whether a combination 
of TLR2, TLR4 and TLR9 was used for GAS recognition, GAS-induced signalling in 
TLR2/4/9 triple-deficient BMDMs was analyzed. The signalling events in triple-deficient 
BMDMs were comparable to those triggered by WT GAS. These data exclude a 
redundant function of TLR2, TLR4 and TLR9 in GAS recognition, and demonstrate that 
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macrophages sense GAS using a PRR other than the most common bacterial receptors. 
GAS-induced activation of p38MAPK was almost completely abolished and the 
degradation of IκB was strongly diminished in MyD88-/-cells when compared to WT 
cells. These data show that GAS-induced proinflammatory cytokine production is 
absolutely dependent on MyD88. It was further demonstrated that GAS also elicits 
MyD88-independent signaling that results in type I IFN production. Analysis of Stat1 
activation revealed that neither the deletion of the single cytolysin genes (sagA or slo) nor 
the double deletion of cytolysin genes (sagA-slo) caused a reduction of GAS-induced IFN 
signalling. The inflammatory signalling was also not dependent on the expression of the 
GAS cytolysins as shown by p38MAPK activation. Hence it is surprising that IFN 
production did not require cytolysins because in other gram-positive pathogens either 
cytolysins itself or cytolysin-mediated escape of bacteria from phagocytic vesicles trigger 
IFN production. 
This is the first description of activation of MyD88-dependent and -independent 
pathways upon GAS infection. This data indicate that first, GAS is recognized by an 
unknown receptor upstream of MyD88, and second, the MyD88-independent signaling 
proceeds without cytolysins that are often required for IFN production by other gram-
positive bacteria. In agreement with our results, a recent study showed that dentritic cells 
deficient in TLR1, 2, 4, 9 or 2/6 were not impaired in the secretion of the 
proinflammatory cytokines and argues for the role of a multi-model recognition that is 
the combination of several different TLR-mediated signaling in S. pyogenes (Loof et al., 
2008). The activation of multiple signaling pathways may contribute to the known high 
potential of GAS to induce toxic shock and other GAS-derived pathologies. 
This work was done in collaboration with a.o. Prof. Pavel Kovarik’s lab. I constructed 
two mutants: the slo (encoding Streptolysin O)-deficient and the double slo-sls (encoding 
Streptolysin O and Streptolysin S)-deficient mutants for this study. These mutants were 
analyzed by PCR, Southern blot and DNA sequencing, in order to verify the correct 
deletion events in the mutants as well as by doing hemolysis assays. 
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Bacterial pathogens are recognized by the innate immune sys-
tem through pattern recognition receptors, such as Toll-like
receptors (TLRs). Engagement of TLRs triggers signaling cas-
cades that launch innate immune responses. Activation of
MAPKs and NF-B, elements of the major signaling pathways
induced by TLRs, depends in most cases on the adaptor mole-
cule MyD88. In addition, Gram-negative or intracellular bacte-
ria elicit MyD88-independent signaling that results in produc-
tion of type I interferon (IFN). Here we show that in mouse
macrophages, the activation of MyD88-dependent signaling by
the extracellularGram-positive humanpathogen groupA strep-
tococcus (GAS; Streptococcus pyogenes) does not require TLR2,
a receptor implicated in sensing of Gram-positive bacteria, or
TLR4 and TLR9. Redundant engagement of either of these TLR
molecules was excluded by using TLR2/4/9 triple-deficient
macrophages. We further demonstrate that infection of macro-
phages by GAS causes IRF3 (interferon-regulatory factor 3)-de-
pendent, MyD88-independent production of IFN. Surprisingly,
IFN is induced also by GAS lacking slo and sagA, the genes
encoding cytolysins that were shown to be required for IFN pro-
duction in response to other Gram-positive bacteria. Our data
indicate that (i) GAS is recognized by a MyD88-dependent
receptor other than any of those typically used by bacteria, and
(ii) GAS as well as GAS mutants lacking cytolysin genes induce
type I IFNproduction by similarmechanisms as bacteria requir-
ing cytoplasmic escape and the function of cytolysins.
Group A streptococcus (GAS4; Streptococcus pyogenes) is an
important human Gram-positive pathogen responsible for a
wide spectrum of infections, ranging from mild diseases (e.g.
tonsillitis) to serious illness (e.g. necrotizing fasciitis, sepsis, or
severe poststreptococcal sequelae) (1). The persistence of GAS
in the human population and the severity of someGAS diseases
are the result of activities of a number of virulence factors that
enable the pathogen to escape immune surveillance or, on con-
trary, induce an overreaction of the immune system (2, 3).
Although GAS is generally regarded as an extracellular patho-
gen, recent findings suggest that GAS can survive (although not
multiply) within various host cells, such as neutrophils, macro-
phages, epithelial cells, and fibroblasts (4–7). The surviving
bacteria may serve as a reservoir for recurrent GAS diseases.
Immune responses to bacteria are initiated by recognition of
bacterial components called pathogen-associated molecular
patterns through host cell-encoded pattern recognition recep-
tors (PRRs) (8, 9). Typically, pathogen-associated molecular
patterns are components of the bacterial cell wall (e.g. lipopo-
lysaccharide and lipoteichoic acid), but they may also be
derived from the inside of bacteria (e.g. DNA). The primary
function of PRRs is to trigger signaling cascades that activate
antimicrobial defense programs. The best studied class of PRRs
is the Toll-like receptor (TLR) family, which consists of 13
transmembrane glycoproteins in mammals (8). Virtually all
pathogenic bacteria are recognized by one or more TLRs, with
TLR2 being the receptor for lipoteichoic acid of Gram-positive
bacteria, TLR4 the receptor for lipopolysaccharide of Gram-
negative bacteria, and TLR9 the receptor for bacterial DNA
containing unmethylated CpG sequences. Ligand binding to
TLR3, TLR4, TLR7, and TLR9 but not to TLR2 launches two
distinct signaling pathways that result in the production of
proinflammatory cytokines (e.g. TNF and IL-1) and type I
IFNs, respectively. Five TIR domain-containing adaptor mole-
cules are involved in signaling downstream of TLRs: MyD88,
TIRAP (or MAL), TRIF (or TICAM1), TRAM (or TICAM2),
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and SARM, a negative regulator of TRIF (10).MyD88, an essen-
tial signaling component of all TLRs except TLR3, is required
for activation of MAPKs and NF-B that cause production of
proinflammatory cytokines. Signaling components that are
required for the production of type I IFNs are less uniform, and
they are partially TLR- and cell type-specific. Recently, much
attention has been paid to the elucidation of pathways leading
to TLR-independent production of type I IFN in response to
intracellular bacteria and/or intracellular DNA (11–14).
Although the identity of the critical PRR remains unknown, it is
generally believed that it is a cytoplasmic molecule that recog-
nizes bacterial products (possibly bacterial DNA) in the cyto-
plasm. Signaling downstream of this unknown PRR employs
the serine threonine kinase TBK1 or, less frequently, its relative
IKK (15–18), which phosphorylates primarily the transcription
factor IRF3, causing the activation of the IFN- gene, the first
type I IFN to be expressed (19, 20). Other cytoplasmic PRRs,
such as the NOD proteins, recognize bacterial products in the
cytoplasmand activateMAPKs andNF-Bbut not IFNproduc-
tion (21).
Despite a considerable knowledge of GAS virulence factors,
the PRRs that are responsible for recognition of this pathogen
by the host are unknown. Remarkably little information is avail-
able also about the signaling pathways triggered by GAS in
infected innate immune cells that are known to be required for
defense against GAS (22). Here we show that GAS activates p38
MAPK, NF-B, TNF, and IL-6 production in infected bone
marrow-derived mouse macrophages (BMDMs). Similar to
other bacteria, these responses depend onMyD88. However, in
contrast to most other pathogenic bacteria, the MyD88-medi-
ated signaling was independent of TLR2, the receptor for
Gram-positive bacteria, and the other bacterial receptors TLR4
and TLR9. We also rule out the involvement of IL-1 receptor
signaling. We further demonstrate that GAS also elicits
MyD88-independent signaling that results in type I IFN pro-
duction. The IFN production did not require the presence of
the GAS-encoded cytolysins SLO and SLS. This finding is sur-
prising, since during infections with other Gram-positive bac-
teria, either the cytolysin itself or cytolysin-mediated cytoplas-
mic escape of bacteria from phagocytic vesicles was implicated
in triggering IFN production (12, 23–25). However, the
requirement for IRF3 in the IFN production suggested that
other aspects of the GAS-induced IFN production resembled
the well established TBK1/IRF3 signaling pathway. This is the
first description of activation of MyD88-dependent and -inde-
pendent pathways uponGAS infection. Our data implicate that
GAS is recognized by a yet unknown receptor upstream of
MyD88 and establish GAS as a Gram-positive pathogen capa-
ble of inducing type I IFN synthesis without molecules usually
required for entry of bacterial products into the cytoplasm of
infected cells.
EXPERIMENTAL PROCEDURES
Bacterial Strains—Escherichia coli DH5- and TOP10 were
used as hosts for cloning. S. pyogenes serotype M1 (ATCC
700294) is a clinical strain originally isolated from an infected
wound. The isogenic sagA- and slo-deficientmutantswere con-
structed using a thermosensitive strategy described previously
(26). First, usingwild-type genomicDNAas template and prim-
ers containing flanking restriction sites, a 1111-bp sagA
upstream fragment (primers OLEC120/OLEC143), a 1200-bp
sagA downstream fragment (primers OLEC123/OLEC144), a
1159-bp slo upstream fragment (primersOLEC248/OLEC249),
and a 1033-bp slo downstream fragment (primers OLEC250/
OLEC251) were amplified. After digestion with the respective
restriction enzymes, the upstream and downstream fragments
were cloned into thermo-sensitive plasmids pRDN18 (sagA-
deficient mutant) and pEC84 (slo-deficient mutant) (26). After
introduction of the recombinant plasmids into S. pyogenes
ATCC 700294, a series of temperature shifts with appropriate
antibiotic selection was performed, thus leading to the final
deficient mutants (strain EC548 (sagA-deficient mutant) and
EC997 (slo-deficient mutant)) in which the entire coding
sequence of the gene was deleted in a nonpolar fashion. To
create the sagA/slo-deficient strain (EC1142), the deletion of slo
was performed as mentioned above in the background of the
sagA-deficient strain. The correct deletion event in themutants
was checked by PCR, Southern blot, and sequencing analysis.
SLS and SLO hemolysis assays further confirmed that the
sagA-, slo-, and sagA/slo-deficient mutants were defective in
SLS and/or SLO activity as described (27, 28). DNA manipula-
tions are described in the supplemental materials.
Bacterial Culture—S. pyogenes strains were grown at 37 °C
with 5% CO2 without agitation in Todd-Hewitt broth (BD Bio-
sciences) supplemented with 0.2% yeast extract and on tryptic
soy agar supplemented with 3% defibrinogated sheep blood.
Transformation ofE. coli and S. pyogeneswas performed as pre-
viously described (29, 30).Whenever required, antibiotics were
added to the medium at the following final concentrations:
erythromycin, 300g/ml forE. coli and 3g/ml for S. pyogenes;
spectinomycin, 100 g/ml for both E. coli and S. pyogenes. Bac-
terial cell growth was turbidimetrically monitored at 620 nm
with a microplate reader.
Macrophage Cell Culture—Primary BMDMs were obtained
from the femur bone marrow of 6–10-week-old mice. Cells
were cultivated in Dulbecco’smodified Eagle’s medium supple-
mented with 10% fetal calf serum in the presence of L cell-
derived CSF-1, as described (31). MyD88/, TLR2/,
TLR4/, TLR9/, TLR2/4/9/, IFNAR1/, IRF3/, IL1-
RI/, and control WT mice, all on a C57Bl/6 background,
were housed under specific pathogen-free conditions (32–36).
GAS Infections—For infection assays, BMDMs were seeded
at 5 106 cells/dish in 10-cm dishes containing medium with-
out antibiotics. The next day, S. pyogenes cultures grown in
THY were harvested at midlogarithmic phase, washed with
phosphate-buffered saline, and added to the BMDMmonolay-
ers at a multiplicity of infection (MOI) of 100. After 30 min of
incubation at 37 °C, nonadherent extracellular bacteria were
eliminated by removing the culture medium, and adherent
extracellular bacteria were subsequently killed by incubation
with fresh medium (without fetal calf serum) containing 60
g/ml penicillin. At specific time points after infection, super-
natants were collected for ELISA, and whole cell extracts were
prepared for Western blot analysis. At least three mice of each
genotype were used in all infection experiments.
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Antibodies—Antibodies to Tyr701-phosphorylated Stat1
(pY701-S1) and phosphorylated p38 (pp38) were purchased
from Cell Signaling (Frankfurt/Main, Germany). Antibodies to
IB- and p38were purchased fromSantaCruz Biotechnology,
Inc. (Santa Cruz, CA). Antibody to Stat1- C terminus was
previously described (37).
ELISA andWestern Blot Analysis—For ELISAs, supernatants
of infected macrophages were collected and diluted 1:5 in rea-
gent diluent. TNF and IL-6 were assayed using DuoSET
ELISA kits (R&D Systems, Minneapolis, MN). Western blot
analysis was performed using fluorophore-linked secondary
antibodies (Molecular Probes-Invitrogen (Lofer, Austria) and
Rockland (Gilbertsville, PA)) and an Odyssey infrared imaging
system (LI-COR Bioscience, Lincoln, NE).
qRT-PCR—Total RNA was iso-
lated using Trizol LS reagent
(Invitrogen). Reverse transcription
of total RNA was performed using
oligo(dT)18 as primer and Moloney
murine leukemia virus reverse tran-
scriptase (Fermentas, St. Leon-Rot,
Germany). The cDNA of the IFN-
and Mx2 genes was subsequently
analyzed by qRT-PCR as described
in the supplemental materials.
RESULTS
GAS Activates Inflammatory Sig-
naling Independently of TLR2,
TLR4, and TLR9—To investigate
the role of bacteria-recognizing
TLRs in responses toGAS infection,
we examined the activation of the
transcription factor NF-B by
assaying the degradation of its
inhibitor (IB) and the phosphoryl-
ation of p38 MAPK in infected
BMDMs. Activation of both NF-B
and p38 MAPK was shown in
numerous studies to be essential
for production of proinflammatory
cytokines (38–42). Furthermore,
macrophages express all compo-
nents of the TLR signaling cascade
and are known to be required for
defenses against GAS infection (22).
We first compared the activation of
p38 MAPK and NF-B in WT and
TLR2/ BMDMs, since many
Gram-positive pathogens are recog-
nized by this receptor. GAS induced
in both WT and TLR2/ BMDMs
a rapid and sustained activation of
p38 MAPK (Fig. 1A). The degrada-
tion of IB was maximal after 1 h of
infection. IB gradually reappeared
at later time points but did not reach
the original level during the time
frame of observation (up to 4 h). The internalization of GAS
(monitored by fluorescence microscopy) was equally efficient
in cells of both genotypes (data not shown). These data demon-
strate that TLR2 was not required for GAS-induced signaling.
Other TLRs frequently engaged by bacteria are TLR4 and
TLR9. TLR4 is the receptor for lipopolysaccharide of Gram-
negative bacteria, but it has been shown to recognize also cell
wall components of mycobacteria and several cytolysins of
Gram-positive bacteria (25, 43, 44). TLR9, aCpGDNAreceptor
localized in endosomal and lysosomal membranes of macro-
phages and, most prominently, dendritic cells, can bind DNA
from both Gram-positive and Gram-negative species (35, 45).
Similar to TLR2/ BMDMs, the activation of p38 MAPK and
degradation of IB in TLR4/ and TLR9/ BMDMs was
FIGURE1.GAS-induced inflammatory signalingand theproductionof TNFand IL-6dependsonMyD88
but not on TLR2, TLR4, and TLR9. A–E, BMDMs from TLR2/ (A), TLR4/ (B), TLR9/ (C), TLR2/4/9/ (D),
MyD88/ (E), andWT control mice were infectedwith GAS (MOI 100). At the indicated time points, whole cell
extracts were prepared and analyzed by Western blotting using antibodies to phosphorylated p38 MAPK
(pp38; top) and to IB (bottom). Equal loading was controlled by reprobing the membrane with antibody to
total p38 MAPK. F and G, BMDMs derived from TLR2/4/9 triple-deficient (TLR2/4/9/) (F), MyD88/ (G), and
controlmicewere infectedwith GAS (MOI 100). At the indicated time points, supernatants were collected, and
TNF (left) and IL-6 release (right) was measured by ELISA. The data represent one of at least three infection
experiments carried out independently with different mice of each genotype.
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indistinguishable fromWTBMDMs (Fig. 1,B andC). To exam-
ine whether a combination of TLR2, TLR4, and TLR9 was used
for GAS recognition, we analyzed GAS-induced signaling in
TLR2/4/9 triple-deficient BMDMs. As depicted in Fig. 1D, the
signaling events in triple-deficient BMDMs were comparable
with WT cells. These data exclude a redundant function of
TLR2, TLR4, and TLR9 in GAS recognition and demonstrate
that macrophages sense GAS using a PRR other than the most
common bacterial receptors.
GAS-induced Inflammatory Signaling Depends on MyD88—
All TLRs except for the double-stranded RNA receptor TLR3
require MyD88 for activation of MAPKs, NF-B, and the sub-
sequent proinflammatory cytokine production. To investigate
whether MyD88 was involved in GAS-induced inflammatory
signaling, we examined the activation of p38MAPK and degra-
dation of IB in infected MyD88/ BMDMs. The experiment
revealed thatGAS-induced activation of p38MAPKwas almost
completely abolished, and the degradation of IB was strongly
diminished in MyD88/ cells when compared with WT cells
(Fig. 1E). A weak p38 MAPK activation and IB degradation
were observed in MyD88/ cells at later time points of infec-
tion. Thus, the GAS-induced inflammatory signaling was
markedly reduced and delayed in MyD88/ cells. The activa-
tion of MAPKs and NF-B plays a fundamental role in induc-
tion of proinflammatory cytokines, such as TNF or IL-6. To
estimate the effect of reduced GAS-induced inflammatory sig-
naling in MyD88/ BMDMs, we determined the amounts of
secreted TNF and IL-6 in supernatants of GAS-infected
MyD88/ and controlWT cells. In parallel, we also measured
TNF and IL-6 production by infected TLR2/4/9 triple-defi-
cient cells. Infection of WT BMDMs with GAS resulted in a
robust cytokine production that was only slightly reduced (by
less than 20%) in TLR2/4/9 triple-deficient cells (Fig. 1F). In
marked contrast, TNF and IL-6 production was completely
abolished inGAS-infectedMyD88/BMDMs (Fig. 1E). These
data show that GAS-induced proinflammatory cytokine pro-
duction is absolutely dependent on MyD88. The slight but
reproducible reduction of cytokine production by TLR2/4/9
triple-deficient BMDMs indicates that one of these TLRs or a
combination of them plays aminor role in GAS-induced proin-
flammatory cytokine production. However, the largest part of
GAS-induced inflammatory cytokine production is mediated
by a receptor (or receptors) different from the most common
bacteria-specific TLRs. Importantly, this receptor signals via
MyD88. The only other known pathways that use the adaptor
MyD88 for signaling are the IL-1/IL-18 pathways (32).
Although IL-18 is most relevant for the activation and IFN-
production byTh1 cells (46), IL-1 has been reported be released
by innate immune cells upon infection with various pathogens
that are sensed in the cytoplasm by components of the inflam-
masome (47–49). To investigate whether IL-1 release by GAS-
infectedmacrophages is responsible for theMyD88-dependent
inflammatory signaling, we infected cells deficient in IL1-RI,
themost important IL-1 receptor chain (50). As shown in Fig. 2,
the activation of p38MAPK, the degradation of IB, and TNF
productionwere not affected by the deficiency in IL-1 signaling.
These data further strengthen our notion that GAS is sensed by
a yet unidentified receptor upstream of MyD88.
GAS Induces Type I Interferon—Gram-negative and intracel-
lular bacteria are known to elicitMyD88-independent signaling
that causes activation of the transcription factor IRF3 and sub-
sequent transcription of the type I IFN-. The mechanisms of
IFN production induced by these two types of bacteria differ
upstream of IRF3. Whereas Gram-negative bacteria use TLR4
to stimulate IFN production, intracellular bacteria are recog-
nized by a still unknown cytoplasmic receptor. Engagement of
TLR9 can also trigger IRF3/IRF7-mediated type I IFN expres-
sion. GAS has been previously reported to induce IFN produc-
tion in primary human macrophages (51). We asked whether
GAS can exert similar effects in mouse macrophages and what
the role ofMyD88 or the bacteria-specific TLRs therein is. First,
tyrosine phosphorylation of the crucial IFN-activated tran-
scription factor Stat1 was analyzed. Tyrosine phosphorylation
of Stat1 is a good indicator for autocrine IFN- production,
since this cytokine is the first IFN to be synthetized upon chal-
lenge of macrophages with bacteria or their products (52–54).
Infection of BMDMs with GAS revealed induction of Stat1
FIGURE 2. IL-1 signaling is not required for responses of BMDM to GAS
infection. A and B, BMDMs from IL-1RI/ and control (WT) mice were
infected with GAS (MOI 100) for the indicated periods. p38 MAPK activation
(pp38) (A) and degradation of IB (B) were determined by Western blot anal-
ysis. Equal protein loading was confirmed by reprobing the membrane with
antibody to total p38 MAPK. C, BMDMs derived from IL-1RI/ and control
mice were infected with GAS (MOI 100). At the indicated time points, super-
natants were collected, and TNF release was measured by ELISA. The data
represent one of at least three infection experiments carried out independ-
ently with different mice of each genotype.
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tyrosine phosphorylation after 4 h of infection of WT BMDMs
(Fig. 3,A andB). This late tyrosine phosphorylation is similar to
challenges with other bacteria (e.g. Listeriamonocytogenes) that
do not induce IFN synthesis through direct engagement of an
IFN-inducing TLR (23). Consistently, Stat1 activation pro-
ceeded independently of MyD88 and TLR2, TLR4, and TLR9
signaling, as shown by GAS infection of BMDMs from
MyD88/ (Fig. 3A), TLR2/, TLR4/, TLR9/ (all in Fig.
S1), or TLR2/4/9 triple-deficient (Fig. 3B) mice. In fact, Stat1
tyrosine phosphorylation was slightly but reproducibly
increased in MyD88/ and TLR2/4/9 triple-deficient
BMDMs (Fig. 3,A and B) when normalized to total Stat1 levels.
Since the Stat1 levels were generally slightly lower in BMDMs
derived from the gene-targeted mice compared with WT con-
trols, the Western blots were reprobed with p38 antibody to
allow a more accurate normaliza-
tion. Reduced Stat1 levels have been
already previously observed in cells
that are deficient in IFN or TLR/
MyD88 signaling (11, 55, 56). To
directly assess IFN- expression, we
performed qRT-PCR to determine
IFN-mRNA levels in cells infected
with GAS. The data shown repre-
sent relative IFN- mRNA levels
normalized to GAPDH mRNA. We
did normalize to uninfected cells,
since the IFN- mRNA was very
often below the levels that could be
reliably detected by qRT-PCR. The
experiment confirmed that the
IFN- expression was independent
of TLR2, TLR4, and TLR9 (Fig. 3D).
The IFN-mRNAwas also induced
upon infection of MyD88/ cells
with GAS, albeit the amount was
reduced if compared with WT cells
(Fig. 3C). The reduced IFN-
mRNA levels in MyD88/ did not
result in diminished IFN signaling,
since Stat1 activation was increased
in these cells if compared with the
controlled BMDMs (Fig. 3A). The
functional activation of IFN/Jak/
Stat signaling in MyD88/ and
WT cells was further confirmed by
the induction of the type I IFN tar-
get gene Mx2 (57). The transcrip-
tion ofMx2was induced in both the
control and MyD88/ BMDMs
with a kinetics that correlated well
with the activation profile of Stat1
(Fig. 3E). Moreover,Mx2 transcrip-
tion was more strongly induced in
MyD88/ cells that also display
increased Stat1 activation. Thus,
despite the decreased IFN-
mRNA, the IFN/Jak/Stat1 signaling
was more efficiently turned on in MyD88/ cells, suggesting
that the increased Stat1 phosphorylation was caused by a
more efficient phosphorylation or a lower dephosphoryla-
tion rate. To prove the autocrine/paracrine role of the type I
IFN in Stat1 activation, we examined Stat1 activation and
IFN responses using BMDMs lacking the type I IFN receptor
chain 1 (IFNAR1/). As shown in Fig. 4A, Stat1 tyrosine
phosphorylation was completely abolished in GAS-infected
IFNAR1/ cells despite robust induction of IFN- gene
transcription in these cells (Fig. 4A). Consistently, the induc-
tion of the type I IFN-responsive gene Mx2 was entirely
dependent on signaling by the IFNAR1 receptor (Fig. 4C). In
most cell types, activation of the transcription factor IRF3
launches a feed forward type I IFN amplification loop
through induction of IFN- that drives the expression of
FIGURE 3.GAS induces IFN-production and Stat1 activation independently ofMyD88, TLR2, TLR4, and
TLR9. A and B, BMDMs from control (WT), MyD88/ (A), and TLR2/4/9 triple-deficient (TLR2/4/9/) (B) mice
were infectedwithGAS (MOI 100), andwhole cell extractswerepreparedafter the indicated timeperiods. Stat1
Tyr701 phosphorylation and expression were determined by Western blotting using antibody to phosphoryl-
ated Stat1 (pY-S1) and total Stat1. Differences in Stat1 expression levels were revealed by reprobing the
membrane with antibody to total p38 MAPK (p38). Note the double band on the pY-S1 blot represents the
phosphorylated formsof both Stat1 splicing isoforms Stat1- and Stat1-. Loading control (S1)was performed
with antibody directed to the C terminus of Stat1, which is absent in the Stat1- isoform. C andD, BMDMs from
wild type,MyD88/ (C), and TLR2/4/9 triple-deficient (TLR2/4/9/) mice (D) were exposed to GAS (MOI 100).
After the indicated time points, total mRNA was extracted, reverse-transcribed, and analyzed by qRT-PCR for
IFN- and GAPDH (for normalization) expression. Note that the data show relative IFN-mRNA levels normal-
ized toGAPDHbutnot touninfected samples. E, GAS-induced IFN- stimulates transcriptionof type I IFN target
gene Mx2. BMDMs from MyD88/ and control (wild type) mice were exposed to GAS, and 2.5, 4, and 6 h
postinfection (hours p.i.), total mRNA was extracted, reverse-transcribed, and analyzed by qRT-PCR for Mx2
after normalizing to GAPDH and uninfected samples. Bars, S.D. of three experiments.
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IFN-s (19, 20, 58). Thus, a failure in activation of IRF3
results in a deficient production of both the immediate
IFN- and the late phase IFN-s. To further elucidate the
mechanism of GAS-induced IFN production, we infected
IRF3/ BMDMs with GAS and examined the activation of
the transcription factor Stat1 and induction of the Stat1 tar-
get gene Mx2. Both the tyrosine phosphorylation of Stat1
and the transcription of the type I IFN-inducible gene Mx2
were diminished in IRF3/ (Fig. 4, B and D), whereas the
MyD88 pathway was not affected by the IRF3 deletion, as
revealed by p38 MAPK activation. These data demonstrate
that GAS has the ability to induce IFN- synthesis and IFN
signaling in a way that mechanistically resembles the IFN-
activation by intracellular Gram-positive pathogens.
GAS Stimulates IFN Signaling Independently of Cytolysins—
The TLR-independent IFN- induction by GAS was surpris-
ing, since GAS is generally regarded as an extracellular
pathogen that has only a limited capacity to survive in host
cells (4–7). For the so far characterized induction of IFN-
production by Gram-positive bacteria, the expression of
cytolysins was required (12, 23, 24). Cytolysins are thought
to enable cytoplasmic escape of phagocytosed bacteria. In
addition, cytolysins were also
shown to directly stimulate IFN
production (25). The GAS genome
contains genes for two cytolysins.
The slo gene encodes SLO (strep-
tolysin O), which resembles other
known cytolysins (e.g. listeriolysin,
pneumolysin, and anthrolysin) in
terms of sequence, sensitivity to
oxygen, and cholesterol binding
(59, 60). The other cytolysin, SLS
(streptolysin S), is encoded by the
sagA gene, which is unrelated to
the cholesterol-binding cytolysins
(60). To examine whether the
GAS-derived cytolysins play a role
in GAS-induced IFN signaling,
sagA (SLS)-deficient, slo (SLO)-
deficient, and double sagA/slo-de-
ficient mutants were generated
and used in infection assays. Anal-
ysis of Stat1 activation revealed
that neither the deletion of the sin-
gle cytolysin genes (data not
shown) nor the double deletion
(Fig. 5A) caused a reduction of
GAS-induced IFN signaling. The
inflammatory signaling was also
not dependent on the expression
of the GAS cytolysins, as shown by
p38 MAPK activation (Fig. 5B).
These findings suggest that the
ability of GAS to induce IFN-
synthesis may not require a con-
tact of GAS components with the
still unknown cytoplasmic recep-
tor that is used by other Gram-positive bacteria for IFN-
induction.
DISCUSSION
GAS is the etiological agent of a variety of human diseases.
The heterogeneity of GAS diseases arises in part from the high
diversity of GAS-mediated host-pathogen interactions in
which virulence factors, GAS genome composition, prophage
DNA, and plasticity of the GAS transcriptome play key roles (2,
61–64). A major factor influencing the severity of GAS infec-
tions is also the genetic inventory of the host. In humans, the
differences in susceptibility to severe GAS diseases were
mapped to the major histocompatibility complex locus (65).
More severe infections and a generalized toxic shock syndrome
appear to be associated with higher expression of inflammatory
cytokines in both humans and mice (66). Cytokine production
in GAS responses is regulated by T cells through GAS superan-
tigens and the as yet poorly understood activation of innate
immune cells. Our findings demonstrate that GAS is able to
induce cytokines in macrophages through MyD88-dependent
and -independent pathways. The identity of the GAS-recogniz-
ing receptor upstream of MyD88 poses an intriguing question,
FIGURE 4.GAS-induced IFN signaling depends on IRF3 and IFNAR1. A and B, BMDMs from control (WT),
IFNAR1/ (A), and IRF3-deficient (IRF3/) (B) mice were infected with GAS (MOI 100), and whole cell
extracts were prepared 2.5, 4, and 6 h postinfection. Stat1 Tyr701 phosphorylation and expression were
determined by Western blotting using antibody to phosphorylated Stat1 (pY-S1) and total Stat1. Differ-
ences in Stat1 expression levels were revealed by reprobing the membrane with antibody to total p38
MAPK (p38). C andD, BMDMs from IFNAR1/ (C), IRF3/ (D), and control (WT) mice were exposed to GAS
for the indicated times, and total mRNA was extracted, reverse-transcribed, and analyzed by qRT-PCR for
Mx2 after normalization to GAPDH. E, BMDMs from IFNAR1/ and control (WT) mice were infected with
GAS (MOI 100). IFN- expression was analyzed by qRT-PCR after normalization to GAPDH. Bars, S.D. of
three experiments.
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since our study rules out the exclusive involvement of the most
prominent bacteria-recognizing receptors, TLR2, TLR4, and
TLR9, or their combination. Other MyD88-dependent TLRs
are the flagellin receptor TLR5 and the single-stranded RNA
receptors TLR7 and TLR8 (8). Involvement of these receptors
inGAS-inducedMyD88-dependent signaling is not likely, since
flagellin or a similar protein has not been found in GAS, and
single-stranded RNA is associated with viral recognition. How-
ever, the role of these receptors cannot be entirely excluded,
because PRRs are, in general, not specific for a single molecule.
For example, TLR2 was reported to cooperate with dectin-1 in
recognition of fungi (67). We ruled out the role of signaling
through the IL-1R, which is known to be MyD88-dependent.
IL-1 can be released by infected cells as a result of inflamma-
some-mediated caspase 1 activation, which is required for
IL-1 processing (68). Although we did not address the GAS-
mediated IL-1 production, a role for IL-1 as a possiblemediator
of the MyD88-dependent responses can be excluded. A func-
tion of IL-18 as another molecule requiring MyD88 for signal-
ing is rather unlikely, since the IL-18 receptor is predominantly
expressed onTh1 cells, whereas a prolonged treatmentwith e.g.
IL-18 plus IL-12 is required for stronger expression in mono-
cytic cells (69, 70). The ability of GAS to induce MyD88-de-
pendent signaling independently of TLR2/4/9 may not be
unique, since other Gram-positive pathogens have been
reported to initiate inflammatory responses in the absence of
multiple TLRs. For example, heat-inactivated group B strepto-
cocci and Streptococcus pneumoniae as well as spores of Bacil-
lus anthracis induce MyD88-dependent responses in TLR2-,
TLR4-, and TLR9-deficient macrophages or splenocytes (71–
73). Despite the fact that TLR2/4/9 triple-deficient cells were
not used in these studies, they support our hypothesis that some
Gram-positive pathogenic bacteria are recognized by an as yet
unidentified receptor upstream of MyD88.
The surprising finding thatGAS is able to induce IFN- inde-
pendently of cytolysins represents another so far unique feature
of GAS-induced responses in innate immune cells. In this
regard, GAS-derived streptolysins are different from several
other cytolysins that have been reported to induce IFN- syn-
thesis through activation of TLR4 (25). Another proposed
mechanism of IFN- induction by Gram-positive bacteria (e.g.
L. monocytogenes) involves listeriolysin O-dependent libera-
tion of bacteria and/or bacterial components from phagosomes
(12, 23, 24). Although GAS is a prototype extracellular patho-
gen, it can be efficiently internalized by many phagocytic and
nonphagocytic cells. However, GAS survives only for a short
period of time in host cells due to degradation in lysosomal and
autophagosomal compartments (5, 6). Interestingly, Bacillus
subtilis engineered to express streptococcal SLOwasnot able to
survive or multiply in infected cells, as opposed to listeriolysin
O-expressing B. subtilis (74). This observation suggests that
SLO,which displays a high degree of similaritywith listeriolysin
O, cannot mediate cytoplasmic escape. Thus, the reported data
together with our findings support the hypothesis that GAS
stimulates IFN- synthesis by a novel mechanism that does not
require cytoplasmic escape. Interestingly, the signaling events
that culminate in Stat1 activation and transcription of IFN-
responsive genes follow the well established pathway involving
the transcription factor IRF3 and the type I IFN receptor but
independent of MyD88. The increased IFN signaling in
MyD88/ cells may be explained by reduced expression of the
inhibitor of IFN signaling SOCS1 (75). SOCS1 expression is
known to be dependent on p38 MAPK (76), which we show in
our study to be strongly reduced in GAS-infected MyD88/
cells.
Ourwork demonstrates the ability ofGAS to inducemultiple
inflammatory responses via in part novel recognition mecha-
nisms. MyD88-dependent TLR2/TLR4/TLR9-independent
signaling and cytolysin-independent IFN- induction are so far
exceptional characteristics of host cell responses to infection.
SinceGAS induces proinflammatory cytokine and IFN produc-
tion in human macrophages (51), we assume that our findings
are not restricted to themurine system, which, in the context of
the whole organism, is considerably more resistant to GAS
infection (66). The efficient stimulation of multiple signaling
pathways may contribute to the known high capability of GAS
to cause severe inflammatory diseases.
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5) DISCUSSION  
 
5.1 Project 1: Lysogenic transfer of Group A streptococcus superantigen gene 
among streptococci 
 
An unexplained resurgence of GAS infections observed since mid 1980s. Since then the 
occurrence of new and more severe infections has been observed. Particularly STSS 
caused by GAS was reported from Europe, USA and Japan (Cunningham, 2000) and 
SPEs were found to be involved in the pathogenesis of Streptococcal diseases. 
Furthermore GCSE and GGSE which are normally regarded as commensal organisms 
were found associated with streptococcal toxic shock syndrome (Hashikawa et al., 2004). 
The question arises whether the increase in severe forms of infections by GAS is due to 
enhanced virulence of the pathogen itself or it is due to impairment in the host system. 
Many attempts to correlate a particular severe infection with a particular M serotype, 
could not establish a positive correlation between the two. 
In GAS, bacteriophage-encoding virulence factors play a significant role in the evolution 
and the diversification of clones. Prophages constitute ~15% of the total GAS genome. 
Each of the 12 complete genome sequences of GAS contains 2 to 8 prophages per 
genome (Fischetti, 2007). Since many prophages contain putative or proven virulence 
genes on the integrated phage genome, the situation is highly conducive that GAS 
virulence factors can be transferred from one bacterium to others by lysogenic 
conversion.  
Among bacterial virulence factors, superantigens are one of the most potent 
immunomodulatory agents. SSA is one of the widely distributed SAgs in S. pyogenes, 
which can generate symptoms like STSS. Three ssa alleles were found in the natural 
population of S. pyogenes, while ssa-3 was the most predominant. SSA displays greater 
homology to the staphylococcal enterotoxins SEB and SEC rather than to the 
characterized streptococcal SAgs. A considerable number of superantigens are carried by 
prophages (SpeA, SpeC, SpeH, SpeI, SpeK, SpeL, SpeM and SSA). Superantigen 
carrying bacteriophages have the capability to convert a non toxigenic strain into a 
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toxigenic strain via lysogenic conversion thus enhancing the virulence of the strains. 
Initial studies based on the hypothesis of intergeneric gene transfer, did not identify the 
ssa gene in Staphylococcus aureus clones and in Lancefield group B, C, or G streptococci 
(Reda et al., 1996). However, later on, the identification of ssa in clinical isolates of 
GCSE and GGSE raised the possibility of interspecies gene exchange (Igwe et al., 2003). 
In this study, while trying to identify superantigen-encoding phages that could be 
released under mitomycin C treatment, we found φ149 from an M12 clinical isolate 
carrying the ssa-3 allele. In addition to be induced by mitomycin C, φ149 release was 
also induced by hydrogen peroxide and ultraviolet radiation, which shows that φ149 is 
inducible and not a simply defective prophage like element. Sequence analysis of the att-
L proximal region showed that φ149 is a chimeric phage as it shared one part of the 
phage sequence with φ370.2, φSPsP4, φ315.3 and φ370.2-like phages while the other part 
with φ315.2 and SPsP6 phages. This indicates that the recombination events have taken 
place in φ149 making it a chimeric phage. Later on, the complete genome sequence of 
MGAS10750 revealed φ10750.3 in an M4 serotype that harbours 100% att-L proximal 
region sequence to that of φ149 (Beres et al., 2006). By performing lysogenization 
experiments we could show that φ149 can lysogenize seven different M serotypes (M1, 
M3, M5, M12, M19, M28 and M94) as well as the GCSE clinical isolates. Furthermore, 
φ149 could be transferred back from selected GAS and GCSE lysogenized strains to M12 
serotype, showing that once the phage is integrated in the chromosome of the recipient 
strain, still the phage is active and can again infect other strains when a favorable 
condition is encountered. However lysogenic conversion could not be shown with GGSE. 
As some SAgs including the ssa-3 allele have already been detected in GGSE (Igwe et 
al., 2003), we think that such event can also be possible but the experimental conditions 
used in this study were most likely not optimal enough for their detection. This is the first 
direct experimental evidence of toxigenic conversion via lysogeny among several GAS 
serotypes and between GAS and GCSE. 
In agreement to our data, recently a chimeric phage, φ3396, was isolated from GGSE, 
that not only exhibits high homology to φ315.1 of GAS phage but also the flanking genes 
of the 2 phages are the same, indicating that phage φ3396 has transferred to GGSE from 
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GAS by horizontal transfer (Davies et al., 2007). Not only many GCS and GGS possess 
genes that encode molecules similar to SAgs but as well many GAS superantigens show 
sequence similarity to non-GAS superantigens indicating horizontal gene transfer (Zhao 
et al., 2007). In addition, the globally disseminated clone M1T1 acquired several 
virulence factors, which also indicate the genetic exchange among streptococci (Aziz et 
al., 2005; Aziz & Kotb, 2008). 
Our data strongly support the hypothesis that the spread of superantigen genes in GCSE 
and GGSE have occurred by means of horizontal gene transfer from GAS using 
temperate phages. This event is quite likely as S. pyogenes and GCSE are 
phylogenetically closely related. Our data also question the validity of an old concept that 
M protein acts as a barrier for bacteriophage infection and bacteriophage transfer from 
one serotype to others (Cleary & Johnson, 1977; Spanier & Cleary, 1980), as our data 
establish the role of phage in the spread of virulence factors among the GAS population. 
It is quite evident now that bacteriophages are the major contributors to the genotype 
diversity and to the alteration of the pathogenic potential in GAS. Apart from enhancing 
the virulence repertoire of streptococci, acquisition of phage-encoded genes might also 
promote the colonization to new hosts or new ecological niches, enhanced survival, 
immune evasion and the emergence of fitter clones.  
Given the significant role of prophages in toxigenic conversion and evolution of GAS 
strains, it would be important that additional information is obtained to fully understand 
the mechanisms of toxigenic conversion, transcriptional control of phage-encoded 
virulence factors, in vivo gene transfer, and effect of environmental signals or host 
signals. Simultaneously sequencing of the additional genomes would increase our 
knowledge about new prophage-encoded virulence factors and contribute to the advance 
understanding of the complex host-GAS interactions. 
 
5.2 Project 2: A bioinformatic screen reveals novel small non-coding RNAs in 
Streptococcus pyogenes 
 
In order to cause successful infection, bacterial pathogens need to control their virulence 
expression according to environmental signals. Up to recently, virulence gene expression 
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was thought to be mainly controlled by activator or repressor proteins. However it is 
quite evident now that sRNAs regulate gene expression more than previously anticipated 
(Johansson & Cossart, 2003; Shimizu et al., 2002). In recent years, the combination of 
computational and molecular approaches has led to the identification of an increasing 
number of small, noncoding RNAs in bacteria (e.g. more than 80 small regulatory RNAs 
in E. coli). However, only a subset of these RNAs has been characterized. The most 
studied example of a regulatory RNA controlling bacterial virulence is the 512-nucleotide 
long RNAIII of Staphylococcus aureus, which affects both transcription and translation 
of virulence genes. In addition to RNAIII, the recent work by Johansson and coworkers 
has shown that the control of virulence gene expression in Listeria monocytogenes is 
dependent on an RNA thermosensor, the untranslated 5'-end of the prfA transcript. 
Information regarding sRNAs in the important human pathogen S. pyogenes is rather 
limited. So far only 3 putative regulatory sRNAs have been identified in S. pyogenes: 
fasXRNA, pelRNA and rivXRNA. 
In this study we used a bioinformatic approach to identify novel sRNAs in S. pyogenes 
M1 strain SF370 as its whole genome is sequenced and it is one of the most 
representative serotypes. We used bioinformatic tools such as ‘QRNA’, ‘RNAz’, 
‘Alifoldz’, ‘sRNAPredict2’ and the Rfam database to predict potential ncRNAs in 
intergenic regions. All together, 218 predictions were found at 178 loci. Candidates were 
chosen for Northern blot analysis on the basis of sRNAPredict2 prediction, level of 
sequence conservation, presence of strong RIT, presence of promoter, absence of any 
putative ORF and RBS. 90 of the loci were verified by Northern blot analysis and 29 
sRNA (32%) were expressed under normal growth conditions. All of the selected 
candidates were mapped and analyzed for their stability, expression in stress conditions 
(pH, salt and temperature), secondary RNA structure prediction and mRNA target 
predictions. Overall we identified 5 riboswitches, 8 T-boxes, 5 ribosomal protein leaders, 
4 functional RNAs and 5 novel sRNAs.  
Comparing all the expressed RNA candidates to the Rfam database revealed 5 
riboswitches, which are yybP-ykoY, Glycine, Purine, TPP and FMN. In order to validate 
our predictions about riboswitches, we chose FMN as an example to characterize further. 
Remarkably, S. pyogenes lacks the riboflavin synthetic genes and therefore bacterial 
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growth depends strictly on uptake of the metabolites from the environment, which 
suggests an essentiality of the riboflavin transporter gene. Northern blot and RT-PCR 
analyses showed that the expression of riboflavin transporter was dependent on the 
absence of riboflavin from the growth medium. Similarly S. pyogenes also lacks the 
terminal tryptophan biosynthetic pathway, therefore the growth of bacterium depends on 
tryptophan uptake from the environment. One of the unknown sRNA, candidate 
SpyRNA069, was found in 5’ UTR region of gene Spy1016, which BLASTx analysis 
result indicated to be an ABC transporter substrate-binding protein, and which Panina et 
al. (2003) had predicted as tryptophan transporter. Northern blot and RT-PCR analyses 
indicated that indeed the Spy1016 gene has a role in tryptophan transport as this gene is 
expressed only in the absence of tryptophan from the growth medium. Our data shows 
that the metabolite transporter genes are controlled by sRNAs (residing in 5’ UTR) in a 
way that they are expressed only when bacteria are in need of that metabolite. Our data 
suggest also a direct or indirect effect of these metabolites on the expression of the 
downstream genes via transcriptional termination or translational attenuation mechanisms 
involving the 5’ UTR-located sRNAs. In B. subtilis, tryptophan biosynthesis genes are 
regulated either by tryptophan-activated RNA binding attenuation protein (TRAP) or by a 
T-box mechanism. In S. pyogenes, the TRAP protein-encoding gene is not present in the 
genome (Gutierrez-Preciado et al., 2007) and the T-box consensus sequence and the 
structural features involved in the codon-anticodon pairing are not evident in the Spy1016 
5’ UTR. Thus, the expression of the S. pyogenes tryptophan transporter is most likely 
regulated by transcriptional attenuation mechanism. In gram-positive bacteria 
transcriptional termination is the most widely seen mode of gene regulation mechanism 
(Winkler & Breaker, 2003), however to our knowledge transcription attenuation 
mechanism operating for a tryptophan transporter has not yet been reported. Thus, taken 
together vital components in the regulation of expression of these important genes reside 
in the 5’UTRs, indicating the importance of riboswitches and leader elements in S. 
pyogenes gene regulation. 
Our screen also revealed 5 novel sRNAs of unknown function. Three of these were 
located in 5’ UTRs, one in 3’ UTR while one was present in truly intergenic region. 
sRNA candidate SpyRNA049, which was truly present in the intergenic region, could be 
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a trans-acting regulatory sRNA. mRNA target analysis suggested the CAMP factor gene 
cfa as its target, as the 3’ end of SpyRNA049 was base pairing with the 5’ end of the cfa 
gene. As CAMP protein has been suggested to have a role in pathogenicity (Jurgens et 
al., 1987), it was interesting to verify this target. But surprisingly, this base pairing also 
included the promoter region of the cfa gene, which either could be an artifact or a novel 
mechanism of regulation by sRNA binding to DNA. However, we could not observe an 
effect of SpyRNA049 at the level of transcription of cfa, but an effect at the level of 
translation can not be ruled out. SpyRNA049 is located near a CRISPR locus and 
immediately next to a CAS protein gene. As CRISPR has a role in defense against 
phages, it is possible that SpyRNA049 also has a role in this mechanism. But whether 
SpyRNA049 has a role associated with CRISPR in phage defense needs to be 
investigated. Interestingly, two of the novel sRNA candidates. SpyRNA014 and 
SpyRNA027 were found next to scpA, a gene encoding the virulence factor C5a 
peptidase and putative cardiolipin synthetase gene respectively. Thus novel sRNAs might 
play a role in the pathogenicity of S. pyogenes by regulating the expression of virulence. 
Therefore, it would be interesting to further characterize these candidates and explore 
their function in the pathogenicity, metabolism and physiology of bacteria. 
Our bioinformatic screen identified eight T-boxes, which are alaS, glyQS, ileS, pheST, 
thrS, trsA, valS and serS. T-boxes were identified on the basis that these contained 18 nt 
T-box consensus sequence in the leader region and by pattern search program “fuzznuc”.  
In gram-positive bacteria, the expression of many amino acid biosynthesis genes is 
regulated by T-box terminator-antiterminator mechanism (Grundy & Henkin, 1993). In S. 
pyogenes 7 out of 19 aminoacyl-tRNA synthetases (AARS) are regulated via a T-box 
mechanism (Steiner & Malke, 2001). 
Five ribosomal protein leaders namely as L10, L13, L19, L20 and L21 were identified 
during the screen. In bacteria, ribosomal protein leaders are mainly regulated at the 
translational level by protein-mediated autoregulatory process. It is mainly described in E 
coli, where a protein released from the operon binds to its own mRNA and inhibits its 
translation (Haentjens-Sitri et al., 2008; Zengel & Lindahl, 1994). There is limited 
information regarding the mechanism of ribosomal protein control in gram-positive 
bacteria, however it indicates rather a transcription attenuation mechanism (Choonee et 
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al., 2007). It would be interesting to investigate the mechanism of ribosomal proteins 
expression control in S. pyogenes. 
This study is the first genomic search for sRNAs in the notorious human pathogen S. 
pyogenes and the first information regarding novel sRNAs, riboswitches, T-boxes and 
functional RNAs on a genome-wide basis. The discovery of riboswitches has helped to 
know the functions of many uncharacterized genes. Studies are further required as there 
may be a wide variety of molecular mechanisms for the control of gene regulation 
employed by riboswitches. As S. pyogenes is a poly-auxotrophic organism, it seems that 
it relies heavily on riboswitches for the control of important metabolite transport from the 
environment. Given the importance of riboswitches in bacteria, these might also serve as 
novel drug targets for the development of new classes of antibiotics. It would be 
interesting to further study novel sRNAs identified by in silico search to reveal their 
function and determine their role in pathogenicity and physiology of bacteria. As most of 
the sRNA candidates found in this in silico search were cis-encoded, bioinformatic 
programs needed to be improved so that they can allow-identifying trans-encoded RNAs 
in gram-positive bacteria.  
 
5.3 Project 3: Functional analysis of the group A streptococcal luxS/AI-2 system in 
metabolism, adaptation to stress and interaction with host cells 
 
The luxS/AI-2 signaling pathway involved in cell-cell communication has been reported 
to interfere with important physiological and pathogenic functions in a variety of bacteria 
(Henke & Bassler, 2004; Vendeville et al., 2005). Two recent studies reported a role of 
luxS in the regulation of virulence gene expression in S. pyogenes (Lyon et al., 2001; 
Marouni & Sela, 2003). Here, we investigated the functional role of the luxS/AI-2 system 
in metabolism and diverse aspects of pathogenicity including the adaptation of the 
organism to stress conditions in two serotypes of S. pyogenes, M1 and M19.  
In our study luxS expression analysis showed a monocistronic transcript of 664 bases 
expressed in a growth-phase dependent manner in GAS serotypes M1 and M19 whereas, 
a previous study based on sequence analysis had predicted luxS expression to be 
polycistronic in M6 serotype (Lyon et al., 2001). Other studies showed that in 
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Streptococcus bovis, luxS is expressed in a growth phase-dependent manner but it was 
constitutively expressed in Salmonella typhimurium and V. fischeri (Asanuma et al., 
2004; Beeston & Surette, 2002; Lupp & Ruby, 2004). Similarly, in these species AI-2 
like activity was observed in a temporal manner but it was not corresponding to the luxS 
expression. In our study as well, in S. pyogenes AI-2 like activity peaked at late-
logarithmic phase, but luxS expression was already declining at that time point. In 
addition, induction experiments failed to show an auto-regulation mechanism of luxS 
expression i.e. regulation of luxS expression by AI-2, in GAS. Our results are in 
agreement with a previous study in S. typhimurium, where luxS expression and AI-2 like 
activity were not corresponding, thus suggesting that luxS expression was not regulated 
by AI-2 (Beeston & Surette, 2002).  
Many reports have hypothesized the role of luxS/AI-2 in bacterial metabolism. 
Interestingly in S. pyogenes the AMC is incomplete as it lacks homocysteine 
methyltransferases (MetE or MetH) which converts SAH-derived metabolic product 
homocysteine to methionine. However, S. pyogenes contains the SAM synthetase 
ortholog (MetK), which converts methionine to SAM. If there is defect in de novo 
methionine synthesis, bacterial growth would depend exclusively on sulfur from external 
sources. Our data showed that the decrease in cysteine and methionine from media had 
similar effect on the growth and yield of both wild-type and luxS deficient strains, thus 
indicating that S. pyogenes is unable to convert homocysteine to methionine and 
inactivation of luxS did not trigger a metabolic burden on bacteria. It has also been 
described in Borrelia burgdorferi that it cannot recycle homocysteine to methionine (von 
Lackum et al., 2006). Moreover, luxS-deficient strains did not have an effect on the 
viability and growth in various media including sulfur deficient minimal media, which 
suggest that luxS does not have an essential role in AMC-related metabolism. In S. 
pyogenes, recycling might be occurring by other types of methyltransferases.  
During infection, bacteria face many different environmental challenges. Bacteria need to 
develop an adaptive response according to the challenging host conditions encountered. 
As regulatory role of luxS has already been shown in virulence factor expression, we 
investigated its role in adaptation to host-induced stress conditions. Although we could 
not find a role of luxS in adaptation to oxidative and salt stress, the luxS-deficient strain 
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survived better under acidic conditions. Accordingly, luxS expression and AI-2 
production were also significantly lowered under low pH conditions. On the contrary, a 
previous study with S. mutans showed higher acid sensitivity (Sztajer et al., 2008; Wen & 
Burne, 2004) and increased luxS expression at low pH in the luxS deficient strain (Hasona 
et al., 2007; Lemos et al., 2004). But the acid tolerance results need to be considered in 
reference to the different living habitat and pathogenesis of GAS and S. mutans. 
Furthermore, luxS expression and AI-2 production also decreased when cells were grown 
in RPMI medium supplemented with 10% serum, considered to be a host environment-
mimicking medium. To further investigate that the down-regulation of luxS/AI-2 play a 
role when bacteria interact with host cells, we observed that luxS-deficient mutants 
survived 3 folds better in epithelial as well as in macrophage cells in both M1 and M19 
serotypes compared to the wild-type strains. However, we could not find a significant 
difference in adherence rates to epithelial cells between the wild-type and luxS-deficient 
strains. Marouni et al. (2003) had also found that a luxS-deficient mutant survived better 
than the wild-type strain in epithelial cells at 4 hours after infection in an M3 serotype. 
Our results indicate that lowering the luxS/AI-2 response provides bacteria an advantage 
to survive inside host cells during infections. 
After linking the role of luxS/AI-2 with adaptation to stress, we further wanted to 
investigate its role in virulence factor expression, as previous studies showed that luxS 
regulates SLS expression at transcriptional level and SpeB cysteine protease activity in an 
M6 serotype (Lyon et al., 2001), SpeB and M protein at the transcriptional level and 
hyaluronic acid capsule at the post-transcriptional level (Marouni & Sela, 2003). Our data 
adds fasX and sibA (psp) as two additional targets of luxS to the list. luxS exerts a positive 
effect on the expression of fasX, a regulatory small RNA affecting virulence factor 
expression and suggested to have a role in local tissue destruction and bacterial 
aggressiveness towards host cells (Klenk et al., 2005; Kreikemeyer et al., 2001). luxS 
exerts a negative effect on sibA (psp), which is a virulence gene encoding a secreted 
immunoglobulin binding protein (Fagan et al., 2001). However, luxS regulatory effects 
were seen only with M19 serotype, suggesting a strain or serotype dependent effects. 
luxS-strain specific manifestation of virulence-associated gene regulation was also 
observed in Neisseria meningitides and Serratia marcescens (Coulthurst et al., 2004; 
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Dove et al., 2003). Marouni et al. also attributed their dissimilar results with Lyon et al., 
study about the effect of luxS on bacterial growth and level of SpeB regulation to a strain-
specific effect (Marouni & Sela, 2003). Furthermore, differences in regulatory pathways 
among different GAS isolates can alter disease progression as mutations in the sensor 
encoding gene covS under selective pressure were shown to be correlated with human 
disease severity (Sumby et al., 2006; Walker et al., 2007).  
Together with earlier studies demonstrating a role for luxS in the regulation of virulence 
properties in GAS, we suggest that luxS is not exclusively a key part of a detoxification 
pathway but seems to provide GAS a tool allowing to thrive under conditions often 
encountered during infections.  
 
5.4 Project 4: Group A Streptococcus activates type I interferon production and 
MyD88-dependent signalling without involvement of TLR2, TLR4 and  TLR9 
 
GAS causes a variety of human diseases ranging from mild superficial infections like 
pharyngitis and impetigo to severe invasive infections like streptococcal toxic shock 
syndrome and necrotizing fasciitis. GAS ability to cause diversified diseases and the 
diversity of GAS-host interactions might be due to the fact that GAS has a number of 
properly regulated virulence factors, polylysogenization, GAS genome compositions and 
diversified transcriptome profiles. Host factors and interactions with the host cells also 
play major a role in the outcome of an infection. In this context, the activation of innate 
immune cells during GAS infections is poorly understood.  
Our study showed that GAS is able to induce cytokines from macrophages by MyD88-
dependent and independent pathways. Surprisingly, the induction was independent of the 
most commonly used receptors to recognize bacteria, TLR2, TLR4 and TLR9 and their 
combination. Remaining MyD88-dependent receptors flagellin recognizing TLR5 and 
single-stranded RNA recognizing TLR7 and TLR8 (Nakagawa et al., 2004) are unlikely 
to be used as GAS recognizing receptors as flagellin is absent in S. pyogenes and single-
stranded RNA are associated with viral recognition. However, roles of these receptors 
cannot be ruled out entirely as PRRs are not always specific for a single molecule like 
TLR2 also cooperate with dectin-1 to recognize fungi (Rogers et al., 2005). Other gram-
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positive pathogens have also been reported to induce MyD88-dependent signalling 
independent of multiple TLRs like heat-inactivated S. pneumoniae and group B 
streptococci as well as spores of Bacillus anthracis, which induce inflammatory 
responses in TLR2-, TLR4- and TLR9-deficient macrophages and splenocytes (Glomski 
et al., 2007; Henneke et al., 2002; Lee et al., 2007) though TLR2/4/9 triple-deficient cells 
were not used in these studies. Moreover, recently a study in dendritic cells deficient in 
TLR1, TLR2, TLR4, TLR9 and TLR2/6 were not impaired in the secretion of 
proinflammatory cytokines against S. pyogenes (Loof et al., 2008). All these findings are 
in accordance with our results that some gram-positive pathogens are recognized by a yet 
unidentified receptor upstream of MyD88.  
Yet another interesting finding was that IFN-β synthesis was still observed when GAS 
deficient in SLS and SLO was used for infection thus indicating that GAS induces IFN-β 
independent of cytolysins. Several cytolysins have been reported to induce IFN-β 
synthesis through TLR4-dependent pathway, however GAS cytolysins are different from 
other cytolysins reported to induce IFN-β synthesis (Park et al., 2004). In another IFN-β 
synthesis mechanism, L. monocytogenes induces IFN-β synthesis by involvement of 
escape from the phagosomes using listeriolysin O (O'Riordan et al., 2002; Stetson & 
Medzhitov, 2006; Stockinger et al., 2002). In the case of GAS, it is supposed to be an 
extracellular organism, however it can be internalized in many phagocytic and 
nonphagocytic cells (Thulin et al., 2006) but degraded in lysosomal and autophagosomal 
compartments quickly (Hakansson et al., 2005; Nakagawa et al., 2004). In a study where 
SLO and LLO were expressed from B. subtilis, only LLO-expressing B. subtilis could 
multiply and survive in infected cells (Portnoy et al., 1992). This indicates that although 
SLO shows high degree of sequence and functional similarity with LLO, it can not 
mediate cytoplasmic escape in GAS. All of these findings support the hypothesis that 
GAS induce IFN-β synthesis by a novel mechanism, which does not require cytoplasmic 
escape.  
GAS induces multiple inflammatory responses using novel recognition mechanisms. Our 
data reveal some unique features of bacterial recognition like MyD88-dependent 
TLR2/TLR4/TLR9-independent signalling and cytolysin-independent IFN-β induction, 
by which GAS induces host cell responses to infection. Our findings are not only 
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restricted to the murine system as GAS also induces proinflammatory cytokines and IFN 
production in human macrophages (Medina & Lengeling, 2005). The ability of GAS to 
cause severe inflammatory diseases may be in part also because it can efficiently 
stimulate multiple signalling pathways. 
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